primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
155469667,15546966,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230129.0,20181024,20230207,EXP,,CA-TEVA-2018-CA-967835,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Muscular weakness,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Condition aggravated,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Decreased activity,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Malaise,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Pain,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1562023914,15620239,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,14,F,20180119.0,20230201.0,20181115,20230207,EXP,,JP-ABBVIE-18P-087-2319797-00,ABBVIE,,40.0,YR,,M,Y,95.9,KG,20230207,,MD,JP,JP,2023,Q1,Adult
1566392239,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Tubulointerstitial nephritis,,2023,Q1,39,F,20181001.0,20230104.0,20181128,20230104,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K, et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; P31-2.",71.0,YR,E,M,Y,60.3,KG,20230104,,PH,JP,JP,2023,Q1,Elderly
1566392239,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Prescribed overdose,,2023,Q1,39,F,20181001.0,20230104.0,20181128,20230104,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K, et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; P31-2.",71.0,YR,E,M,Y,60.3,KG,20230104,,PH,JP,JP,2023,Q1,Elderly
1566392239,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Cardiogenic shock,,2023,Q1,39,F,20181001.0,20230104.0,20181128,20230104,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K, et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; P31-2.",71.0,YR,E,M,Y,60.3,KG,20230104,,PH,JP,JP,2023,Q1,Elderly
1566392239,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Immune-mediated myocarditis,,2023,Q1,39,F,20181001.0,20230104.0,20181128,20230104,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K, et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; P31-2.",71.0,YR,E,M,Y,60.3,KG,20230104,,PH,JP,JP,2023,Q1,Elderly
163850045,16385004,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,D,,,,,,,,,2023,Q1,Myocardial infarction,,2023,Q1,5,F,20190515.0,20190625.0,20190603,20230310,EXP,,CA-JNJFOC-20190538025,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,103.0,KG,20230310,,MD,CA,CA,2023,Q1,Adult
1656345014,16563450,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
1656345014,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,14,F,,20221221.0,20190712,20230104,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230104,,MD,CA,CA,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Disease progression,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Neutrophil percentage increased,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Hypotension,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Dehydration,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Cerebral infarction,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Cardiac failure chronic,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Monocyte percentage decreased,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Low cardiac output syndrome,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Lymphocyte percentage decreased,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,C-reactive protein increased,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
166517589,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q1,Red blood cell count increased,,2023,Q1,9,F,20190710.0,20230221.0,20190731,20230224,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230224,,MD,JP,JP,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Overdose,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Overdose,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Overdose,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
1722313911,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,11,F,,20230302.0,20200102,20230323,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230323,,MD,CA,,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,15,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
178539486,17853948,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,6,F,,20230216.0,20200603,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-026822",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,101.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Sepsis,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Kidney infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Neuralgia,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Musculoskeletal pain,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Pain in extremity,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Therapeutic response shortened,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Paranasal cyst,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Malaise,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Weight decreased,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Viral infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Constipation,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Tympanic membrane perforation,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Bronchitis,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Ear infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Neck pain,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Urinary tract infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Weight increased,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Polyp,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Blood pressure systolic increased,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Tinnitus,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Heart rate increased,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hypotension,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Influenza,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Sinusitis,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Fungal infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Eyelid infection,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Ear disorder,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
179072094,17907209,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,4,F,,20230303.0,20200617,20230307,EXP,,CA-ROCHE-2619589,ROCHE,,61.0,YR,,F,Y,122.0,KG,20230307,,HP,CA,,2023,Q1,Adult
1793661310,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,32,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,32,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,32,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,32,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
1793661310,17936613,32,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,10,F,,20230224.0,20200624,20230307,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230307,,CN,CA,CA,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Perirectal abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Anal abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Urinary tract infection,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Sepsis,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Depression,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Genital abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Anal abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Soft tissue necrosis,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Cellulitis,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Fournier's gangrene,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Subcutaneous abscess,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Skin disorder,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Abscess limb,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
183645265,18364526,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Gangrene,,2023,Q1,5,F,20181001.0,20230109.0,20201009,20230117,EXP,,US-AstraZeneca-2020SF28034,ASTRAZENECA,,445.0,MON,,M,Y,,,20230117,,LW,US,,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Expired product administered,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Urinary tract infection,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Bladder cancer,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Needle issue,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Device infusion issue,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Illness,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Infusion site pain,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Death,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Lower respiratory tract infection,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
187421916,18742191,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,6,F,20200916.0,20230112.0,20210114,20230117,EXP,,IE-SHIRE-IE202020753,TAKEDA,,84.0,YR,,M,Y,,,20230117,,CN,IE,IE,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,50,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
189784165,18978416,51,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,5,F,,20230222.0,20210307,20230303,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
190017742,19001774,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,2,F,,20230118.0,20210312,20230127,EXP,,CA-JNJFOC-20210316789,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Elderly
190017742,19001774,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230118.0,20210312,20230127,EXP,,CA-JNJFOC-20210316789,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Elderly
190017742,19001774,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230118.0,20210312,20230127,EXP,,CA-JNJFOC-20210316789,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Elderly
190017742,19001774,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,2,F,,20230118.0,20210312,20230127,EXP,,CA-JNJFOC-20210316789,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Elderly
190017742,19001774,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,2,F,,20230118.0,20210312,20230127,EXP,,CA-JNJFOC-20210316789,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1901242933,19012429,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,33,F,,20230303.0,20210315,20230310,EXP,,CA-TAKEDA-2021TJP006850,TAKEDA,,76.0,YR,,F,Y,,,20230310,,MD,CA,CA,2023,Q1,Elderly
1902563538,19025635,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (tablet),,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
1902563538,19025635,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK(Tablet),,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,38,F,,20230313.0,20210318,20230317,EXP,,CA-PFIZER INC-2021284310,MYLAN,,76.0,YR,,F,Y,,,20230317,,CN,CA,CA,2023,Q1,Elderly
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug intolerance,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Anti-cyclic citrullinated peptide antibody positive,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug hypersensitivity,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hypertension,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hand deformity,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Synovitis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone erosion,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Psoriatic arthropathy,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pruritus,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase increased,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Skin injury,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Infection,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Rheumatoid arthritis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Product use issue,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase abnormal,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic response decreased,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug-induced liver injury,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone cyst,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Upper respiratory tract infection,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Liver disorder,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Transaminases increased,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein abnormal,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Osteolysis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint swelling,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diarrhoea,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pain,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspepsia,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Treatment failure,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrointestinal infection,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthropathy,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Red blood cell sedimentation rate abnormal,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug ineffective,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Abdominal discomfort,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic fibrosis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein increased,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint ankylosis,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
190983484,19098348,41,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Nausea,,2023,Q1,4,F,,20230110.0,20210406,20230123,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Device infusion issue,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Infusion site swelling,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Upper respiratory tract infection,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Injection site mass,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Injection site swelling,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Injection site oedema,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Anal abscess,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194071394,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Injection site pain,,2023,Q1,4,F,20210201.0,20230310.0,20210611,20230321,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.773,KG,20230321,,CN,CA,CA,2023,Q1,Adult
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Gait disturbance,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Musculoskeletal toxicity,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Muscle disorder,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Drug-induced liver injury,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Drug interaction,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Drug level increased,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Laboratory test abnormal,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Toxicity to various agents,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Drug level above therapeutic,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Hepatocellular injury,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q1,Rhabdomyolysis,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Gait disturbance,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Musculoskeletal toxicity,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Muscle disorder,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Drug-induced liver injury,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Drug interaction,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Drug level increased,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Laboratory test abnormal,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Toxicity to various agents,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Drug level above therapeutic,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Hepatocellular injury,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
194193872,19419387,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,,2023,Q1,Rhabdomyolysis,,2023,Q1,2,F,,20230224.0,20210615,20230306,EXP,,CA-TEVA-2021-CA-1921721,TEVA,,76.0,YR,E,F,Y,,,20230306,,HP,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Intentional product use issue,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
200638997,20063899,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20221226.0,20211112,20230105,EXP,CA-MHPD-E2B_03478055,CA-Accord-244860,ACCORD,,73.0,YR,E,F,Y,101.0,KG,20230105,,CN,CA,CA,2023,Q1,Elderly
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure systolic decreased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Weight fluctuation,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Nasal congestion,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Abdominal pain upper,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure systolic abnormal,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Nasopharyngitis,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Road traffic accident,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Medication error,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Muscle tightness,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Peripheral swelling,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Nasopharyngitis,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Swelling face,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Oropharyngeal pain,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Tooth disorder,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Bronchitis,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Disability assessment scale score increased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Lower respiratory tract congestion,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Soft tissue injury,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Lower respiratory tract infection,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Sinus congestion,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Bladder disorder,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Cough,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure decreased,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201507304,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,4,F,,20230109.0,20211206,20230113,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,85.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
201787727,20178772,23,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,peroral medicine,QD,2023,Q1,Pneumonia,,2023,Q1,7,F,20181115.0,20221222.0,20211214,20230103,EXP,,JP-JNJFOC-20211206069,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,36.9,KG,20230104,,MD,JP,JP,2023,Q1,Elderly
201787727,20178772,23,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,peroral medicine,QD,2023,Q1,Right ventricular failure,,2023,Q1,7,F,20181115.0,20221222.0,20211214,20230103,EXP,,JP-JNJFOC-20211206069,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,36.9,KG,20230104,,MD,JP,JP,2023,Q1,Elderly
201787727,20178772,23,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,peroral medicine,QD,2023,Q1,Middle lobe syndrome,,2023,Q1,7,F,20181115.0,20221222.0,20211214,20230103,EXP,,JP-JNJFOC-20211206069,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,36.9,KG,20230104,,MD,JP,JP,2023,Q1,Elderly
201787727,20178772,23,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,peroral medicine,QD,2023,Q1,Disease progression,,2023,Q1,7,F,20181115.0,20221222.0,20211214,20230103,EXP,,JP-JNJFOC-20211206069,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,36.9,KG,20230104,,MD,JP,JP,2023,Q1,Elderly
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Joint injury,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Muscle strain,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Fall,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Nervousness,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Tooth fracture,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Alopecia,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Immunosuppression,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Limb injury,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Myalgia,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Discomfort,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Rhinitis allergic,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Inflammation,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Pulpitis dental,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Arthritis,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Nasal congestion,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Rhinorrhoea,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Exposure to SARS-CoV-2,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Mobility decreased,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Dry throat,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Gait disturbance,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202403345,20240334,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q1,Product use issue,,2023,Q1,5,F,,20230321.0,20211228,20230329,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Platelet count decreased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Ill-defined disorder,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Haematocrit decreased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dyslipidaemia,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Illness,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Acute respiratory distress syndrome,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Eosinophil percentage increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Neutrophil count increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,White blood cell count increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Ocular hyperaemia,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Basophil percentage increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Red cell distribution width increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Low density lipoprotein increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood creatinine increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Deformity thorax,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Protein urine present,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood cholesterol increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,C-reactive protein increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Influenza,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Red blood cell count increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Basophil count increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Malaise,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood triglycerides increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Back pain,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Creatinine urine increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Osteoarthritis,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hepatitis B surface antibody positive,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Lymphocyte percentage increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,High density lipoprotein decreased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Haemoglobin increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Very low density lipoprotein increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Alanine aminotransferase increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,COVID-19 pneumonia,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Influenza,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Product supply issue,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypersensitivity,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Red blood cell sedimentation rate increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Plantar fasciitis,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Lymphadenopathy,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Lymphocyte count increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Photosensitivity reaction,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
204092398,20409239,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Adjusted calcium increased,,2023,Q1,8,F,20190917.0,20230130.0,20220201,20230202,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20230202,,CN,CO,CO,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Crohn's disease,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Intentional product use issue,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Visual impairment,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Ocular discomfort,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
205710093,20571009,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,3,F,,20230321.0,20220309,20230331,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-05496,SAMSUNG BIOEPIS,,48.0,YR,A,F,Y,88.0,KG,20230331,,HP,CA,CA,2023,Q1,Adult
207022383,20702238,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd (100 ng, 1x/day)",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Cardiac failure congestive,,2023,Q1,3,F,20200201.0,20230110.0,20220412,20230112,EXP,,TW-PFIZER INC-202200532661,MYLAN,"Lin, C.. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. International Journal of Clinical and Experimental Medicine. 2022;15(2):68-73",60.0,YR,,M,Y,,,20230112,,MD,TW,TW,2023,Q1,Adult
207022383,20702238,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd (100 ng, 1x/day)",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Hydronephrosis,,2023,Q1,3,F,20200201.0,20230110.0,20220412,20230112,EXP,,TW-PFIZER INC-202200532661,MYLAN,"Lin, C.. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. International Journal of Clinical and Experimental Medicine. 2022;15(2):68-73",60.0,YR,,M,Y,,,20230112,,MD,TW,TW,2023,Q1,Adult
207022383,20702238,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd (100 ng, 1x/day)",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Pneumothorax,,2023,Q1,3,F,20200201.0,20230110.0,20220412,20230112,EXP,,TW-PFIZER INC-202200532661,MYLAN,"Lin, C.. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. International Journal of Clinical and Experimental Medicine. 2022;15(2):68-73",60.0,YR,,M,Y,,,20230112,,MD,TW,TW,2023,Q1,Adult
207022383,20702238,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd (100 ng, 1x/day)",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Renal impairment,,2023,Q1,3,F,20200201.0,20230110.0,20220412,20230112,EXP,,TW-PFIZER INC-202200532661,MYLAN,"Lin, C.. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. International Journal of Clinical and Experimental Medicine. 2022;15(2):68-73",60.0,YR,,M,Y,,,20230112,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Pneumothorax,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Hydronephrosis,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Renal failure,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Cardiac failure congestive,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Pneumonia,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
207095142,20709514,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 nanogram, qd",,,Y,U,,,,100.0,NG,,QD,2023,Q1,Pleural effusion,,2023,Q1,2,F,,20230110.0,20220414,20230117,EXP,,TW-MYLANLABS-2022M1027166,MYLAN,"Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. IJCEM 2022;15(2):68-73.",60.0,YR,,M,Y,,,20230117,,MD,TW,TW,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hand deformity,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Rheumatoid arthritis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint ankylosis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hypertension,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone cyst,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug intolerance,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diarrhoea,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Abdominal discomfort,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Skin injury,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Psoriatic arthropathy,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthropathy,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Anti-cyclic citrullinated peptide antibody positive,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Synovitis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Red blood cell sedimentation rate abnormal,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug ineffective,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase abnormal,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic fibrosis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein abnormal,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone erosion,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspepsia,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pruritus,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrointestinal infection,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Nausea,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Infection,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Osteolysis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Treatment failure,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Transaminases increased,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug-induced liver injury,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug hypersensitivity,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint swelling,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pain,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Upper respiratory tract infection,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein increased,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
208442765,20844276,47,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,5,F,,20230301.0,20220518,20230309,EXP,,NVSC2022CA110853,NOVARTIS,,61.0,YR,,M,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Mobility decreased,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Antinuclear antibody,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Vitamin D decreased,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Vitamin B12 decreased,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Sensory loss,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Immune-mediated myositis,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Muscular weakness,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Paraesthesia,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Suspected COVID-19,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Blood creatine phosphokinase increased,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210121082,21012108,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Liver disorder,,2023,Q1,2,F,20220428.0,20230126.0,20220627,20230203,EXP,,NVSC2022CA144681,NOVARTIS,,64.0,YR,,F,Y,72.56,KG,20230203,,CN,CA,CA,2023,Q1,Adult
210711283,21071128,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,153,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,153,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,153,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,153,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,153,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,154,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,154,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,154,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,154,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,154,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,155,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,155,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,155,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,155,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,155,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,156,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,156,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,156,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,156,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,156,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,196,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,196,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,196,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,196,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
210711283,21071128,196,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230111.0,20220712,20230119,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230119,,MD,CA,,2023,Q1,Elderly
211672975,21167297,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Protein urine,,2023,Q1,5,F,20220117.0,20230208.0,20220803,20230215,EXP,,JP-JNJFOC-20220804627,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,,,20230215,,MD,JP,JP,2023,Q1,Adult
211672975,21167297,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Urinary occult blood,,2023,Q1,5,F,20220117.0,20230208.0,20220803,20230215,EXP,,JP-JNJFOC-20220804627,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,,,20230215,,MD,JP,JP,2023,Q1,Adult
211672975,21167297,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q1,IgA nephropathy,,2023,Q1,5,F,20220117.0,20230208.0,20220803,20230215,EXP,,JP-JNJFOC-20220804627,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,,,20230215,,MD,JP,JP,2023,Q1,Adult
2118192413,21181924,44,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Acute kidney injury,,2023,Q1,13,F,20220729.0,20230222.0,20220807,20230224,EXP,,TW-ROCHE-3152629,ROCHE,,68.0,YR,,M,Y,,,20230224,,MD,TW,,2023,Q1,Elderly
2118192413,21181924,44,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Hyperglycaemia,,2023,Q1,13,F,20220729.0,20230222.0,20220807,20230224,EXP,,TW-ROCHE-3152629,ROCHE,,68.0,YR,,M,Y,,,20230224,,MD,TW,,2023,Q1,Elderly
2118192413,21181924,44,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Pneumonia,,2023,Q1,13,F,20220729.0,20230222.0,20220807,20230224,EXP,,TW-ROCHE-3152629,ROCHE,,68.0,YR,,M,Y,,,20230224,,MD,TW,,2023,Q1,Elderly
2118192413,21181924,44,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Acute kidney injury,,2023,Q1,13,F,20220729.0,20230222.0,20220807,20230224,EXP,,TW-ROCHE-3152629,ROCHE,,68.0,YR,,M,Y,,,20230224,,MD,TW,,2023,Q1,Elderly
212012793,21201279,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd, HS",,,,,,,,100.0,MG,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,3,F,20190104.0,20220906.0,20220811,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005977,AEGERION,,12.0,YR,,F,Y,42.8,KG,20230207,,HP,US,US,2023,Q1,Child
212012793,21201279,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd, HS",,,,,,,,100.0,MG,,QD,2023,Q1,Treatment noncompliance,,2023,Q1,3,F,20190104.0,20220906.0,20220811,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005977,AEGERION,,12.0,YR,,F,Y,42.8,KG,20230207,,HP,US,US,2023,Q1,Child
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Pulmonary embolism,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Deep vein thrombosis,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Multiple allergies,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Chronic obstructive pulmonary disease,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Mycobacterial infection,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Respiratory failure,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Lung disorder,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Productive cough,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Bronchiectasis,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Obesity,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Asthma-chronic obstructive pulmonary disease overlap syndrome,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Renal failure,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Obstructive airways disorder,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212086212,21208621,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,100.0,MG,,QD,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230119.0,20220812,20230125,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186572",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,128.0,KG,20230125,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Multiple allergies,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Respiratory failure,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Chronic obstructive pulmonary disease,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Mycobacterial infection,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Productive cough,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Pulmonary embolism,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Deep vein thrombosis,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Bronchiectasis,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Renal failure,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Asthma-chronic obstructive pulmonary disease overlap syndrome,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Obstructive airways disorder,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Obesity,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212147982,21214798,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q1,Lung disorder,,2023,Q1,2,F,,20230119.0,20220816,20230123,EXP,,CA-BAUSCH-BL-2022-020150,BAUSCH AND LOMB,,70.0,YR,,M,Y,128.0,KG,20230123,,HP,CA,CA,2023,Q1,Elderly
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
213164813,21316481,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,UNK,,2023,Q1,Diabetes mellitus,,2023,Q1,3,F,20180725.0,20230209.0,20220910,20230219,EXP,,JP-ABBVIE-22P-087-4533465-00,ABBVIE,,34.0,YR,,M,Y,70.3,KG,20230219,,MD,JP,JP,2023,Q1,Young Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213797467,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,272,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,272,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,272,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,272,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,272,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,273,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,273,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,273,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,273,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,273,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,274,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,274,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,274,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,274,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,274,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,275,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,275,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,275,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,275,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,275,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
213797467,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,7,F,,20230321.0,20220927,20230329,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230329,,HP,CA,CA,2023,Q1,Elderly
214163752,21416375,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Bradycardia,,2023,Q1,2,F,20210709.0,20230217.0,20221006,20230221,EXP,,JP-GILEAD-2022-0600072,GILEAD,,64.0,YR,A,M,Y,93.0,KG,20230221,,PH,JP,JP,2023,Q1,Adult
214522022,21452202,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 mg,,,,,,,,,,,,2023,Q1,Pemphigus,,2023,Q1,2,F,20220721.0,20230207.0,20221013,20230210,EXP,,JP-AstraZeneca-2022A267148,ASTRAZENECA,,65.0,YR,,M,Y,53.0,KG,20230210,,MD,JP,,2023,Q1,Elderly
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,C-reactive protein increased,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Hepatic steatosis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,C-reactive protein abnormal,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Treatment failure,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Infection,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Hand deformity,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Arthropathy,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Abdominal discomfort,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Drug-induced liver injury,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Anti-cyclic citrullinated peptide antibody positive,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Alanine aminotransferase abnormal,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Pruritus,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Bone cyst,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Skin injury,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Hepatic cirrhosis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Drug intolerance,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Transaminases increased,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Dyspepsia,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Synovitis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Osteolysis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Red blood cell sedimentation rate abnormal,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Drug hypersensitivity,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Hepatic fibrosis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Gastrointestinal infection,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Localised infection,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Bone erosion,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Joint ankylosis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Rheumatoid arthritis,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215217753,21521775,33,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Psoriatic arthropathy,,2023,Q1,3,F,,20230227.0,20221028,20230228,EXP,,CA-ROCHE-3205507,ROCHE,,61.0,YR,,M,Y,,,20230228,,HP,CA,,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Dyspepsia,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Rheumatoid arthritis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Drug intolerance,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Treatment failure,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Drug ineffective,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Pain,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hepatic fibrosis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hand deformity,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Nausea,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Arthropathy,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Bone erosion,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hypertension,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,C-reactive protein increased,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Joint swelling,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Upper respiratory tract infection,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Transaminases increased,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Psoriatic arthropathy,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,C-reactive protein abnormal,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Skin injury,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase abnormal,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Pruritus,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Anti-cyclic citrullinated peptide antibody positive,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Joint ankylosis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Red blood cell sedimentation rate abnormal,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Abdominal discomfort,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Osteolysis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Bone cyst,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Drug-induced liver injury,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Drug hypersensitivity,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Gastrointestinal infection,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Synovitis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Infection,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215315542,21531554,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,2,F,,20230302.0,20221031,20230303,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-127096,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Adult
215847104,21584710,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,N,,,,,,,,2023,Q1,Nausea,,2023,Q1,4,F,20220415.0,20230224.0,20221111,20230314,EXP,,JP-PFIZER INC-PV202200098748,PFIZER,,49.0,YR,,F,Y,59.0,KG,20230313,,MD,JP,JP,2023,Q1,Adult
216179223,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Vascular stenosis,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Off label use,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Renal impairment,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Blood glucose abnormal,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q1,Vascular stenosis,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q1,Renal impairment,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216179223,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q1,Blood glucose abnormal,,2023,Q1,3,F,20210901.0,20230119.0,20221119,20230127,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230127,,MD,JP,JP,2023,Q1,Elderly
216365102,21636510,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Ketoacidosis,,2023,Q1,2,F,20211102.0,20221228.0,20221124,20230106,EXP,,JP-JNJFOC-20220862324,JOHNSON AND JOHNSON,,54.0,YR,A,M,Y,,,20230106,,MD,JP,JP,2023,Q1,Adult
216533462,21653346,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Retinal haemorrhage,,2023,Q1,2,F,,20230210.0,20221128,20230217,EXP,,JP-JNJFOC-20221156523,JOHNSON AND JOHNSON,,53.0,YR,A,M,Y,,,20230217,,MD,JP,JP,2023,Q1,Adult
216533462,21653346,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Diabetic retinopathy,,2023,Q1,2,F,,20230210.0,20221128,20230217,EXP,,JP-JNJFOC-20221156523,JOHNSON AND JOHNSON,,53.0,YR,A,M,Y,,,20230217,,MD,JP,JP,2023,Q1,Adult
216533462,21653346,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Retinal haemorrhage,,2023,Q1,2,F,,20230210.0,20221128,20230217,EXP,,JP-JNJFOC-20221156523,JOHNSON AND JOHNSON,,53.0,YR,A,M,Y,,,20230217,,MD,JP,JP,2023,Q1,Adult
216533462,21653346,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Diabetic retinopathy,,2023,Q1,2,F,,20230210.0,20221128,20230217,EXP,,JP-JNJFOC-20221156523,JOHNSON AND JOHNSON,,53.0,YR,A,M,Y,,,20230217,,MD,JP,JP,2023,Q1,Adult
216871872,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q1,Metabolic acidosis,,2023,Q1,2,F,20220225.0,20230116.0,20221206,20230125,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230125,,PH,PT,PT,2023,Q1,Elderly
216871872,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q1,Hyperkalaemia,,2023,Q1,2,F,20220225.0,20230116.0,20221206,20230125,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230125,,PH,PT,PT,2023,Q1,Elderly
216871872,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q1,Acute kidney injury,,2023,Q1,2,F,20220225.0,20230116.0,20221206,20230125,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230125,,PH,PT,PT,2023,Q1,Elderly
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Thrombophlebitis migrans,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Fatigue,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Alanine aminotransferase increased,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Blood alkaline phosphatase increased,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Underdose,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217146763,21714676,10,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,Tablet,QD,2023,Q1,Decreased appetite,,2023,Q1,3,F,20220621.0,20230313.0,20221212,20230314,EXP,,JP-DSJP-DSJ-2022-140685,DAIICHI,,63.0,YR,,M,Y,47.6,KG,20230314,,MD,JP,JP,2023,Q1,Adult
217348423,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,3,F,20210726.0,20230307.0,20221215,20230316,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230316,,MD,JP,JP,2023,Q1,Child
217348423,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Cholecystitis,,2023,Q1,3,F,20210726.0,20230307.0,20221215,20230316,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230316,,MD,JP,JP,2023,Q1,Child
217348423,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Abdominal abscess,,2023,Q1,3,F,20210726.0,20230307.0,20221215,20230316,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230316,,MD,JP,JP,2023,Q1,Child
217500432,21750043,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,2,F,,20230315.0,20221219,20230323,EXP,,CA-BAUSCH-BL-2022-027303,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Elderly
217500432,21750043,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230315.0,20221219,20230323,EXP,,CA-BAUSCH-BL-2022-027303,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Elderly
217500432,21750043,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,2,F,,20230315.0,20221219,20230323,EXP,,CA-BAUSCH-BL-2022-027303,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Elderly
217500432,21750043,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,2,F,,20230315.0,20221219,20230323,EXP,,CA-BAUSCH-BL-2022-027303,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Elderly
217500432,21750043,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230315.0,20221219,20230323,EXP,,CA-BAUSCH-BL-2022-027303,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Elderly
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Nausea,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Platelet count decreased,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Flank pain,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Haematuria,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Decreased appetite,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Renal vein thrombosis,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Chills,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Renal disorder,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Cerebral venous sinus thrombosis,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Platelet count increased,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Abdominal pain upper,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Thrombosis,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Abdominal abscess,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217517164,21751716,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Headache,,2023,Q1,4,F,20221125.0,20230203.0,20221220,20230211,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230211,,CN,CA,CA,2023,Q1,Adult
217764502,21776450,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,Y,,,,,100.0,MG,Tablet,QD,2023,Q1,Diabetic ketoacidosis,,2023,Q1,2,F,20221119.0,20230306.0,20221226,20230317,EXP,JP-MHLW-I2210005791,JP-NOVOPROD-1004004,NOVO NORDISK,,49.0,YR,,F,Y,,,20230317,,PH,JP,JP,2023,Q1,Adult
218071231,21807123,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028190,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071231,21807123,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028190,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071231,21807123,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028190,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071231,21807123,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028190,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071231,21807123,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028190,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071261,21807126,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028172,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071261,21807126,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028172,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071261,21807126,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028172,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071261,21807126,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028172,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218071261,21807126,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20221226.0,20230102,20230102,EXP,,CA-BAUSCH-BL-2022-028172,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230102,,CN,CA,CA,2023,Q1,Elderly
218106812,21810681,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230320.0,20230103,20230327,EXP,,CA-MYLANLABS-2022M1148771,MYLAN,,76.0,YR,,F,Y,,,20230327,,HP,CA,CA,2023,Q1,Elderly
218106812,21810681,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230320.0,20230103,20230327,EXP,,CA-MYLANLABS-2022M1148771,MYLAN,,76.0,YR,,F,Y,,,20230327,,HP,CA,CA,2023,Q1,Elderly
218106812,21810681,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,2,F,,20230320.0,20230103,20230327,EXP,,CA-MYLANLABS-2022M1148771,MYLAN,,76.0,YR,,F,Y,,,20230327,,HP,CA,CA,2023,Q1,Elderly
218106812,21810681,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,2,F,,20230320.0,20230103,20230327,EXP,,CA-MYLANLABS-2022M1148771,MYLAN,,76.0,YR,,F,Y,,,20230327,,HP,CA,CA,2023,Q1,Elderly
218106812,21810681,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,2,F,,20230320.0,20230103,20230327,EXP,,CA-MYLANLABS-2022M1148771,MYLAN,,76.0,YR,,F,Y,,,20230327,,HP,CA,CA,2023,Q1,Elderly
218118612,21811861,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,QD,2023,Q1,Drug-induced liver injury,,2023,Q1,2,F,20221228.0,20230110.0,20230103,20230111,EXP,,GB-ROCHE-3255186,ROCHE,,74.0,YR,,M,Y,80.5,KG,20230112,,MD,GB,,2023,Q1,Elderly
218138501,21813850,1,PS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,,,204353.0,,,Tablet,,2023,Q1,Drug interaction,,2023,Q1,1,I,20220227.0,20230103.0,20230104,20230104,EXP,IT-MINISAL02-902607,IT-JNJFOC-20230102689,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230104,,MD,IT,IT,2023,Q1,Adult
218138501,21813850,1,PS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,,,204353.0,,,Tablet,,2023,Q1,Metabolic acidosis,,2023,Q1,1,I,20220227.0,20230103.0,20230104,20230104,EXP,IT-MINISAL02-902607,IT-JNJFOC-20230102689,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230104,,MD,IT,IT,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hand deformity,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Red blood cell sedimentation rate abnormal,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pain,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Psoriatic arthropathy,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug-induced liver injury,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone erosion,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase abnormal,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug hypersensitivity,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug intolerance,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Transaminases increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Infection,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Upper respiratory tract infection,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Treatment failure,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Pruritus,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hypertension,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrointestinal infection,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,C-reactive protein abnormal,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Nausea,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint ankylosis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bone cyst,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Abdominal discomfort,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Joint swelling,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Osteolysis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Liver disorder,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Product use issue,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Alanine aminotransferase increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Skin injury,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hepatic fibrosis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Synovitis,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Arthropathy,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspepsia,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Anti-cyclic citrullinated peptide antibody positive,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218161581,21816158,34,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-056599,AUROBINDO,,50.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Adult
218165501,21816550,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218165501,21816550,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218165501,21816550,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,,,,,100.0,MG,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218165501,21816550,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,,,,,100.0,MG,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Bronchiectasis,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Off label use,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Blood immunoglobulin E increased,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Rhinorrhoea,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218211841,21821184,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Malignant mediastinal neoplasm,,2023,Q1,1,I,,20221227.0,20230105,20230105,EXP,,CA-ORGANON-O2301CAN000101,ORGANON,,73.0,YR,,F,Y,101.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
218336161,21833616,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 days,,,U,,,,,100.0,MG,Tablet,,2023,Q1,Drug interaction,,2023,Q1,1,I,,20221228.0,20230107,20230107,EXP,CA-MHPD-001015010,CA-Accord-294403,ACCORD,,76.0,YR,E,F,Y,,,20230107,,HP,CA,CA,2023,Q1,Elderly
218336161,21833616,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 days,,,U,,,,,100.0,MG,Tablet,,2023,Q1,Hepatocellular injury,,2023,Q1,1,I,,20221228.0,20230107,20230107,EXP,CA-MHPD-001015010,CA-Accord-294403,ACCORD,,76.0,YR,E,F,Y,,,20230107,,HP,CA,CA,2023,Q1,Elderly
218336161,21833616,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 days,,,U,,,,,100.0,MG,Tablet,,2023,Q1,Rhabdomyolysis,,2023,Q1,1,I,,20221228.0,20230107,20230107,EXP,CA-MHPD-001015010,CA-Accord-294403,ACCORD,,76.0,YR,E,F,Y,,,20230107,,HP,CA,CA,2023,Q1,Elderly
218401411,21840141,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218401411,21840141,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Extradural abscess,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218401411,21840141,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Post streptococcal glomerulonephritis,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218467232,21846723,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK, qd",,,,,,,,,,,QD,2023,Q1,Drug-induced liver injury,,2023,Q1,2,F,20221228.0,20230112.0,20230111,20230121,PER,,GB-AMGEN-GBRNI2023001584,AMGEN,,74.0,YR,E,M,Y,80.5,KG,20230121,,MD,GB,GB,2023,Q1,Elderly
218532961,21853296,2,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q1,Metabolic acidosis,,2023,Q1,1,I,20220227.0,20221230.0,20230112,20230112,EXP,IT-MINISAL02-902607,IT-ELI_LILLY_AND_COMPANY-IT202212015001,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20230112,,CN,IT,IT,2023,Q1,Adult
218532961,21853296,2,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q1,Drug interaction,,2023,Q1,1,I,20220227.0,20221230.0,20230112,20230112,EXP,IT-MINISAL02-902607,IT-ELI_LILLY_AND_COMPANY-IT202212015001,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20230112,,CN,IT,IT,2023,Q1,Adult
218844672,21884467,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,204042.0,,,Tablet,,2023,Q1,Ketosis,,2023,Q1,2,F,,20230126.0,20230119,20230202,EXP,,JP-JNJFOC-20230136592,JOHNSON AND JOHNSON,"Samoto A, Kadowaki C, Sugiyama T, Hoashi K, Suzuki S, Ito Y, et al. 52 A case of euglycaemic ketosis after the family member made the patient took an oral SGLT2 inhibitor on sick day. The 238th Kinki Regional Meeting of the Japanese Society of Internal Medicine Society. 2022.12. 10",86.0,YR,E,F,Y,,,20230202,,MD,JP,JP,2023,Q1,Elderly
218845261,21884526,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,U,,,204042.0,,,Tablet,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230111.0,20230119,20230119,EXP,,JP-JNJFOC-20230136642,JOHNSON AND JOHNSON,Tatsujo M and Yagi I. 61 A case of prolonged effect up to 14 days after discontinuation of SGLT2 inhibitor. The 683rd Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2022.12. 10,55.0,YR,A,F,Y,,,20230119,,MD,JP,JP,2023,Q1,Adult
218845261,21884526,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,U,,,204042.0,,,Tablet,,2023,Q1,Epiglottitis,,2023,Q1,1,I,,20230111.0,20230119,20230119,EXP,,JP-JNJFOC-20230136642,JOHNSON AND JOHNSON,Tatsujo M and Yagi I. 61 A case of prolonged effect up to 14 days after discontinuation of SGLT2 inhibitor. The 683rd Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2022.12. 10,55.0,YR,A,F,Y,,,20230119,,MD,JP,JP,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219049162,21904916,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,20230103.0,20230123.0,20230124,20230126,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230126,,MD,IT,IT,2023,Q1,Elderly
219049162,21904916,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Productive cough,,2023,Q1,2,F,20230103.0,20230123.0,20230124,20230126,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230126,,MD,IT,IT,2023,Q1,Elderly
219049162,21904916,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Acute respiratory failure,,2023,Q1,2,F,20230103.0,20230123.0,20230124,20230126,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230126,,MD,IT,IT,2023,Q1,Elderly
219165531,21916553,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20230116.0,20230122.0,20230126,20230126,EXP,,GB-MYLANLABS-2023M1008234,MYLAN,,63.0,YR,,F,Y,,,20230126,,HP,GB,GB,2023,Q1,Adult
219244691,21924469,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20230116.0,20230122.0,20230130,20230130,EXP,,GB-EMD Serono-E2B_90090528,EMD SERONO INC,,63.0,YR,A,F,Y,,,20230130,,HP,GB,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219337301,21933730,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20230116.0,20230122.0,20230201,20230201,EXP,,GB-AUROBINDO-AUR-APL-2023-003673,AUROBINDO,,63.0,YR,,F,Y,,,20230201,,HP,GB,GB,2023,Q1,Adult
219361632,21936163,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q1,Off label use,,2023,Q1,2,F,20230101.0,20230127.0,20230201,20230208,EXP,IT-MINISAL02-905895,IT-ELI_LILLY_AND_COMPANY-IT202301010249,ELI LILLY AND CO,,77.0,YR,,M,Y,64.0,KG,20230208,,CN,IT,IT,2023,Q1,Elderly
219361632,21936163,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q1,Pancreatitis acute,,2023,Q1,2,F,20230101.0,20230127.0,20230201,20230208,EXP,IT-MINISAL02-905895,IT-ELI_LILLY_AND_COMPANY-IT202301010249,ELI LILLY AND CO,,77.0,YR,,M,Y,64.0,KG,20230208,,CN,IT,IT,2023,Q1,Elderly
219361632,21936163,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q1,Cholangitis,,2023,Q1,2,F,20230101.0,20230127.0,20230201,20230208,EXP,IT-MINISAL02-905895,IT-ELI_LILLY_AND_COMPANY-IT202301010249,ELI LILLY AND CO,,77.0,YR,,M,Y,64.0,KG,20230208,,CN,IT,IT,2023,Q1,Elderly
219370421,21937042,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20230116.0,20230122.0,20230201,20230201,EXP,,GB-TEVA-2023-GB-2849451,TEVA,,63.0,YR,A,F,Y,,,20230201,,HP,GB,GB,2023,Q1,Adult
219401974,21940197,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,4,F,20220615.0,20230317.0,20230201,20230324,EXP,,JP-JNJFOC-20230200949,JOHNSON AND JOHNSON,"Okamoto Y, Todo H, Kanamoto M, and Yamauchi K. 2-A A case of the patient with type 2 diabetes mellitus who was revealed to be pregnant at 33 weeks after taking 5 oral hypoglycemic drugs -12. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 79",37.0,YR,A,F,Y,,,20230324,,MD,JP,JP,2023,Q1,Adult
219401974,21940197,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Hypertensive nephropathy,,2023,Q1,4,F,20220615.0,20230317.0,20230201,20230324,EXP,,JP-JNJFOC-20230200949,JOHNSON AND JOHNSON,"Okamoto Y, Todo H, Kanamoto M, and Yamauchi K. 2-A A case of the patient with type 2 diabetes mellitus who was revealed to be pregnant at 33 weeks after taking 5 oral hypoglycemic drugs -12. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 79",37.0,YR,A,F,Y,,,20230324,,MD,JP,JP,2023,Q1,Adult
219408131,21940813,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Sepsis,,2023,Q1,1,I,,20230124.0,20230201,20230201,EXP,,JP-JNJFOC-20230200933,JOHNSON AND JOHNSON,"Kobayashi H, Yoshida S, Fujishiro T, Yashima C, Yamamoto S, and Kondo S. 1-C-06 A case developed euglycaemic ketoacidosis and extensive cerebral infarction during treatments of suppurative knee arthritis and sepsis. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 65",63.0,YR,A,M,Y,,,20230202,,MD,JP,JP,2023,Q1,Adult
219408131,21940813,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Cardio-respiratory arrest,,2023,Q1,1,I,,20230124.0,20230201,20230201,EXP,,JP-JNJFOC-20230200933,JOHNSON AND JOHNSON,"Kobayashi H, Yoshida S, Fujishiro T, Yashima C, Yamamoto S, and Kondo S. 1-C-06 A case developed euglycaemic ketoacidosis and extensive cerebral infarction during treatments of suppurative knee arthritis and sepsis. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 65",63.0,YR,A,M,Y,,,20230202,,MD,JP,JP,2023,Q1,Adult
219408131,21940813,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Cerebral infarction,,2023,Q1,1,I,,20230124.0,20230201,20230201,EXP,,JP-JNJFOC-20230200933,JOHNSON AND JOHNSON,"Kobayashi H, Yoshida S, Fujishiro T, Yashima C, Yamamoto S, and Kondo S. 1-C-06 A case developed euglycaemic ketoacidosis and extensive cerebral infarction during treatments of suppurative knee arthritis and sepsis. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 65",63.0,YR,A,M,Y,,,20230202,,MD,JP,JP,2023,Q1,Adult
219408131,21940813,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230124.0,20230201,20230201,EXP,,JP-JNJFOC-20230200933,JOHNSON AND JOHNSON,"Kobayashi H, Yoshida S, Fujishiro T, Yashima C, Yamamoto S, and Kondo S. 1-C-06 A case developed euglycaemic ketoacidosis and extensive cerebral infarction during treatments of suppurative knee arthritis and sepsis. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 65",63.0,YR,A,M,Y,,,20230202,,MD,JP,JP,2023,Q1,Adult
219408131,21940813,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Arthritis bacterial,,2023,Q1,1,I,,20230124.0,20230201,20230201,EXP,,JP-JNJFOC-20230200933,JOHNSON AND JOHNSON,"Kobayashi H, Yoshida S, Fujishiro T, Yashima C, Yamamoto S, and Kondo S. 1-C-06 A case developed euglycaemic ketoacidosis and extensive cerebral infarction during treatments of suppurative knee arthritis and sepsis. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 65",63.0,YR,A,M,Y,,,20230202,,MD,JP,JP,2023,Q1,Adult
219492891,21949289,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20230116.0,20230122.0,20230203,20230203,EXP,,GB-MICRO LABS LIMITED-ML2023-00461,MICRO LABS,,63.0,YR,A,F,Y,,,20230203,,HP,GB,,2023,Q1,Adult
219584561,21958456,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230129.0,20230206,20230206,EXP,,CA-TEVA-2023-CA-2851961,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219584561,21958456,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230129.0,20230206,20230206,EXP,,CA-TEVA-2023-CA-2851961,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219584561,21958456,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230129.0,20230206,20230206,EXP,,CA-TEVA-2023-CA-2851961,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219584561,21958456,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230129.0,20230206,20230206,EXP,,CA-TEVA-2023-CA-2851961,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219584561,21958456,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230129.0,20230206,20230206,EXP,,CA-TEVA-2023-CA-2851961,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219616731,21961673,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230129.0,20230207,20230207,EXP,,CA-TEVA-2023-CA-2851666,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219616731,21961673,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230129.0,20230207,20230207,EXP,,CA-TEVA-2023-CA-2851666,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219616731,21961673,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230129.0,20230207,20230207,EXP,,CA-TEVA-2023-CA-2851666,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219616731,21961673,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230129.0,20230207,20230207,EXP,,CA-TEVA-2023-CA-2851666,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219616731,21961673,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230129.0,20230207,20230207,EXP,,CA-TEVA-2023-CA-2851666,TEVA,,76.0,YR,E,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Elderly
219630941,21963094,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Non-cardiac chest pain,,2023,Q1,1,I,20220901.0,20230105.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006212,AEGERION,,17.0,YR,,F,Y,,,20230207,,MD,US,US,2023,Q1,Youth
219792361,21979236,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Post streptococcal glomerulonephritis,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219792361,21979236,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Extradural abscess,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219792361,21979236,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219809952,21980995,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,Film Coated Tablet,,2023,Q1,Acute kidney injury,,2023,Q1,2,F,20230125.0,20230218.0,20230211,20230301,EXP,,ES-AUROBINDO-AUR-APL-2023-005798,AUROBINDO,,60.0,YR,,M,Y,61.5,KG,20230301,,MD,ES,ES,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219930072,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230222.0,20230215,20230301,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230301,,HP,JP,,2023,Q1,Adult
219930072,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,,2023,Q1,Lactic acidosis,,2023,Q1,2,F,,20230222.0,20230215,20230301,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230301,,HP,JP,,2023,Q1,Adult
219930072,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,,2023,Q1,Accidental overdose,,2023,Q1,2,F,,20230222.0,20230215,20230301,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230301,,HP,JP,,2023,Q1,Adult
219945522,21994552,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,100.0,MG,Tablet,QD,2023,Q1,Lactic acidosis,,2023,Q1,2,F,20220624.0,20230320.0,20230215,20230328,EXP,,JP-EMD Serono-9383369,EMD SERONO INC,,51.0,YR,A,M,Y,91.0,KG,20230328,,HP,JP,,2023,Q1,Adult
219945522,21994552,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,100.0,MG,Tablet,QD,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,2,F,20220624.0,20230320.0,20230215,20230328,EXP,,JP-EMD Serono-9383369,EMD SERONO INC,,51.0,YR,A,M,Y,91.0,KG,20230328,,HP,JP,,2023,Q1,Adult
219969272,21996927,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,,,,,,,,Tablet,,2023,Q1,Hyperkalaemia,,2023,Q1,2,F,20230203.0,20230323.0,20230215,20230330,EXP,,JP-EMD Serono-9383382,EMD SERONO INC,,61.0,YR,A,M,Y,74.0,KG,20230330,,HP,JP,,2023,Q1,Adult
220030612,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,2,F,,20230309.0,20230217,20230314,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230314,,HP,JP,,2023,Q1,Elderly
220030612,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Ketosis,,2023,Q1,2,F,,20230309.0,20230217,20230314,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230314,,HP,JP,,2023,Q1,Elderly
220030612,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q1,Fulminant type 1 diabetes mellitus,,2023,Q1,2,F,,20230309.0,20230217,20230314,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230314,,HP,JP,,2023,Q1,Elderly
220109043,22010904,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,form strength : 50 mg/1000 mg,,,,,UNKNOWN,,,,,Film-coated tablet,,2023,Q1,Acute kidney injury,,2023,Q1,3,F,20230125.0,20230314.0,20230220,20230324,EXP,ES-AEMPS-1325827,ES-TEVA-2023-ES-2856955,TEVA,,60.0,YR,A,M,Y,61.5,KG,20230324,,MD,ES,ES,2023,Q1,Adult
220165922,22016592,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Myocardial infarction,,2023,Q1,2,F,20221028.0,20230303.0,20230221,20230309,EXP,,JP-JNJFOC-20230244443,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,,,20230310,,MD,JP,JP,2023,Q1,Adult
220165922,22016592,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Amputation,,2023,Q1,2,F,20221028.0,20230303.0,20230221,20230309,EXP,,JP-JNJFOC-20230244443,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,,,20230310,,MD,JP,JP,2023,Q1,Adult
220236391,22023639,6,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,Film-coated tablet,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,20230125.0,20230220.0,20230223,20230223,EXP,ES-AEMPS-1325827,ES-BAUSCH-BL-2023-003111,BAUSCH AND LOMB,,60.0,YR,,M,Y,61.5,KG,20230222,,MD,ES,ES,2023,Q1,Adult
220244211,22024421,9,C,Canagliflozin-metformin,,2,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q1,Human herpesvirus 6 encephalitis,,2023,Q1,1,I,,20230210.0,20230223,20230223,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-01779,ALKEM,"Gannamani V, Varma A, Nathan S, Ustun C. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant Immunology. 2023;76:101742",51.0,YR,,F,Y,,,20230223,,HP,US,US,2023,Q1,Adult
220244211,22024421,9,C,Canagliflozin-metformin,,2,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q1,Hyponatraemia,,2023,Q1,1,I,,20230210.0,20230223,20230223,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-01779,ALKEM,"Gannamani V, Varma A, Nathan S, Ustun C. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant Immunology. 2023;76:101742",51.0,YR,,F,Y,,,20230223,,HP,US,US,2023,Q1,Adult
220244211,22024421,9,C,Canagliflozin-metformin,,2,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q1,Post transplant distal limb syndrome,,2023,Q1,1,I,,20230210.0,20230223,20230223,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-01779,ALKEM,"Gannamani V, Varma A, Nathan S, Ustun C. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant Immunology. 2023;76:101742",51.0,YR,,F,Y,,,20230223,,HP,US,US,2023,Q1,Adult
220311411,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Unknown,QD,2023,Q1,Depression,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230224,,HP,CA,CA,2023,Q1,Adult
220311411,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Unknown,QD,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230224,,HP,CA,CA,2023,Q1,Adult
220311411,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Unknown,QD,2023,Q1,Product prescribing error,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230224,,HP,CA,CA,2023,Q1,Adult
220311411,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Unknown,QD,2023,Q1,Suicidal ideation,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230224,,HP,CA,CA,2023,Q1,Adult
220311411,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Unknown,QD,2023,Q1,Anxiety,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230224,,HP,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Hepatic steatosis,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Neuralgia,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Fungal infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Therapeutic response shortened,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Localised infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Paranasal cyst,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Pain in extremity,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Neck pain,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Tympanic membrane perforation,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Ear disorder,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Malaise,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Kidney infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Sinusitis,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Urinary tract infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Influenza,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Constipation,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Tinnitus,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Hepatic cirrhosis,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Musculoskeletal pain,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Sepsis,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Ear infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Cough,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Viral infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Polyp,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Eyelid infection,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220320041,22032004,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q1,Bronchitis,,2023,Q1,1,I,,20230217.0,20230224,20230224,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219819",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,122.0,KG,20230224,,CN,CA,CA,2023,Q1,Adult
220346261,22034626,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,37,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,37,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,37,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,37,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220346261,22034626,37,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230215.0,20230224,20230224,EXP,,CA-APOTEX-2023AP003783,APOTEX,,76.0,YR,,F,Y,,,20230224,,HP,CA,CA,2023,Q1,Elderly
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Anxiety,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Suicidal ideation,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Insomnia,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Sleep disorder,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,"Hallucination, auditory",,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Product prescribing error,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Psychotic disorder,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220395932,22039593,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Daily dose: 100 Milligram,,,,,,,,100.0,MG,,,2023,Q1,Depression,,2023,Q1,2,F,,20230227.0,20230227,20230306,EXP,,CA-CHEPLA-2023002480,CHEPLAPHARM,"Rapha?l C, Agid O. When No Treatment Is the Treatment: Mental Illness-Related?Case Report. Can J Hosp Pharm. 2022 Winter;75(1):58-61. doi:?10.4212/cjhp.v75i1.3063. PMID: 34987265; PMCID: PMC8676994.",56.0,YR,,M,Y,,,20230306,,HP,COUNTRY NOT SPECIFIED,CA,2023,Q1,Adult
220427072,22042707,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Daily",,,Y,,,,,100.0,MG,,,2023,Q1,Myopathy toxic,,2023,Q1,2,F,,20230213.0,20230228,20230228,EXP,,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-259531,RANBAXY,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Ann Intern Med. 2020;Oct 6; 173 (7):585-587",76.0,YR,,F,Y,,,20230228,,MD,CA,CA,2023,Q1,Elderly
220427072,22042707,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Daily",,,Y,,,,,100.0,MG,,,2023,Q1,Drug interaction,,2023,Q1,2,F,,20230213.0,20230228,20230228,EXP,,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-259531,RANBAXY,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Ann Intern Med. 2020;Oct 6; 173 (7):585-587",76.0,YR,,F,Y,,,20230228,,MD,CA,CA,2023,Q1,Elderly
220452793,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Depression,,2023,Q1,3,F,,20230303.0,20230228,20230308,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230308,,HP,CA,CA,2023,Q1,Adult
220452793,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,Psychiatric symptom,,2023,Q1,3,F,,20230303.0,20230228,20230308,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230308,,HP,CA,CA,2023,Q1,Adult
220452793,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q1,"Hallucination, auditory",,2023,Q1,3,F,,20230303.0,20230228,20230308,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230308,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Anxiety,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Depression,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,"Hallucination, visual",,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Suicidal ideation,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,"Hallucination, auditory",,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Psychotic disorder,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q1,Product prescribing error,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Anxiety,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Depression,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,"Hallucination, visual",,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Suicidal ideation,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,"Hallucination, auditory",,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Psychotic disorder,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483432,22048343,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q1,Product prescribing error,,2023,Q1,2,F,,20230223.0,20230301,20230304,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230304,,HP,CA,CA,2023,Q1,Adult
220483761,22048376,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,,QD,2023,Q1,Knee arthroplasty,,2023,Q1,1,I,,20230222.0,20230301,20230301,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05256,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,,,20230301,,HP,CA,CA,2023,Q1,Adult
220483761,22048376,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,,QD,2023,Q1,Postoperative wound infection,,2023,Q1,1,I,,20230222.0,20230301,20230301,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05256,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,,,20230301,,HP,CA,CA,2023,Q1,Adult
220556981,22055698,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,U,,,,,300.0,MG,Film-coated tablet,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044318,NOVARTIS,,17.0,YR,,M,Y,,,20230302,,CN,CA,CA,2023,Q1,Youth
220556981,22055698,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 mg,,,U,,,,,100.0,MG,Film-coated tablet,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044318,NOVARTIS,,17.0,YR,,M,Y,,,20230302,,CN,CA,CA,2023,Q1,Youth
220566671,22056667,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,Y,,,,,100.0,MG,,QD,2023,Q1,Vertigo positional,,2023,Q1,1,I,20230101.0,20230214.0,20230302,20230302,EXP,,JP-NOVOPROD-1026496,NOVO NORDISK,,67.0,YR,,F,Y,,,20230227,,MD,JP,JP,2023,Q1,Elderly
220566671,22056667,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,Y,,,,,100.0,MG,,QD,2023,Q1,Condition aggravated,,2023,Q1,1,I,20230101.0,20230214.0,20230302,20230302,EXP,,JP-NOVOPROD-1026496,NOVO NORDISK,,67.0,YR,,F,Y,,,20230227,,MD,JP,JP,2023,Q1,Elderly
220566671,22056667,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,Y,,,,,100.0,MG,,QD,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,20230101.0,20230214.0,20230302,20230302,EXP,,JP-NOVOPROD-1026496,NOVO NORDISK,,67.0,YR,,F,Y,,,20230227,,MD,JP,JP,2023,Q1,Elderly
220568941,22056894,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,D,,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Hip arthroplasty,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,JP-JNJFOC-20230304099,JOHNSON AND JOHNSON,,80.0,YR,E,F,Y,,,20230303,,PH,JP,JP,2023,Q1,Elderly
220573041,22057304,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Weight loss poor,,2023,Q1,1,I,20220922.0,20230223.0,20230303,20230303,EXP,,JP-EMD Serono-9387183,EMD SERONO INC,,40.0,YR,A,F,Y,101.0,KG,20230303,,HP,JP,,2023,Q1,Adult
220573041,22057304,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,20220922.0,20230223.0,20230303,20230303,EXP,,JP-EMD Serono-9387183,EMD SERONO INC,,40.0,YR,A,F,Y,101.0,KG,20230303,,HP,JP,,2023,Q1,Adult
220573041,22057304,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,20220922.0,20230223.0,20230303,20230303,EXP,,JP-EMD Serono-9387183,EMD SERONO INC,,40.0,YR,A,F,Y,101.0,KG,20230303,,HP,JP,,2023,Q1,Adult
220603611,22060361,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044306,NOVARTIS,,17.0,YR,,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Youth
220603611,22060361,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 mg,,,U,,,,,100.0,MG,Tablet,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044306,NOVARTIS,,17.0,YR,,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Youth
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Pemphigus,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220632441,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230224.0,20230306,20230306,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20230306,,HP,CA,CA,2023,Q1,Adult
220656321,22065632,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,204042.0,,,Tablet,,2023,Q1,COVID-19,,2023,Q1,1,I,,20210929.0,20230306,20230306,EXP,,US-JNJFOC-20211000863,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20230306,,CN,US,US,2023,Q1,Adult
220656321,22065632,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,204042.0,,,Tablet,,2023,Q1,Seizure,,2023,Q1,1,I,,20210929.0,20230306,20230306,EXP,,US-JNJFOC-20211000863,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20230306,,CN,US,US,2023,Q1,Adult
220675131,22067513,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Headache,,2023,Q1,1,I,20230201.0,20230228.0,20230307,20230307,EXP,,US-JNJFOC-20230302540,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220675131,22067513,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230201.0,20230228.0,20230307,20230307,EXP,,US-JNJFOC-20230302540,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220675131,22067513,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Fatigue,,2023,Q1,1,I,20230201.0,20230228.0,20230307,20230307,EXP,,US-JNJFOC-20230302540,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Pemphigus,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220706421,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230301.0,20230307,20230307,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230307,,HP,CA,CA,2023,Q1,Adult
220717412,22071741,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Azotaemia,,2023,Q1,2,F,,20230309.0,20230307,20230316,EXP,,JP-JNJFOC-20230316129,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20230316,,MD,JP,JP,2023,Q1,Elderly
220717412,22071741,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q1,Renal impairment,,2023,Q1,2,F,,20230309.0,20230307,20230316,EXP,,JP-JNJFOC-20230316129,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20230316,,MD,JP,JP,2023,Q1,Elderly
220720421,22072042,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,,QD,2023,Q1,Lower respiratory tract infection bacterial,,2023,Q1,1,I,,20230301.0,20230308,20230308,EXP,,CA-JNJFOC-20230308082,JOHNSON AND JOHNSON,,33.0,YR,A,F,Y,115.0,KG,20230308,,HP,CA,CA,2023,Q1,Young Adult
220720421,22072042,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,,QD,2023,Q1,Off label use,,2023,Q1,1,I,,20230301.0,20230308,20230308,EXP,,CA-JNJFOC-20230308082,JOHNSON AND JOHNSON,,33.0,YR,A,F,Y,115.0,KG,20230308,,HP,CA,CA,2023,Q1,Young Adult
220720421,22072042,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,,QD,2023,Q1,Intentional product use issue,,2023,Q1,1,I,,20230301.0,20230308,20230308,EXP,,CA-JNJFOC-20230308082,JOHNSON AND JOHNSON,,33.0,YR,A,F,Y,115.0,KG,20230308,,HP,CA,CA,2023,Q1,Young Adult
220751301,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220751301,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230228.0,20230308,20230308,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230308,,MD,CA,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Tinea infection,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Cardiac failure,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Dermatitis diaper,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Bacterial test positive,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220837901,22083790,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,U,,,,,,,,,2023,Q1,Acute myocardial infarction,,2023,Q1,1,I,,20230301.0,20230310,20230310,EXP,,JP-EMD Serono-9387756,EMD SERONO INC,,86.0,YR,E,F,Y,,,20230310,,HP,JP,,2023,Q1,Elderly
220874923,22087492,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,,,unknown,,,100.0,MG,Tablet,QD,2023,Q1,Hypothalamo-pituitary disorder,,2023,Q1,3,F,,20230316.0,20230313,20230327,EXP,,JP-NOVOPROD-1034845,NOVO NORDISK,,67.0,YR,,F,Y,70.5,KG,20230327,,MD,JP,JP,2023,Q1,Elderly
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Pemphigus,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220879131,22087913,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230301.0,20230313,20230313,EXP,CA-MHPD-E2B_05985319,CA-Accord-303224,ACCORD,,62.0,YR,A,M,Y,,,20230313,,HP,CA,CA,2023,Q1,Adult
220902031,22090203,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,U,,,204042.0,300.0,MG,Tablet,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230302.0,20230313,20230313,EXP,,JP-JNJFOC-20230262498,JOHNSON AND JOHNSON,,27.0,YR,A,M,Y,,,20230313,,MD,JP,US,2023,Q1,Young Adult
220902031,22090203,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,U,,,204042.0,300.0,MG,Tablet,,2023,Q1,Off label use,,2023,Q1,1,I,,20230302.0,20230313,20230313,EXP,,JP-JNJFOC-20230262498,JOHNSON AND JOHNSON,,27.0,YR,A,M,Y,,,20230313,,MD,JP,US,2023,Q1,Young Adult
220902031,22090203,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,U,,,204042.0,300.0,MG,Tablet,,2023,Q1,Off label use,,2023,Q1,1,I,,20230302.0,20230313,20230313,EXP,,JP-JNJFOC-20230262498,JOHNSON AND JOHNSON,,27.0,YR,A,M,Y,,,20230313,,MD,JP,US,2023,Q1,Young Adult
220972841,22097284,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,QD,2023,Q1,Swollen tongue,,2023,Q1,1,I,20230301.0,20230311.0,20230315,20230315,EXP,GB-MHRA-TPP12212140C122227YC1677850940435,GB-009507513-2303GBR003845,MERCK,,61.0,YR,,F,Y,129.0,KG,20230315,,HP,GB,GB,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Sinus congestion,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Cough,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Medication error,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure decreased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Disability assessment scale score increased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Swelling face,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure systolic decreased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure systolic abnormal,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Road traffic accident,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Muscle tightness,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Abdominal pain upper,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Bladder disorder,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Soft tissue injury,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Weight fluctuation,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Lower respiratory tract congestion,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Lower respiratory tract infection,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Oropharyngeal pain,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Tooth disorder,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220988371,22098837,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Bronchitis,,2023,Q1,1,I,,20230308.0,20230315,20230315,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230315,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,"Hallucination, visual",,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Psychotic disorder,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Anxiety,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,"Hallucination, auditory",,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Product prescribing error,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Depression,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Suicidal ideation,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
220989662,22098966,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230320.0,20230315,20230327,EXP,,NVSC2023CA055487,NOVARTIS,,56.0,YR,,M,Y,,,20230327,,HP,CA,CA,2023,Q1,Adult
221010461,22101046,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2023,Q1,Stevens-Johnson syndrome,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,JP-ROCHE-3309692,ROCHE,,69.0,YR,,M,Y,66.0,KG,20230316,,PH,JP,JP,2023,Q1,Elderly
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Depression,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Oxygen saturation decreased,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pemphigus,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221040241,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230308.0,20230316,20230316,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230316,,HP,CA,CA,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Urinary tract infection,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Oedema peripheral,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Device related infection,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Hepatic function abnormal,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Right ventricular failure,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221155141,22115514,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 mg,,,,,,,,100.0,MG,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20180724.0,20230310.0,20230320,20230320,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230320,,CN,JP,JP,2023,Q1,Adult
221225921,22122592,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"take one daily, preferably before breakfast",,,,,,,,,,,,2023,Q1,Urinary incontinence,,2023,Q1,1,I,20220928.0,20230316.0,20230321,20230321,EXP,,GB-AstraZeneca-2023A063854,ASTRAZENECA,,75.0,YR,,F,Y,63.0,KG,20230322,,MD,GB,,2023,Q1,Elderly
221348251,22134825,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Psychiatric symptom,,2023,Q1,1,I,,20230316.0,20230324,20230324,EXP,,NVSC2023CA061636,NOVARTIS,,56.0,YR,,M,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221348251,22134825,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,Depression,,2023,Q1,1,I,,20230316.0,20230324,20230324,EXP,,NVSC2023CA061636,NOVARTIS,,56.0,YR,,M,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221348251,22134825,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q1,"Hallucination, auditory",,2023,Q1,1,I,,20230316.0,20230324,20230324,EXP,,NVSC2023CA061636,NOVARTIS,,56.0,YR,,M,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Oropharyngeal pain,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Headache,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Tachycardia,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Influenza like illness,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Sinusitis,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221363061,22136306,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,Unknown,,2023,Q1,Myalgia,,2023,Q1,1,I,,20230320.0,20230324,20230324,EXP,,CA-JNJFOC-20230356558,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20230324,,HP,CA,CA,2023,Q1,Adult
221466681,22146668,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-PFIZER INC-202201018350,MYLAN,,76.0,YR,,F,Y,,,20230328,,HP,CA,CA,2023,Q1,Elderly
221466681,22146668,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-PFIZER INC-202201018350,MYLAN,,76.0,YR,,F,Y,,,20230328,,HP,CA,CA,2023,Q1,Elderly
221466681,22146668,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-PFIZER INC-202201018350,MYLAN,,76.0,YR,,F,Y,,,20230328,,HP,CA,CA,2023,Q1,Elderly
221466681,22146668,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-PFIZER INC-202201018350,MYLAN,,76.0,YR,,F,Y,,,20230328,,HP,CA,CA,2023,Q1,Elderly
221466681,22146668,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-PFIZER INC-202201018350,MYLAN,,76.0,YR,,F,Y,,,20230328,,HP,CA,CA,2023,Q1,Elderly
221471431,22147143,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, unknown",,,U,,,,,100.0,MG,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221471431,22147143,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, unknown",,,U,,,,,100.0,MG,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221471431,22147143,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"300 mg, unknown",,,U,,,,,300.0,MG,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221471431,22147143,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"300 mg, unknown",,,U,,,,,300.0,MG,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221540001,22154000,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,JP-JNJFOC-20230371300,JOHNSON AND JOHNSON,"Kashima K, Kita H, Onishi S, Saito H. 50 A case of type 2 diabetes mellitus in elderly with hyperosmolar hyperglycemic state (HHS) complicated by osmotic encephalopathy after switching from insulin to SGLT2 inhibitors. The 239th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023.3. 4",91.0,YR,E,F,Y,,,20230330,,MD,JP,JP,2023,Q1,Elderly
221540001,22154000,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,204042.0,,,Tablet,,2023,Q1,Encephalopathy,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,JP-JNJFOC-20230371300,JOHNSON AND JOHNSON,"Kashima K, Kita H, Onishi S, Saito H. 50 A case of type 2 diabetes mellitus in elderly with hyperosmolar hyperglycemic state (HHS) complicated by osmotic encephalopathy after switching from insulin to SGLT2 inhibitors. The 239th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023.3. 4",91.0,YR,E,F,Y,,,20230330,,MD,JP,JP,2023,Q1,Elderly
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Asthma,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Hypoacusis,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Wheezing,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221612681,22161268,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q1,Death,,2023,Q1,1,I,,20230324.0,20230331,20230331,EXP,,CA-PFIZER INC-202300130638,PFIZER,,50.0,YR,,M,Y,,,20230331,,HP,CA,CA,2023,Q1,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Osteolysis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Skin injury,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Rheumatoid arthritis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Drug-induced liver injury,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Treatment failure,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Gastrointestinal infection,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Dyspepsia,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Red blood cell sedimentation rate abnormal,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Hand deformity,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Drug hypersensitivity,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Localised infection,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Therapeutic response decreased,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Synovitis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Bone cyst,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Hepatic fibrosis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Drug intolerance,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Product use issue,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Bone erosion,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Alanine aminotransferase abnormal,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Transaminases increased,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Arthralgia,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Therapeutic product effect decreased,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Diarrhoea,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Hepatic steatosis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Arthropathy,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,C-reactive protein increased,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Pruritus,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Pain,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Anti-cyclic citrullinated peptide antibody positive,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Hepatic cirrhosis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Joint swelling,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,C-reactive protein abnormal,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Infection,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Liver disorder,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Joint ankylosis,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Drug ineffective,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Abdominal discomfort,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Psoriatic arthropathy,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Hypertension,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Upper respiratory tract infection,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
123262569,12326256,56,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Nausea,,2023,Q2,9,F,,20230529.0,20160503,20230601,EXP,,CA-ROCHE-1750136,ROCHE,,50.0,YR,,M,Y,,,20230601,,HP,CA,,2023,Q2,Adult
1656345015,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
1656345015,16563450,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,15,F,,20230606.0,20190712,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230617,,MD,CA,CA,2023,Q2,Elderly
165636083,16563608,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,3,F,,20230414.0,20190712,20230427,EXP,,CA-AUROBINDO-AUR-APL-2019-038537,AUROBINDO,,76.0,YR,,F,Y,,,20230427,,CN,CA,CA,2023,Q2,Elderly
165636083,16563608,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,3,F,,20230414.0,20190712,20230427,EXP,,CA-AUROBINDO-AUR-APL-2019-038537,AUROBINDO,,76.0,YR,,F,Y,,,20230427,,CN,CA,CA,2023,Q2,Elderly
165636083,16563608,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230414.0,20190712,20230427,EXP,,CA-AUROBINDO-AUR-APL-2019-038537,AUROBINDO,,76.0,YR,,F,Y,,,20230427,,CN,CA,CA,2023,Q2,Elderly
165636083,16563608,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,3,F,,20230414.0,20190712,20230427,EXP,,CA-AUROBINDO-AUR-APL-2019-038537,AUROBINDO,,76.0,YR,,F,Y,,,20230427,,CN,CA,CA,2023,Q2,Elderly
165636083,16563608,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,3,F,,20230414.0,20190712,20230427,EXP,,CA-AUROBINDO-AUR-APL-2019-038537,AUROBINDO,,76.0,YR,,F,Y,,,20230427,,CN,CA,CA,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Hypotension,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Low cardiac output syndrome,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Red blood cell count increased,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Lymphocyte percentage decreased,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Cerebral infarction,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,C-reactive protein increased,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Monocyte percentage decreased,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Disease progression,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Neutrophil percentage increased,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Dehydration,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
1665175810,16651758,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Cardiac failure chronic,,2023,Q2,10,F,20190710.0,20230428.0,20190731,20230504,EXP,,JP-PFIZER INC-2019318023,PFIZER,,72.0,YR,,M,Y,51.0,KG,20230504,,MD,JP,JP,2023,Q2,Elderly
166848767,16684876,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram everyday,,,U,,,,,100.0,MG,Tablet,QD,2023,Q2,Malignant neoplasm progression,,2023,Q2,7,F,20190701.0,20230522.0,20190808,20230528,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-077926,BRISTOL MYERS SQUIBB,,57.0,YR,A,M,Y,42.9,KG,20230529,,MD,JP,JP,2023,Q2,Adult
166848767,16684876,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram everyday,,,U,,,,,100.0,MG,Tablet,QD,2023,Q2,Cholangitis,,2023,Q2,7,F,20190701.0,20230522.0,20190808,20230528,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-077926,BRISTOL MYERS SQUIBB,,57.0,YR,A,M,Y,42.9,KG,20230529,,MD,JP,JP,2023,Q2,Adult
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Asthma,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Bronchiectasis,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Cough,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Wheezing,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Nasal congestion,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Dyspnoea,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Full blood count abnormal,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Rhinorrhoea,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
172217748,17221774,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"120 milligram, Once a Day",,,U,U,,,,120.0,MG,Tablet,QD,2023,Q2,Intentional product use issue,,2023,Q2,8,F,,20230414.0,20200101,20230424,EXP,,CA-AUROBINDO-AUR-APL-2019-107105,AUROBINDO,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,109,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Overdose,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Overdose,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1722313912,17223139,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Overdose,,2023,Q2,12,F,,20230501.0,20200102,20230509,EXP,,CA-Orion Corporation ORION PHARMA-TREX2019-6148,ORION,,73.0,YR,E,F,Y,101.0,KG,20230509,,MD,CA,,2023,Q2,Elderly
1793661311,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,33,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,33,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,33,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,33,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
1793661311,17936613,33,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,11,F,,20230426.0,20200624,20230508,EXP,000736566,CA-Accord-185852,ACCORD,,76.0,YR,E,F,Y,,,20230508,,CN,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Nodule,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Rheumatoid arthritis,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Intentional product use issue,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Pain,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Kidney infection,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Intercepted medication error,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Finger deformity,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Fibromyalgia,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Urinary tract infection,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Breast disorder,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Contusion,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Steroid diabetes,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Hypotension,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Vascular stenosis,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Heart rate increased,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Cystitis,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189236275,18923627,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Hypothyroidism,,2023,Q2,5,F,,20230420.0,20210222,20230427,EXP,,CA-PFIZER INC-2021170745,PFIZER,,67.0,YR,,F,Y,69.0,KG,20230427,,HP,CA,CA,2023,Q2,Elderly
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Arthropathy,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug hypersensitivity,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,C-reactive protein abnormal,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Nausea,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Liver disorder,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Bone cyst,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Hepatic cirrhosis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Joint swelling,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Hepatic fibrosis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Osteolysis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Gastrointestinal infection,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Skin injury,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Dyspepsia,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,C-reactive protein increased,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Infection,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Synovitis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Transaminases increased,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug intolerance,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Hepatic steatosis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Localised infection,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Alanine aminotransferase abnormal,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Therapeutic response decreased,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Rheumatoid arthritis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Pain,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Upper respiratory tract infection,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Psoriatic arthropathy,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Anti-cyclic citrullinated peptide antibody positive,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Hand deformity,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Therapeutic product effect decreased,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Joint ankylosis,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Bone erosion,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Red blood cell sedimentation rate abnormal,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug-induced liver injury,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Pruritus,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189687094,18968709,45,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q2,Abdominal discomfort,,2023,Q2,4,F,,20230428.0,20210304,20230508,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019463,BRISTOL MYERS SQUIBB,,50.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,51,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
189784166,18978416,52,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,6,F,,20230508.0,20210307,20230512,EXP,,CA-BAUSCH-BL-2021-006629,BAUSCH AND LOMB,,73.0,YR,,F,Y,101.0,KG,20230512,,CN,CA,CA,2023,Q2,Elderly
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Therapeutic response decreased,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Arthropathy,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Anti-cyclic citrullinated peptide antibody positive,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Alanine aminotransferase abnormal,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Abdominal discomfort,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Drug-induced liver injury,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hepatic steatosis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Synovitis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hepatic fibrosis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrointestinal infection,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Infection,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Pruritus,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Nausea,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Red blood cell sedimentation rate abnormal,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,C-reactive protein abnormal,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Liver disorder,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Drug ineffective,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Arthralgia,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diarrhoea,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hepatic cirrhosis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Rheumatoid arthritis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,C-reactive protein increased,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Skin injury,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Bone cyst,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Product use issue,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Psoriatic arthropathy,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Drug intolerance,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Bone erosion,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Transaminases increased,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Joint swelling,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Pain,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hypertension,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspepsia,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hand deformity,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Joint ankylosis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Localised infection,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Treatment failure,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Therapeutic product effect decreased,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Drug hypersensitivity,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
190983485,19098348,94,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Osteolysis,,2023,Q2,5,F,,20230417.0,20210406,20230425,EXP,,NVSC2021CA074358,NOVARTIS,,50.0,YR,,M,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
191550324,19155032,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,4,F,20181120.0,20230426.0,20210419,20230503,EXP,,JP-ABBVIE-21P-087-3865221-00,ABBVIE,,50.0,YR,,M,Y,75.0,KG,20230503,,MD,JP,JP,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Injection site oedema,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Infusion site swelling,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Injection site swelling,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Injection site pain,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Injection site mass,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Anal abscess,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
194071395,19407139,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Device infusion issue,,2023,Q2,5,F,20210201.0,20230523.0,20210611,20230531,EXP,,CA-TAKEDA-2021TUS035052,TAKEDA,,63.0,YR,,M,Y,99.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Swelling face,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Bronchitis,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Soft tissue injury,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Tooth disorder,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Bladder disorder,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Road traffic accident,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Peripheral swelling,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure decreased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Oropharyngeal pain,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Lower respiratory tract congestion,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Muscle tightness,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Medication error,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Constipation,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Disability assessment scale score increased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure systolic decreased,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Sinus congestion,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Gastrointestinal disorder,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
201507305,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Weight fluctuation,,2023,Q2,5,F,,20230502.0,20211206,20230509,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20230509,,HP,CA,CA,2023,Q2,Adult
206972344,20697234,7,C,Teneligliptin and canagliflozin,,2,Oral,1 Tablet,,,,,,,,,,Tablet,QD,2023,Q2,Laryngeal cancer,,2023,Q2,4,F,20220204.0,20230414.0,20220411,20230427,EXP,,JP-ABBVIE-22K-087-4353892-00,ABBVIE,,80.0,YR,,M,Y,,,20230427,,MD,JP,JP,2023,Q2,Elderly
206972344,20697234,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Laryngeal cancer,,2023,Q2,4,F,20220204.0,20230414.0,20220411,20230427,EXP,,JP-ABBVIE-22K-087-4353892-00,ABBVIE,,80.0,YR,,M,Y,,,20230427,,MD,JP,JP,2023,Q2,Elderly
210711284,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,157,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,158,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,159,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,160,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,161,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,162,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,163,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,164,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,165,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,166,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,166,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,166,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,166,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,166,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,167,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,167,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,167,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,167,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,167,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,168,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,168,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,168,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,168,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,168,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,169,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,169,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,169,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,169,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,169,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,170,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,170,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,170,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,170,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,170,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,171,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,171,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,171,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,171,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,171,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,172,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,172,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,172,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,172,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,172,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,203,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,203,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,203,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,203,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
210711284,21071128,203,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,4,F,,20230620.0,20220712,20230628,EXP,,CA-AstraZeneca-2020SF11610,ASTRAZENECA,,76.0,YR,,F,Y,,,20230628,,MD,CA,,2023,Q2,Elderly
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Depression,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
212012794,21201279,17,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd, HS",,,,,,,,100.0,MG,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,4,F,20190104.0,20230605.0,20220811,20230615,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005977,AEGERION,,12.0,YR,,F,Y,42.8,KG,20230615,,HP,US,US,2023,Q2,Child
212012794,21201279,17,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd, HS",,,,,,,,100.0,MG,,QD,2023,Q2,Treatment noncompliance,,2023,Q2,4,F,20190104.0,20230605.0,20220811,20230615,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005977,AEGERION,,12.0,YR,,F,Y,42.8,KG,20230615,,HP,US,US,2023,Q2,Child
212046755,21204675,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212046755,21204675,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,5,F,,20230515.0,20220812,20230518,EXP,,CA-BAUSCH-BL-2022-019855,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230518,,CN,CA,CA,2023,Q2,Elderly
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
2124491213,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
2124491213,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,,20230619.0,20220823,20230623,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20230623,,MD,CA,CA,2023,Q2,Elderly
216179224,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Off label use,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Renal impairment,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Blood glucose abnormal,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Vascular stenosis,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q2,Renal impairment,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q2,Blood glucose abnormal,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216179224,21617922,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2023,Q2,Vascular stenosis,,2023,Q2,4,F,20210901.0,20230119.0,20221119,20230531,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20230531,,MD,JP,JP,2023,Q2,Elderly
216674179,21667417,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablets,,2023,Q2,Colitis,,2023,Q2,9,F,20221116.0,20230417.0,20221201,20230424,PER,,GB-Eisai Medical Research-EC-2022-129019,EISAI,,62.0,YR,A,M,Y,95.6,KG,20230424,,MD,GB,,2023,Q2,Adult
216871873,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q2,Metabolic acidosis,,2023,Q2,3,F,20220225.0,20230425.0,20221206,20230506,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230506,,PH,PT,PT,2023,Q2,Elderly
216871873,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q2,Acute kidney injury,,2023,Q2,3,F,20220225.0,20230425.0,20221206,20230506,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230506,,PH,PT,PT,2023,Q2,Elderly
216871873,21687187,12,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 cp at breakfast,,,,,,,,100.0,MG,Film-coated tablet,,2023,Q2,Hyperkalaemia,,2023,Q2,3,F,20220225.0,20230425.0,20221206,20230506,EXP,PT-INFARMED-T202205-246,PT-Accord-289636,ACCORD,,82.0,YR,E,M,Y,79.0,KG,20230506,,PH,PT,PT,2023,Q2,Elderly
217348424,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Cholecystitis,,2023,Q2,4,F,20210726.0,20230614.0,20221215,20230622,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230623,,MD,JP,JP,2023,Q2,Child
217348424,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Abdominal abscess,,2023,Q2,4,F,20210726.0,20230614.0,20221215,20230622,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230623,,MD,JP,JP,2023,Q2,Child
217348424,21734842,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Euglycaemic diabetic ketoacidosis,,2023,Q2,4,F,20210726.0,20230614.0,20221215,20230622,EXP,,JP-JNJFOC-20221231605,JOHNSON AND JOHNSON,"Fujita T, Komatsubara Y, Noguchi G, Seshita A. P -211 -3 A case of euglycaemic ketoacidosis associated with oral SGLT -2 inhibitors developed after emergency surgery for gallstone cholecystitis. The 84th Annual Congress of Japan Surgical Association. 2022.11. 24, 25, 26; 2620",6.0,DEC,A,F,Y,,,20230623,,MD,JP,JP,2023,Q2,Child
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Flank pain,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Renal disorder,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Pneumonia,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Abdominal abscess,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Renal vein thrombosis,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Abdominal pain upper,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Decreased appetite,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Haematuria,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Cerebral venous sinus thrombosis,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Platelet count increased,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Nausea,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Chills,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Headache,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Thrombosis,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Pulmonary embolism,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
217517168,21751716,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q2,Platelet count decreased,,2023,Q2,8,F,20221125.0,20230615.0,20221220,20230623,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,,,20230622,,CN,CA,CA,2023,Q2,Adult
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,53,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Cough,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Malignant mediastinal neoplasm,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Off label use,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Bronchiectasis,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Blood immunoglobulin E increased,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219291487,21929148,54,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Intentional product use issue,,2023,Q2,7,F,,20230417.0,20230131,20230424,EXP,,NVSC2023CA016947,NOVARTIS,,73.0,YR,,F,Y,101.0,KG,20230424,,MD,CA,CA,2023,Q2,Elderly
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Depression,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219930074,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,,2023,Q2,Accidental overdose,,2023,Q2,4,F,,20230612.0,20230215,20230622,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230622,,HP,JP,JP,2023,Q2,Adult
219930074,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,,2023,Q2,Hypoglycaemia,,2023,Q2,4,F,,20230612.0,20230215,20230622,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230622,,HP,JP,JP,2023,Q2,Adult
219930074,21993007,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,,2023,Q2,Lactic acidosis,,2023,Q2,4,F,,20230612.0,20230215,20230622,EXP,,JP-EMD Serono-9383361,EMD SERONO INC,,43.0,YR,A,M,Y,,,20230622,,HP,JP,JP,2023,Q2,Adult
219945523,21994552,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,100.0,MG,Tablet,QD,2023,Q2,Euglycaemic diabetic ketoacidosis,,2023,Q2,3,F,20220624.0,20230414.0,20230215,20230421,EXP,,JP-EMD Serono-9383369,EMD SERONO INC,,51.0,YR,A,M,Y,91.0,KG,20230421,,HP,JP,,2023,Q2,Adult
219945523,21994552,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,100.0,MG,Tablet,QD,2023,Q2,Lactic acidosis,,2023,Q2,3,F,20220624.0,20230414.0,20230215,20230421,EXP,,JP-EMD Serono-9383369,EMD SERONO INC,,51.0,YR,A,M,Y,91.0,KG,20230421,,HP,JP,,2023,Q2,Adult
220030613,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Fulminant type 1 diabetes mellitus,,2023,Q2,3,F,,20230519.0,20230217,20230526,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230526,,HP,JP,,2023,Q2,Elderly
220030613,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Ketosis,,2023,Q2,3,F,,20230519.0,20230217,20230526,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230526,,HP,JP,,2023,Q2,Elderly
220030613,22003061,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Glomerular filtration rate decreased,,2023,Q2,3,F,,20230519.0,20230217,20230526,EXP,,JP-EMD Serono-9384176,EMD SERONO INC,,72.0,YR,E,M,Y,57.0,KG,20230526,,HP,JP,,2023,Q2,Elderly
220215732,22021573,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,Dose unknown,,,,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,2,F,20230210.0,20230331.0,20230222,20230407,EXP,,JP-AstraZeneca-2023A039852,ASTRAZENECA,,61.0,YR,,M,Y,,,20230407,,MD,JP,,2023,Q2,Adult
220215732,22021573,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,Dose unknown,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,2,F,20230210.0,20230331.0,20230222,20230407,EXP,,JP-AstraZeneca-2023A039852,ASTRAZENECA,,61.0,YR,,M,Y,,,20230407,,MD,JP,,2023,Q2,Adult
220215732,22021573,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,Dose unknown,,,,,,,,,,,,2023,Q2,Oedema,,2023,Q2,2,F,20230210.0,20230331.0,20230222,20230407,EXP,,JP-AstraZeneca-2023A039852,ASTRAZENECA,,61.0,YR,,M,Y,,,20230407,,MD,JP,,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,"Hallucination, visual",,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Depression,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Anxiety,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Psychotic disorder,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Product prescribing error,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220311412,22031141,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,100.0,MG,Tablet,QD,2023,Q2,Suicidal ideation,,2023,Q2,2,F,,20230605.0,20230223,20230615,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230615,,HP,CA,CA,2023,Q2,Adult
220691223,22069122,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,dose and frequency unknown,,,,,,,,,,Unknown,,2023,Q2,Cerebral infarction,,2023,Q2,3,F,20230104.0,20230403.0,20230307,20230417,PER,,JP-Eisai Medical Research-EC-2023-132906,EISAI,,62.0,YR,A,M,Y,59.0,KG,20230417,,MD,JP,JP,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Mouth ulceration,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Body temperature decreased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Blood pressure systolic increased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Pemphigus,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220706423,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Heart rate increased,,2023,Q2,3,F,,20230621.0,20230307,20230627,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230627,,HP,CA,CA,2023,Q2,Adult
220751302,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Full blood count abnormal,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220751302,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230620.0,20230308,20230627,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20230627,,MD,CA,,2023,Q2,Elderly
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Lower respiratory tract infection,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Oropharyngeal pain,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Swelling face,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Constipation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Peripheral swelling,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Cough,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Medication error,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Disability assessment scale score increased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sinus congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Tooth disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Lower respiratory tract congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Soft tissue injury,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Road traffic accident,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Bronchitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Muscle tightness,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Bladder disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Gastrointestinal disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,28,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Headache,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Lower respiratory tract infection,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Oropharyngeal pain,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Swelling face,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Constipation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Peripheral swelling,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Cough,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Medication error,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Disability assessment scale score increased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sinus congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Tooth disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Lower respiratory tract congestion,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Soft tissue injury,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Road traffic accident,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Bronchitis,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Muscle tightness,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Bladder disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic decreased,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Gastrointestinal disorder,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
220988373,22098837,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Headache,,2023,Q2,3,F,,20230524.0,20230315,20230531,EXP,,NVSC2023CA055585,NOVARTIS,,46.0,YR,,F,Y,90.0,KG,20230531,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Depression,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Heart rate increased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Mouth ulceration,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Off label use,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure systolic increased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pemphigus,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221040243,22104024,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Body temperature decreased,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055464,NOVARTIS,,62.0,YR,,M,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
221211342,22121134,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Renal impairment,,2023,Q2,2,F,,20230406.0,20230321,20230411,EXP,,JP-EMD Serono-9391040,EMD SERONO INC,,76.0,YR,E,M,Y,,,20230411,,PH,JP,,2023,Q2,Elderly
221540002,22154000,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q2,Encephalopathy,,2023,Q2,2,F,,20230418.0,20230330,20230426,EXP,,JP-JNJFOC-20230371300,JOHNSON AND JOHNSON,"Kashima K, Kita H, Onishi S, Saito H. 50 A case of type 2 diabetes mellitus in elderly with hyperosmolar hyperglycemic state (HHS) complicated by osmotic encephalopathy after switching from insulin to SGLT2 inhibitors. The 239th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023.3. 4",91.0,YR,E,F,Y,,,20230426,,MD,JP,JP,2023,Q2,Elderly
221540002,22154000,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2023,Q2,2,F,,20230418.0,20230330,20230426,EXP,,JP-JNJFOC-20230371300,JOHNSON AND JOHNSON,"Kashima K, Kita H, Onishi S, Saito H. 50 A case of type 2 diabetes mellitus in elderly with hyperosmolar hyperglycemic state (HHS) complicated by osmotic encephalopathy after switching from insulin to SGLT2 inhibitors. The 239th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023.3. 4",91.0,YR,E,F,Y,,,20230426,,MD,JP,JP,2023,Q2,Elderly
221793451,22179345,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK, od (take one daily)",,,,,Unknown,,,,,,QD,2023,Q2,Rash erythematous,,2023,Q2,1,I,20230215.0,20230220.0,20230406,20230406,EXP,GB-MHRA-ADR 27695082,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-02257,ALKEM,,63.0,YR,,F,Y,101.0,KG,20230406,,MD,GB,GB,2023,Q2,Adult
221807991,22180799,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Dental caries,,2023,Q2,1,I,19980101.0,20210910.0,20230406,20230406,EXP,GB-MHRA-EYC 00260094,GB-PURDUE-USA-2021-0300987,PURDUE,,60.0,YR,,M,Y,130.0,KG,20230406,,CN,GB,GB,2023,Q2,Adult
221807991,22180799,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Tooth extraction,,2023,Q2,1,I,19980101.0,20210910.0,20230406,20230406,EXP,GB-MHRA-EYC 00260094,GB-PURDUE-USA-2021-0300987,PURDUE,,60.0,YR,,M,Y,130.0,KG,20230406,,CN,GB,GB,2023,Q2,Adult
221807991,22180799,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Tooth discolouration,,2023,Q2,1,I,19980101.0,20210910.0,20230406,20230406,EXP,GB-MHRA-EYC 00260094,GB-PURDUE-USA-2021-0300987,PURDUE,,60.0,YR,,M,Y,130.0,KG,20230406,,CN,GB,GB,2023,Q2,Adult
221857511,22185751,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1.00 tablet, once every one day",,,Y,,LFL5R00,,,,,Tablet,,2023,Q2,Electrolyte imbalance,,2023,Q2,1,I,20220526.0,20230404.0,20230407,20230407,EXP,,CN-AstraZeneca-2023A079892,ASTRAZENECA,,15429.0,DY,,F,Y,65.0,KG,20230407,,MD,CN,,2023,Q2,Elderly
221857511,22185751,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1.00 tablet, once every one day",,,Y,,LFL5R00,,,,,Tablet,,2023,Q2,Gastritis,,2023,Q2,1,I,20220526.0,20230404.0,20230407,20230407,EXP,,CN-AstraZeneca-2023A079892,ASTRAZENECA,,15429.0,DY,,F,Y,65.0,KG,20230407,,MD,CN,,2023,Q2,Elderly
221857511,22185751,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1.00 tablet, once every one day",,,Y,,LFL5R00,,,,,Tablet,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20220526.0,20230404.0,20230407,20230407,EXP,,CN-AstraZeneca-2023A079892,ASTRAZENECA,,15429.0,DY,,F,Y,65.0,KG,20230407,,MD,CN,,2023,Q2,Elderly
221857511,22185751,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1.00 tablet, once every one day",,,Y,,LFL5R00,,,,,Tablet,,2023,Q2,Dermatitis allergic,,2023,Q2,1,I,20220526.0,20230404.0,20230407,20230407,EXP,,CN-AstraZeneca-2023A079892,ASTRAZENECA,,15429.0,DY,,F,Y,65.0,KG,20230407,,MD,CN,,2023,Q2,Elderly
221925642,22192564,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100mg,,,U,,,,,,,,,2023,Q2,Premature delivery,,2023,Q2,2,F,,20230410.0,20230410,20230420,EXP,,JP-NOVOPROD-1048928,NOVO NORDISK,"Okamoto Y, et al.. A case of type 2 diabetes mellitus where pregnancy was revealed in Week 33 during administration of five oral hypoglycaemic drugs. The Japan Diabetes Society. 2022;79",36.0,YR,,F,Y,,,20230420,,MD,JP,JP,2023,Q2,Adult
221925642,22192564,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100mg,,,U,,,,,,,,,2023,Q2,Pre-eclampsia,,2023,Q2,2,F,,20230410.0,20230410,20230420,EXP,,JP-NOVOPROD-1048928,NOVO NORDISK,"Okamoto Y, et al.. A case of type 2 diabetes mellitus where pregnancy was revealed in Week 33 during administration of five oral hypoglycaemic drugs. The Japan Diabetes Society. 2022;79",36.0,YR,,F,Y,,,20230420,,MD,JP,JP,2023,Q2,Adult
221925642,22192564,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100mg,,,U,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,,20230410.0,20230410,20230420,EXP,,JP-NOVOPROD-1048928,NOVO NORDISK,"Okamoto Y, et al.. A case of type 2 diabetes mellitus where pregnancy was revealed in Week 33 during administration of five oral hypoglycaemic drugs. The Japan Diabetes Society. 2022;79",36.0,YR,,F,Y,,,20230420,,MD,JP,JP,2023,Q2,Adult
221933701,22193370,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,D,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Death,,2023,Q2,1,I,20161208.0,20170203.0,20230410,20230410,EXP,,JP-JNJFOC-20211237646,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20230410,,MD,JP,JP,2023,Q2,Elderly
221955771,22195577,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Acute myocardial infarction,,2023,Q2,1,I,,20211122.0,20230411,20230411,EXP,,PL-JNJFOC-20211157842,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230411,,CN,PL,PL,2023,Q2,Adult
221955771,22195577,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,,20211122.0,20230411,20230411,EXP,,PL-JNJFOC-20211157842,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230411,,CN,PL,PL,2023,Q2,Adult
221955771,22195577,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,1,I,,20211122.0,20230411,20230411,EXP,,PL-JNJFOC-20211157842,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230411,,CN,PL,PL,2023,Q2,Adult
221955771,22195577,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,1,I,,20211122.0,20230411,20230411,EXP,,PL-JNJFOC-20211157842,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230411,,CN,PL,PL,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Liver disorder,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Blood creatine phosphokinase increased,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Immune-mediated myositis,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Mobility decreased,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Vitamin D decreased,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Antinuclear antibody,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Vitamin B12 decreased,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Sensory loss,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Paraesthesia,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
221997471,22199747,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,,,2023,Q2,Suspected COVID-19,,2023,Q2,1,I,,20230330.0,20230412,20230412,EXP,,CA-drreddys-SPO/CAN/23/0163561,DR REDDYS,,64.0,YR,A,F,Y,72.0,KG,20230412,,CN,CA,CA,2023,Q2,Adult
222045382,22204538,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Acute myocardial infarction,,2023,Q2,2,F,,20230516.0,20230413,20230523,EXP,,JP-JNJFOC-20230420981,JOHNSON AND JOHNSON,,54.0,YR,A,M,Y,,,20230523,,MD,JP,JP,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Depression,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Anxiety,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Suicidal ideation,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Product prescribing error,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222202991,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, visual",,2023,Q2,1,I,,20230412.0,20230417,20230417,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230417,,CN,CA,CA,2023,Q2,Adult
222203912,22220391,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Angina pectoris,,2023,Q2,2,F,20220314.0,20230601.0,20230417,20230607,EXP,,JP-009507513-2304JPN001784J,MERCK,,6.0,DEC,,M,Y,,,20230607,,MD,JP,JP,2023,Q2,Child
222203912,22220391,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Intervertebral disc protrusion,,2023,Q2,2,F,20220314.0,20230601.0,20230417,20230607,EXP,,JP-009507513-2304JPN001784J,MERCK,,6.0,DEC,,M,Y,,,20230607,,MD,JP,JP,2023,Q2,Child
222266582,22226658,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Therapy non-responder,,2023,Q2,2,F,,20230523.0,20230419,20230529,EXP,,JP-EMD Serono-9393010,EMD SERONO INC,,6.0,DEC,A,F,Y,,,20230529,,PH,JP,,2023,Q2,Child
222266582,22226658,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Ketoacidosis,,2023,Q2,2,F,,20230523.0,20230419,20230529,EXP,,JP-EMD Serono-9393010,EMD SERONO INC,,6.0,DEC,A,F,Y,,,20230529,,PH,JP,,2023,Q2,Child
222266582,22226658,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Dizziness,,2023,Q2,2,F,,20230523.0,20230419,20230529,EXP,,JP-EMD Serono-9393010,EMD SERONO INC,,6.0,DEC,A,F,Y,,,20230529,,PH,JP,,2023,Q2,Child
222272112,22227211,12,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,UNK,,,,,,,,,,,,2023,Q2,Intervertebral disc protrusion,,2023,Q2,2,F,20200511.0,20230601.0,20230419,20230608,EXP,,JP-GILEAD-2021-0525220,GILEAD,,6.0,DEC,A,M,Y,,,20230608,,MD,JP,JP,2023,Q2,Child
222272112,22227211,12,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,UNK,,,,,,,,,,,,2023,Q2,Angina pectoris,,2023,Q2,2,F,20200511.0,20230601.0,20230419,20230608,EXP,,JP-GILEAD-2021-0525220,GILEAD,,6.0,DEC,A,M,Y,,,20230608,,MD,JP,JP,2023,Q2,Child
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Therapeutic product effect decreased,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Pain,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Drug intolerance,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Arthralgia,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Skin injury,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Upper respiratory tract infection,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Hepatic cirrhosis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Anti-cyclic citrullinated peptide antibody positive,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Osteolysis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Bone erosion,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Red blood cell sedimentation rate abnormal,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Localised infection,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Alanine aminotransferase abnormal,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Hypertension,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Drug hypersensitivity,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Hepatic steatosis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Psoriatic arthropathy,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Drug-induced liver injury,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Infection,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Abdominal discomfort,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,C-reactive protein increased,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Nausea,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Transaminases increased,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Rheumatoid arthritis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Diarrhoea,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Synovitis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Hand deformity,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Treatment failure,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Bone cyst,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Joint ankylosis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Gastrointestinal infection,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Hepatic fibrosis,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Pruritus,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Joint swelling,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,C-reactive protein abnormal,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Arthropathy,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222328272,22232827,53,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Tablet,,2023,Q2,Dyspepsia,,2023,Q2,2,F,,20230508.0,20230420,20230510,EXP,,CA-ORGANON-O2304CAN001364,ORGANON,,61.0,YR,,M,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Psychotic disorder,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, visual",,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Depression,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Suicidal ideation,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Anxiety,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423052,22242305,12,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Product prescribing error,,2023,Q2,2,F,,20230414.0,20230422,20230427,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230427,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222428851,22242885,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Therapeutic response shortened,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,CA-MHPD-E2B_06100780,CA-Accord-308907,ACCORD,,53.0,YR,,M,Y,,,20230424,,MD,CA,CA,2023,Q2,Adult
222428851,22242885,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Hypertransaminasaemia,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,CA-MHPD-E2B_06100780,CA-Accord-308907,ACCORD,,53.0,YR,,M,Y,,,20230424,,MD,CA,CA,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Electrocardiogram ST segment elevation,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Vascular stent stenosis,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Restlessness,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Thrombosis with thrombocytopenia syndrome,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Vascular stent occlusion,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222460791,22246079,12,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Oral,"100mg/20mg, qd",,,,,,,,,,Tablet,QD,2023,Q2,Device occlusion,,2023,Q2,1,I,,20230418.0,20230424,20230424,EXP,,JP-DSJP-DSJ-2023-115467,DAIICHI,"Koshida N, Horie K, Kuroki N, Kobayashi Y, Kasahara T, Kaneko S, et al.. Possible VITT in a patient with acute myocardial infarction who was suffured from repeat stent thrombosis, after COVID-19 vaccination. The 41st Tokyo CCU Study Group.. Japanese Journal of Intensive Care Medicine. 2022;46S:S63-S67",61.0,YR,,M,Y,71.2,KG,20230424,,MD,JP,JP,2023,Q2,Adult
222516711,22251671,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230417.0,20230425,20230425,EXP,,CA-BAUSCH-BL-2023-006213,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Elderly
222516711,22251671,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230417.0,20230425,20230425,EXP,,CA-BAUSCH-BL-2023-006213,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Elderly
222516711,22251671,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230417.0,20230425,20230425,EXP,,CA-BAUSCH-BL-2023-006213,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Elderly
222516711,22251671,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230417.0,20230425,20230425,EXP,,CA-BAUSCH-BL-2023-006213,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Elderly
222516711,22251671,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230417.0,20230425,20230425,EXP,,CA-BAUSCH-BL-2023-006213,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Elderly
222580501,22258050,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230419.0,20230427,20230427,EXP,,CA-AstraZeneca-2023A094102,ASTRAZENECA,,76.0,YR,,F,Y,,,20230427,,MD,CA,,2023,Q2,Elderly
222580501,22258050,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230419.0,20230427,20230427,EXP,,CA-AstraZeneca-2023A094102,ASTRAZENECA,,76.0,YR,,F,Y,,,20230427,,MD,CA,,2023,Q2,Elderly
222580501,22258050,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230419.0,20230427,20230427,EXP,,CA-AstraZeneca-2023A094102,ASTRAZENECA,,76.0,YR,,F,Y,,,20230427,,MD,CA,,2023,Q2,Elderly
222580501,22258050,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230419.0,20230427,20230427,EXP,,CA-AstraZeneca-2023A094102,ASTRAZENECA,,76.0,YR,,F,Y,,,20230427,,MD,CA,,2023,Q2,Elderly
222580501,22258050,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230419.0,20230427,20230427,EXP,,CA-AstraZeneca-2023A094102,ASTRAZENECA,,76.0,YR,,F,Y,,,20230427,,MD,CA,,2023,Q2,Elderly
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Thrombosis with thrombocytopenia syndrome,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Vascular stent stenosis,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Restlessness,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Electrocardiogram ST segment elevation,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Vascular stent occlusion,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222643801,22264380,10,C,CANAGLIFLOZIN HEMIHYDRATE;TENELIGLIPTIN HYDROBROMIDE,,1,Unknown,,,,,,Unknown,,,,,Tablet,,2023,Q2,Device occlusion,,2023,Q2,1,I,,20230418.0,20230428,20230428,EXP,,JP-COSETTE-CP2023JP000078,COSETTE PHARMACEUTICALS,,61.0,YR,A,M,Y,71.2,KG,20230428,,HP,JP,JP,2023,Q2,Adult
222675811,22267581,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,1,I,,20230417.0,20230430,20230430,EXP,,CA-AUROBINDO-AUR-APL-2023-032748,AUROBINDO,,56.0,YR,,M,Y,,,20230429,,HP,CA,CA,2023,Q2,Adult
222675811,22267581,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Depression,,2023,Q2,1,I,,20230417.0,20230430,20230430,EXP,,CA-AUROBINDO-AUR-APL-2023-032748,AUROBINDO,,56.0,YR,,M,Y,,,20230429,,HP,CA,CA,2023,Q2,Adult
222675811,22267581,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q2,Psychiatric symptom,,2023,Q2,1,I,,20230417.0,20230430,20230430,EXP,,CA-AUROBINDO-AUR-APL-2023-032748,AUROBINDO,,56.0,YR,,M,Y,,,20230429,,HP,CA,CA,2023,Q2,Adult
222714053,22271405,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Atrial fibrillation,,2023,Q2,3,F,20221213.0,20230606.0,20230501,20230609,EXP,,JP-AMGEN-JPNSP2023074064,AMGEN,,54.0,YR,A,M,Y,102.0,KG,20230609,,PH,JP,JP,2023,Q2,Adult
222714053,22271405,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q2,Cardiac failure,,2023,Q2,3,F,20221213.0,20230606.0,20230501,20230609,EXP,,JP-AMGEN-JPNSP2023074064,AMGEN,,54.0,YR,A,M,Y,102.0,KG,20230609,,PH,JP,JP,2023,Q2,Adult
222763483,22276348,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",139800.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Melaena,,2023,Q2,3,F,20230117.0,20230623.0,20230503,20230630,EXP,,JP-JNJFOC-20230460577,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,,,20230630,,MD,JP,JP,2023,Q2,Elderly
222763483,22276348,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",139800.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Metabolic acidosis,,2023,Q2,3,F,20230117.0,20230623.0,20230503,20230630,EXP,,JP-JNJFOC-20230460577,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,,,20230630,,MD,JP,JP,2023,Q2,Elderly
222770791,22277079,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-TAKEDA-2023TUS043495,TAKEDA,,76.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Elderly
222770791,22277079,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-TAKEDA-2023TUS043495,TAKEDA,,76.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Elderly
222770791,22277079,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-TAKEDA-2023TUS043495,TAKEDA,,76.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Elderly
222770791,22277079,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-TAKEDA-2023TUS043495,TAKEDA,,76.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Elderly
222770791,22277079,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-TAKEDA-2023TUS043495,TAKEDA,,76.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Elderly
222774861,22277486,3,C,CANAGLIFLOZIN;METFORMIN,,1,Oral,,,,,,,,,500.0,MG,Prolonged-release tablet,,2023,Q2,Hypersensitivity,,2023,Q2,1,I,20220101.0,20230425.0,20230503,20230503,EXP,,CA-JNJFOC-20230457616,JOHNSON AND JOHNSON,,44.0,YR,A,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222774861,22277486,3,C,CANAGLIFLOZIN;METFORMIN,,1,Oral,,,,,,,,,500.0,MG,Prolonged-release tablet,,2023,Q2,Asthma,,2023,Q2,1,I,20220101.0,20230425.0,20230503,20230503,EXP,,CA-JNJFOC-20230457616,JOHNSON AND JOHNSON,,44.0,YR,A,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222774861,22277486,3,C,CANAGLIFLOZIN;METFORMIN,,1,Oral,,,,,,,,,500.0,MG,Prolonged-release tablet,,2023,Q2,COVID-19,,2023,Q2,1,I,20220101.0,20230425.0,20230503,20230503,EXP,,CA-JNJFOC-20230457616,JOHNSON AND JOHNSON,,44.0,YR,A,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222819782,22281978,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q2,Tubulointerstitial nephritis,,2023,Q2,2,F,,20230508.0,20230504,20230515,EXP,,JP-JNJFOC-20230502569,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20230515,,PH,JP,JP,2023,Q2,Elderly
222870291,22287029,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-APOTEX-2023AP007741,APOTEX,,76.0,YR,,F,Y,,,20230505,,HP,CA,CA,2023,Q2,Elderly
222870291,22287029,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-APOTEX-2023AP007741,APOTEX,,76.0,YR,,F,Y,,,20230505,,HP,CA,CA,2023,Q2,Elderly
222870291,22287029,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-APOTEX-2023AP007741,APOTEX,,76.0,YR,,F,Y,,,20230505,,HP,CA,CA,2023,Q2,Elderly
222870291,22287029,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-APOTEX-2023AP007741,APOTEX,,76.0,YR,,F,Y,,,20230505,,HP,CA,CA,2023,Q2,Elderly
222870291,22287029,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-APOTEX-2023AP007741,APOTEX,,76.0,YR,,F,Y,,,20230505,,HP,CA,CA,2023,Q2,Elderly
222877381,22287738,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, qd",,,Y,U,,,,300.0,MG,,QD,2023,Q2,Rebound effect,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,GB-MYLANLABS-2023M1046525,MYLAN,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract-Diabetes 2023;40(2):24-27.",59.0,YR,,M,Y,,,20230505,,MD,GB,GB,2023,Q2,Adult
222877381,22287738,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, qd",,,Y,U,,,,300.0,MG,,QD,2023,Q2,Acetonaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,GB-MYLANLABS-2023M1046525,MYLAN,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract-Diabetes 2023;40(2):24-27.",59.0,YR,,M,Y,,,20230505,,MD,GB,GB,2023,Q2,Adult
222877381,22287738,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, qd",,,Y,U,,,,300.0,MG,,QD,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,GB-MYLANLABS-2023M1046525,MYLAN,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract-Diabetes 2023;40(2):24-27.",59.0,YR,,M,Y,,,20230505,,MD,GB,GB,2023,Q2,Adult
222906651,22290665,69,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,69,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,69,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,69,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,69,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,70,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,70,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,70,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,70,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,70,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,71,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,71,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,71,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,71,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,71,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,72,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,72,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,72,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,72,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,72,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,73,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,73,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,73,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,73,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,73,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,74,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,74,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,74,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,74,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,74,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,75,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,75,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,75,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,75,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,75,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,76,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,76,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,76,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,76,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,76,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,77,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,77,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,77,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,77,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,77,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,78,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,78,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Full blood count abnormal,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,78,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,78,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222906651,22290665,78,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CA-TEVA-2023-CA-2882545,TEVA,,76.0,YR,E,F,Y,,,20230506,,HP,CA,CA,2023,Q2,Elderly
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Suicidal ideation,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Product prescribing error,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Depression,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Anxiety,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222952131,22295213,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222953951,22295395,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,"Hallucination, auditory",,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883105,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222953951,22295395,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Depression,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883105,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222953951,22295395,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q2,Psychiatric symptom,,2023,Q2,1,I,,20230428.0,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883105,TEVA,,56.0,YR,A,M,Y,,,20230508,,HP,CA,CA,2023,Q2,Adult
222966671,22296667,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,,QD,2023,Q2,Vitreous floaters,,2023,Q2,1,I,20180807.0,20230501.0,20230508,20230508,EXP,,US-ABBVIE-4749234,ABBVIE,,64.0,YR,,F,Y,,,20230505,,MD,US,US,2023,Q2,Adult
222989161,22298916,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 mg, qd (in the morning)",,,Y,,,,,100.0,MG,,QD,2023,Q2,Ketoacidosis,,2023,Q2,1,I,20230424.0,20230428.0,20230509,20230509,EXP,,GB-NOVOPROD-1060984,NOVO NORDISK,,56.0,YR,,M,Y,100.0,KG,20230509,,PH,GB,GB,2023,Q2,Adult
223002712,22300271,4,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,D,,,,,,,Tablet,,2023,Q2,Death,,2023,Q2,2,F,,20230508.0,20230509,20230516,EXP,,JP-EMD Serono-9400479,EMD SERONO INC,,52.0,YR,A,M,Y,,,20230516,,HP,JP,,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Asthma,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,Tablet,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223158032,22315803,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 Milligram Daily;,,,Y,,,,,300.0,MG,,QD,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230515.0,20230512,20230525,EXP,,GB-TEVA-2023-GB-2886505,TEVA,,59.0,YR,A,M,Y,,,20230525,,MD,GB,GB,2023,Q2,Adult
223158032,22315803,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 Milligram Daily;,,,Y,,,,,300.0,MG,,QD,2023,Q2,Diabetic ketoacidosis,,2023,Q2,2,F,,20230515.0,20230512,20230525,EXP,,GB-TEVA-2023-GB-2886505,TEVA,,59.0,YR,A,M,Y,,,20230525,,MD,GB,GB,2023,Q2,Adult
223173933,22317393,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,,,,,,,,,,,Tablet,,2023,Q2,Death,,2023,Q2,3,F,20230428.0,20230608.0,20230515,20230612,EXP,,JP-EMD Serono-9401238,EMD SERONO INC,,52.0,YR,A,M,Y,71.0,KG,20230612,,MD,JP,,2023,Q2,Adult
223333092,22333309,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q2,Sinus arrest,,2023,Q2,2,F,,20230520.0,20230517,20230526,EXP,,JP-JNJFOC-20230540752,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20230526,,MD,JP,JP,2023,Q2,Elderly
223333092,22333309,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q2,Atrial fibrillation,,2023,Q2,2,F,,20230520.0,20230517,20230526,EXP,,JP-JNJFOC-20230540752,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20230526,,MD,JP,JP,2023,Q2,Elderly
223398171,22339817,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2023,Q2,Cholecystitis acute,,2023,Q2,1,I,,20230510.0,20230518,20230518,EXP,,JP-BAXTER-2023BAX021985,BAXTER,Urushino K.A Case of Acquired Hemophilia A Diagnosed in the Occurrence of Post-catheterization Radial Artery Pseudoaneurysm.The Japanese Journal of Vascular Surgery (e-journal) 2023;32(2):87-91.,79.0,YR,,M,Y,,,20230518,,HP,JP,JP,2023,Q2,Elderly
223398171,22339817,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2023,Q2,Sepsis,,2023,Q2,1,I,,20230510.0,20230518,20230518,EXP,,JP-BAXTER-2023BAX021985,BAXTER,Urushino K.A Case of Acquired Hemophilia A Diagnosed in the Occurrence of Post-catheterization Radial Artery Pseudoaneurysm.The Japanese Journal of Vascular Surgery (e-journal) 2023;32(2):87-91.,79.0,YR,,M,Y,,,20230518,,HP,JP,JP,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Peripheral coldness,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Epistaxis,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Fatigue,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Diarrhoea,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Decreased appetite,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Squamous cell carcinoma,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Peripheral coldness,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Epistaxis,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Squamous cell carcinoma,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Peripheral coldness,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Epistaxis,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223734301,22373430,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Squamous cell carcinoma,,2023,Q2,1,I,20220401.0,20230521.0,20230526,20230526,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,81.0,KG,20230526,,MD,GB,GB,2023,Q2,Elderly
223769561,22376956,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,U,U,,,204042.0,100.0,MG,Tablet,,2023,Q2,Trismus,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-JNJFOC-20230563267,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Fall,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Flank pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Sleep disorder,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Weight increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Cough,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Bone pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Rales,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,Restless legs syndrome,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,COVID-19,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, 1x/day",,,,,,,,300.0,MG,,QD,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223836232,22383623,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 mg,,,Y,,,,,100.0,MG,,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,2,F,,20230605.0,20230530,20230614,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305011961,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20230614,,CN,JP,JP,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Weight increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Sleep disorder,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Fall,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Cough,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Restless legs syndrome,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,COVID-19,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Rales,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Bone pain,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Flank pain,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 mg, QD",,,U,,UNK,,,300.0,MG,,QD,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Ageusia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Affective disorder,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Vitamin B12 decreased,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Hallucination,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Depression,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Fall,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Nightmare,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Insomnia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Sleep talking,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Anosmia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Urinary tract infection,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Stress,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Renal pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Neck injury,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Mobility decreased,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Back pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Road traffic accident,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Muscle twitching,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Sensory loss,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Dizziness,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Pollakiuria,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,General physical health deterioration,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Decreased appetite,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Abnormal dreams,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,,QD,2023,Q2,Anger,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223909531,22390953,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Therapeutic response shortened,,2023,Q2,1,I,,20230523.0,20230601,20230601,EXP,,CA-TEVA-2023-CA-2891590,TEVA,,53.0,YR,A,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Adult
223909531,22390953,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230523.0,20230601,20230601,EXP,,CA-TEVA-2023-CA-2891590,TEVA,,53.0,YR,A,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Adult
223909531,22390953,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230523.0,20230601,20230601,EXP,,CA-TEVA-2023-CA-2891590,TEVA,,53.0,YR,A,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Adult
223909531,22390953,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q2,Hypertransaminasaemia,,2023,Q2,1,I,,20230523.0,20230601,20230601,EXP,,CA-TEVA-2023-CA-2891590,TEVA,,53.0,YR,A,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Adult
225221981,22522198,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2023,Q2,Hallucination,,2023,Q2,1,I,20220307.0,20230526.0,20230605,20230605,EXP,,NVSC2023GB121105,NOVARTIS,,72.0,YR,,M,Y,,,20230602,,MD,GB,GB,2023,Q2,Elderly
225896991,22589699,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,unknown,,,,,Tablet,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230506.0,20230530.0,20230612,20230612,EXP,,JP-NOVOPROD-1067089,NOVO NORDISK,,69.0,YR,,M,Y,64.4,KG,20230612,,MD,JP,JP,2023,Q2,Elderly
225896991,22589699,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,unknown,,,,,Tablet,,2023,Q2,Decreased appetite,,2023,Q2,1,I,20230506.0,20230530.0,20230612,20230612,EXP,,JP-NOVOPROD-1067089,NOVO NORDISK,,69.0,YR,,M,Y,64.4,KG,20230612,,MD,JP,JP,2023,Q2,Elderly
225896991,22589699,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,unknown,,,,,Tablet,,2023,Q2,Dehydration,,2023,Q2,1,I,20230506.0,20230530.0,20230612,20230612,EXP,,JP-NOVOPROD-1067089,NOVO NORDISK,,69.0,YR,,M,Y,64.4,KG,20230612,,MD,JP,JP,2023,Q2,Elderly
225896991,22589699,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,unknown,,,,,Tablet,,2023,Q2,Vomiting,,2023,Q2,1,I,20230506.0,20230530.0,20230612,20230612,EXP,,JP-NOVOPROD-1067089,NOVO NORDISK,,69.0,YR,,M,Y,64.4,KG,20230612,,MD,JP,JP,2023,Q2,Elderly
225954891,22595489,9,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablets,,2023,Q2,Diverticulum intestinal haemorrhagic,,2023,Q2,1,I,20210723.0,20230605.0,20230613,20230613,PER,,JP-Eisai Medical Research-EC-2023-142358,EISAI,,74.0,YR,E,M,Y,70.0,KG,20230613,,MD,JP,JP,2023,Q2,Elderly
226104102,22610410,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,100.0,MG,Film-coated tablet,QD,2023,Q2,Renal cancer,,2023,Q2,2,F,20180420.0,20181023.0,20230616,20230616,EXP,,JP-JNJFOC-20181101401,JOHNSON AND JOHNSON,,61.0,YR,A,M,Y,73.0,KG,20230616,,HP,JP,JP,2023,Q2,Adult
226127431,22612743,1,PS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,U,,,204353.0,,,Film-coated tablet,,2023,Q2,Systemic candida,,2023,Q2,1,I,20230515.0,20230614.0,20230617,20230617,EXP,ES-AEMPS-1376718,ES-JNJFOC-20230638330,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20230617,,MD,ES,ES,2023,Q2,Elderly
226320751,22632075,8,C,CANAGLIFLOZIN;METFORMIN,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP009880,STRIDES,"Gannamani V, Varma A, Nathan S, Ustun C.. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.. Transpl-Immunol. 2023",51.0,YR,,F,Y,,,20230623,,HP,US,US,2023,Q2,Adult
226320751,22632075,8,C,CANAGLIFLOZIN;METFORMIN,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Human herpesvirus 6 infection,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP009880,STRIDES,"Gannamani V, Varma A, Nathan S, Ustun C.. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.. Transpl-Immunol. 2023",51.0,YR,,F,Y,,,20230623,,HP,US,US,2023,Q2,Adult
226320751,22632075,8,C,CANAGLIFLOZIN;METFORMIN,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Calcineurin inhibitor induced pain syndrome,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP009880,STRIDES,"Gannamani V, Varma A, Nathan S, Ustun C.. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.. Transpl-Immunol. 2023",51.0,YR,,F,Y,,,20230623,,HP,US,US,2023,Q2,Adult
226320751,22632075,8,C,CANAGLIFLOZIN;METFORMIN,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hyponatraemia,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP009880,STRIDES,"Gannamani V, Varma A, Nathan S, Ustun C.. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.. Transpl-Immunol. 2023",51.0,YR,,F,Y,,,20230623,,HP,US,US,2023,Q2,Adult
226443001,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Neuropathy peripheral,,2023,Q2,1,I,20210705.0,20230620.0,20230627,20230627,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230627,,MD,JP,JP,2023,Q2,Adult
226443001,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Insomnia,,2023,Q2,1,I,20210705.0,20230620.0,20230627,20230627,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230627,,MD,JP,JP,2023,Q2,Adult
226443001,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q2,Chest discomfort,,2023,Q2,1,I,20210705.0,20230620.0,20230627,20230627,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230627,,MD,JP,JP,2023,Q2,Adult
226591311,22659131,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Femoral neck fracture,,2023,Q2,1,I,20220101.0,20230621.0,20230630,20230630,EXP,,JP-JNJFOC-20230670491,JOHNSON AND JOHNSON,,80.0,YR,E,F,Y,,,20230630,,HP,JP,JP,2023,Q2,Elderly
226591311,22659131,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q2,Renal impairment,,2023,Q2,1,I,20220101.0,20230621.0,20230630,20230630,EXP,,JP-JNJFOC-20230670491,JOHNSON AND JOHNSON,,80.0,YR,E,F,Y,,,20230630,,HP,JP,JP,2023,Q2,Elderly
1566392240,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Prescribed overdose,,2023,Q3,40,F,20181001.0,20230905.0,20181128,20230912,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K. et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; 31-2.",71.0,YR,E,M,Y,60.3,KG,20230912,,PH,JP,JP,2023,Q3,Elderly
1566392240,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Tubulointerstitial nephritis,,2023,Q3,40,F,20181001.0,20230905.0,20181128,20230912,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K. et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; 31-2.",71.0,YR,E,M,Y,60.3,KG,20230912,,PH,JP,JP,2023,Q3,Elderly
1566392240,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Cardiogenic shock,,2023,Q3,40,F,20181001.0,20230905.0,20181128,20230912,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K. et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; 31-2.",71.0,YR,E,M,Y,60.3,KG,20230912,,PH,JP,JP,2023,Q3,Elderly
1566392240,15663922,19,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Immune-mediated myocarditis,,2023,Q3,40,F,20181001.0,20230905.0,20181128,20230912,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-091356,BRISTOL MYERS SQUIBB,"Tai T, Watanabe M, Yamashita S, Mizuoka D, Motoki T, Yamaguchi K. et al. A case of myocardial immune-related adverse event due to nivolumab and ipilimumab combination therapy used for a patient with advanced renal cell carcinoma. The 30th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences. 2020; 31-2.",71.0,YR,E,M,Y,60.3,KG,20230912,,PH,JP,JP,2023,Q3,Elderly
160267552,16026755,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,,100.0,MG,,QD,2023,Q3,Hyperglycaemia,,2023,Q3,2,F,,20230714.0,20190303,20230724,EXP,,US-TEVA-2019-US-1017208,TEVA,,69.0,YR,E,F,Y,,,20230724,,MD,US,US,2023,Q3,Elderly
160267552,16026755,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,,100.0,MG,,QD,2023,Q3,Diarrhoea,,2023,Q3,2,F,,20230714.0,20190303,20230724,EXP,,US-TEVA-2019-US-1017208,TEVA,,69.0,YR,E,F,Y,,,20230724,,MD,US,US,2023,Q3,Elderly
160267552,16026755,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,,100.0,MG,,QD,2023,Q3,Ketoacidosis,,2023,Q3,2,F,,20230714.0,20190303,20230724,EXP,,US-TEVA-2019-US-1017208,TEVA,,69.0,YR,E,F,Y,,,20230724,,MD,US,US,2023,Q3,Elderly
160267552,16026755,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,,100.0,MG,,QD,2023,Q3,Nausea,,2023,Q3,2,F,,20230714.0,20190303,20230724,EXP,,US-TEVA-2019-US-1017208,TEVA,,69.0,YR,E,F,Y,,,20230724,,MD,US,US,2023,Q3,Elderly
163218952,16321895,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily; receiving for 14 months,,,U,,,,,100.0,MG,,QD,2023,Q3,Systemic candida,,2023,Q3,2,F,,20230714.0,20190516,20230724,EXP,,US-TEVA-2019-US-1049675,TEVA,,38.0,YR,A,F,Y,,,20230724,,HP,US,US,2023,Q3,Adult
163218952,16321895,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily; receiving for 14 months,,,U,,,,,100.0,MG,,QD,2023,Q3,Klebsiella infection,,2023,Q3,2,F,,20230714.0,20190516,20230724,EXP,,US-TEVA-2019-US-1049675,TEVA,,38.0,YR,A,F,Y,,,20230724,,HP,US,US,2023,Q3,Adult
163218952,16321895,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily; receiving for 14 months,,,U,,,,,100.0,MG,,QD,2023,Q3,Urinary tract candidiasis,,2023,Q3,2,F,,20230714.0,20190516,20230724,EXP,,US-TEVA-2019-US-1049675,TEVA,,38.0,YR,A,F,Y,,,20230724,,HP,US,US,2023,Q3,Adult
1656345016,16563450,11,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,11,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,11,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,11,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,11,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
1656345016,16563450,36,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,16,F,,20230811.0,20190712,20230826,EXP,,CA-AUROBINDO-AUR-APL-2019-038508,AUROBINDO,,76.0,YR,,F,Y,,,20230826,,MD,CA,CA,2023,Q3,Elderly
167450362,16745036,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q3,Lens disorder,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q3,Toxicity to various agents,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q3,Cataract subcapsular,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Lens disorder,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Toxicity to various agents,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
167450362,16745036,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Cataract subcapsular,,2023,Q3,2,F,,20230717.0,20190827,20230727,EXP,,US-TEVA-2019-US-1098665,TEVA,,48.0,YR,A,F,Y,112.0,KG,20230727,,MD,US,US,2023,Q3,Adult
172697327,17269732,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q3,Pain,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q3,Fall,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,3,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2023,Q3,Gait disturbance,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,,,2023,Q3,Pain,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,,,2023,Q3,Fall,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
172697327,17269732,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,,,2023,Q3,Gait disturbance,,2023,Q3,7,F,20200103.0,20230908.0,20200114,20230914,EXP,,JP-ABBVIE-20P-087-3231624-00,ABBVIE,,67.0,YR,,M,Y,68.0,KG,20230914,,MD,JP,JP,2023,Q3,Elderly
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Oropharyngeal pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Muscle spasms,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Back pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Insulin-like growth factor increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Nasal congestion,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Groin abscess,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Drug resistance,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Laryngitis bacterial,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Sinusitis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Illness,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Blood growth hormone increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Back injury,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Blood cholesterol abnormal,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Off label use,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Sciatic nerve injury,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Infectious mononucleosis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Body temperature decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Nasopharyngitis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Subcutaneous abscess,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Stress,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Anxiety,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Heart rate increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Abdominal pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Heart rate decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Intervertebral disc protrusion,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Cortisol decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Movement disorder,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Ligament sprain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Blood pressure increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Cough,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Headache,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,COVID-19,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Blood pressure diastolic decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Facial pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,38,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 every 1 Days)",,,U,,,,,,,Tablet,QD,2023,Q3,Drug ineffective for unapproved indication,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Musculoskeletal toxicity,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Laboratory test abnormal,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Drug-induced liver injury,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Drug level above therapeutic,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Gait disturbance,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Muscle disorder,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Drug interaction,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Hepatocellular injury,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Toxicity to various agents,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Rhabdomyolysis,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,100.0,MG,,,2023,Q3,Drug level increased,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Musculoskeletal toxicity,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Laboratory test abnormal,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Drug-induced liver injury,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Drug level above therapeutic,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Gait disturbance,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Muscle disorder,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Drug interaction,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Hepatocellular injury,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Rhabdomyolysis,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
181569287,18156928,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Drug level increased,,2023,Q3,7,F,,20230823.0,20200817,20230904,EXP,,CA-Accord-195666,ACCORD,"Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. Annals of internal medicine. 2020.",76.0,YR,E,F,Y,,,20230904,,MD,CA,CA,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Depression,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Duodenal ulcer haemorrhage,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Depressive symptom,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Spinal compression fracture,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Diabetic nephropathy,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
1972718015,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q3,Small intestinal haemorrhage,,2023,Q3,15,F,20171222.0,20230913.0,20210819,20230920,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20230920,,MD,JP,JP,2023,Q3,Elderly
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,Unknown,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Immunosuppression,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Myalgia,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,COVID-19,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Joint injury,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Tooth fracture,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Alopecia,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Product use issue,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Dry throat,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Inflammation,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Muscle strain,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Limb injury,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Exposure to SARS-CoV-2,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Mobility decreased,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Pulpitis dental,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Nervousness,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Malaise,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Rhinitis allergic,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Discomfort,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Gait disturbance,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Arthritis,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Arthralgia,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202403346,20240334,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Constipation,,2023,Q3,6,F,,20230721.0,20211228,20230731,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-30067,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,91.0,KG,20230731,,HP,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
210361703,21036170,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,at 100 mg/day gradually increased to 300 mg/day,,,U,,,,,100.0,MG,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
210361703,21036170,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,at 100 mg/day gradually increased to 300 mg/day,,,U,,,,,100.0,MG,,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
210361703,21036170,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,at 100 mg/day gradually increased to 300 mg/day,,,U,,,,,300.0,MG,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
210361703,21036170,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,at 100 mg/day gradually increased to 300 mg/day,,,U,,,,,300.0,MG,,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
211227662,21122766,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Drug interaction,,2023,Q3,2,F,,20230705.0,20220723,20230717,EXP,CA-MHPD-E2B_04438537,CA-Accord-270184,ACCORD,,76.0,YR,E,F,Y,,,20230717,,MD,CA,CA,2023,Q3,Elderly
211227662,21122766,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,Tablet,,2023,Q3,Myopathy toxic,,2023,Q3,2,F,,20230705.0,20220723,20230717,EXP,CA-MHPD-E2B_04438537,CA-Accord-270184,ACCORD,,76.0,YR,E,F,Y,,,20230717,,MD,CA,CA,2023,Q3,Elderly
211227662,21122766,3,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Drug interaction,,2023,Q3,2,F,,20230705.0,20220723,20230717,EXP,CA-MHPD-E2B_04438537,CA-Accord-270184,ACCORD,,76.0,YR,E,F,Y,,,20230717,,MD,CA,CA,2023,Q3,Elderly
211227662,21122766,3,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Myopathy toxic,,2023,Q3,2,F,,20230705.0,20220723,20230717,EXP,CA-MHPD-E2B_04438537,CA-Accord-270184,ACCORD,,76.0,YR,E,F,Y,,,20230717,,MD,CA,CA,2023,Q3,Elderly
213164814,21316481,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,4,F,20180725.0,20230817.0,20220910,20230822,EXP,,JP-ABBVIE-22P-087-4533465-00,ABBVIE,,34.0,YR,,M,Y,70.3,KG,20230822,,MD,JP,JP,2023,Q3,Young Adult
213410292,21341029,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,,Unknown,,,,,,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,2,F,,20220905.0,20220916,20230830,EXP,,IN-EPICPHARMA-IN-2022EPCLIT01300,EPIC PHARM,"Vadi S.Diabetic Ketoacidosis with Lower-than-anticipated Glucose Levels, and Recalcitrant Metabolic Acidosis Requiring Rescue Hemodialysis in a Patient of COVID-19 Infection.Indian journal of critical care medicine.JUN-2022;26:752-754",45.0,YR,A,F,Y,,,20230830,,HP,IN,IN,2023,Q3,Adult
213797468,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,45,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,46,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,47,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,48,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,49,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,276,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,277,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,277,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,277,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,277,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,277,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,278,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,278,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,278,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,278,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,278,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,279,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,279,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,279,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,279,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,279,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,280,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,280,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,280,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,280,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
213797468,21379746,280,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,8,F,,20230713.0,20220927,20230719,EXP,,NVSC2022CA214707,NOVARTIS,,76.0,YR,,F,Y,,,20230719,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,35,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,36,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,36,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,36,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,36,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,36,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,37,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,37,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,37,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,37,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,37,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,38,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,38,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,38,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,38,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,38,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,39,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,40,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,41,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,42,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,256,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,256,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,256,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,256,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,256,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,257,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,257,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,257,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,257,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,257,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,258,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,258,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,258,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,258,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,258,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,259,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Asthma,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,259,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,259,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Full blood count abnormal,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,259,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
214147359,21414735,259,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,9,F,,20230920.0,20221006,20230930,EXP,,CA-ROCHE-3188997,ROCHE,,76.0,YR,,F,Y,,,20230930,,HP,CA,CA,2023,Q3,Elderly
215597403,21559740,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 mg,,,D,,,,,100.0,MG,Tablet,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 mg,,,D,,,,,100.0,MG,Tablet,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 mg,,,D,,,,,100.0,MG,Tablet,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,D,,,,,300.0,MG,Tablet,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,D,,,,,300.0,MG,Tablet,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,8,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,D,,,,,300.0,MG,Tablet,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Dyspepsia,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Product use issue,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Hepatic fibrosis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Joint ankylosis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Therapeutic response decreased,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Anti-cyclic citrullinated peptide antibody positive,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Therapeutic product effect decreased,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Hepatic steatosis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Drug-induced liver injury,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Joint swelling,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Arthralgia,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Synovitis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Red blood cell sedimentation rate abnormal,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Bone erosion,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Infection,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Liver disorder,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Hepatic cirrhosis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Gastrointestinal infection,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Abdominal discomfort,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Upper respiratory tract infection,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Skin injury,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Arthropathy,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Musculoskeletal stiffness,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Psoriatic arthropathy,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Hand deformity,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Alanine aminotransferase abnormal,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Transaminases increased,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Alanine aminotransferase increased,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Bone cyst,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Rheumatoid arthritis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Osteolysis,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,C-reactive protein abnormal,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,C-reactive protein increased,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Treatment failure,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Drug hypersensitivity,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Drug intolerance,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Localised infection,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217292662,21729266,48,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,2,F,,20230807.0,20221214,20230815,EXP,,CA-BAYER-2022A168101,BAYER,,57.0,YR,A,M,Y,,,20230815,,HP,CA,CA,2023,Q3,Adult
217890692,21789069,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q3,Ischaemic hepatitis,,2023,Q3,2,F,20221216.0,20230627.0,20221228,20230703,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202212013678,ELI LILLY AND CO,,63.0,YR,,M,Y,64.0,KG,20230703,,CN,JP,JP,2023,Q3,Adult
217890692,21789069,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q3,Acidosis,,2023,Q3,2,F,20221216.0,20230627.0,20221228,20230703,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202212013678,ELI LILLY AND CO,,63.0,YR,,M,Y,64.0,KG,20230703,,CN,JP,JP,2023,Q3,Adult
217890692,21789069,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q3,Hepatic function abnormal,,2023,Q3,2,F,20221216.0,20230627.0,20221228,20230703,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202212013678,ELI LILLY AND CO,,63.0,YR,,M,Y,64.0,KG,20230703,,CN,JP,JP,2023,Q3,Adult
217890692,21789069,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q3,Cardiac tamponade,,2023,Q3,2,F,20221216.0,20230627.0,20221228,20230703,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202212013678,ELI LILLY AND CO,,63.0,YR,,M,Y,64.0,KG,20230703,,CN,JP,JP,2023,Q3,Adult
219049163,21904916,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,20230103.0,20230208.0,20230124,20230811,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230214,,MD,IT,IT,2023,Q3,Elderly
219049163,21904916,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Acute respiratory failure,,2023,Q3,3,F,20230103.0,20230208.0,20230124,20230811,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230214,,MD,IT,IT,2023,Q3,Elderly
219049163,21904916,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Productive cough,,2023,Q3,3,F,20230103.0,20230208.0,20230124,20230811,EXP,,IT-ABBVIE-4280049,ABBVIE,,65.0,YR,,F,Y,120.0,KG,20230214,,MD,IT,IT,2023,Q3,Elderly
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Product prescribing error,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Anxiety,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Depression,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,"Hallucination, visual",,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220311413,22031141,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Suicidal ideation,,2023,Q3,3,F,,20230828.0,20230223,20230904,EXP,,CA-JNJFOC-20230239625,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Product prescribing error,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, visual",,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, auditory",,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Depression,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Anxiety,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220316742,22031674,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Suicidal ideation,,2023,Q3,2,F,,20230713.0,20230224,20230725,EXP,,CA-APOTEX-2023AP003748,APOTEX,,56.0,YR,,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Adult
220452794,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q3,Depression,,2023,Q3,4,F,,20230630.0,20230228,20230710,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
220452794,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q3,Psychiatric symptom,,2023,Q3,4,F,,20230630.0,20230228,20230710,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
220452794,22045279,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,4,F,,20230630.0,20230228,20230710,EXP,,CA-PFIZER INC-202300081630,PFIZER,,56.0,YR,,M,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Anxiety,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Depression,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Psychotic disorder,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Product prescribing error,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Hypoglycaemia,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Psychiatric symptom,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Suicidal ideation,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, visual",,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,14,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, auditory",,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Anxiety,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Depression,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Psychotic disorder,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Product prescribing error,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Hypoglycaemia,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Psychiatric symptom,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,Suicidal ideation,,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,"Hallucination, visual",,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220483434,22048343,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,1 every 1 Days,,,,,,,,100.0,MG,,,2023,Q3,"Hallucination, auditory",,2023,Q3,4,F,,20230823.0,20230301,20230904,EXP,CA-MHPD-E2B_05992367,CA-Accord-302245,ACCORD,,56.0,YR,A,M,Y,,,20230904,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Body temperature decreased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Blood pressure systolic abnormal,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Blood pressure fluctuation,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Mouth ulceration,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Pemphigus,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Oxygen saturation decreased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Blood pressure systolic increased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
220706424,22070642,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Heart rate increased,,2023,Q3,4,F,,20230731.0,20230307,20230803,EXP,,CA-PFIZER INC-202300091643,PFIZER,,62.0,YR,,M,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Urinary tract infection,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Hepatic function abnormal,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Right ventricular failure,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Diarrhoea,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Oedema peripheral,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Renal impairment,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
221155142,22115514,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Device related infection,,2023,Q3,2,F,20180724.0,20230721.0,20230320,20230801,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202107009747,ELI LILLY AND CO,,48.0,YR,,F,Y,78.7,KG,20230801,,CN,JP,JP,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Suicidal ideation,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, visual",,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Anxiety,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Product prescribing error,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222202992,22220299,17,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, daily",,,U,,,,,100.0,MG,,QD,2023,Q3,Depression,,2023,Q3,2,F,,20230724.0,20230417,20230727,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202304006092,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230727,,CN,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Product prescribing error,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,"Hallucination, visual",,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Anxiety,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Suicidal ideation,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423053,22242305,9,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,Tablet,QD,2023,Q3,Depression,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031383,AUROBINDO,,56.0,YR,,M,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222780666,22278066,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Formulation unknown,QD,2023,Q3,Chronic inflammatory demyelinating polyradiculoneuropathy,,2023,Q3,6,F,20230423.0,20230726.0,20230503,20230802,EXP,,TW-ASTELLAS-2023US013543,ASTELLAS,,47.0,YR,,M,Y,,,20230802,,MD,TW,TW,2023,Q3,Adult
222966672,22296667,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,,QD,2023,Q3,Vitreous floaters,,2023,Q3,2,F,20180807.0,20230809.0,20230508,20230814,EXP,,US-ABBVIE-4749234,ABBVIE,,64.0,YR,,F,Y,,,20230814,,MD,US,US,2023,Q3,Adult
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Peripheral coldness,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Decreased appetite,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Epistaxis,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Diarrhoea,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Squamous cell carcinoma,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
223734302,22373430,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Fatigue,,2023,Q3,2,F,20220401.0,20230802.0,20230526,20230804,EXP,,GB-AMGEN-GBRNI2022079480,AMGEN,,78.0,YR,E,M,Y,80.2,KG,20230804,,MD,GB,GB,2023,Q3,Elderly
225221983,22522198,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2023,Q3,Hallucination,,2023,Q3,3,F,20220307.0,20230813.0,20230605,20230816,EXP,,NVSC2023GB121105,NOVARTIS,,72.0,YR,,M,Y,,,20230816,,MD,GB,GB,2023,Q3,Elderly
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, visual",,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Product prescribing error,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Suicidal ideation,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Depression,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram,,,U,,,,,100.0,MG,,QD,2023,Q3,Anxiety,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,"Hallucination, auditory",,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,"Hallucination, visual",,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Product prescribing error,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Suicidal ideation,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
225891633,22589163,23,C,"INVOKAMET (CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE) Tablet",,2,,,,,,,,,,,,,,2023,Q3,Anxiety,,2023,Q3,3,F,,20230821.0,20230612,20230825,EXP,,CA-ABBVIE-5281900,ABBVIE,,56.0,YR,,M,Y,,,20230825,,HP,CA,CA,2023,Q3,Adult
226443002,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Angina pectoris,,2023,Q3,2,F,20210705.0,20230725.0,20230627,20230801,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230801,,MD,JP,JP,2023,Q3,Adult
226443002,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Insomnia,,2023,Q3,2,F,20210705.0,20230725.0,20230627,20230801,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230801,,MD,JP,JP,2023,Q3,Adult
226443002,22644300,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Neuropathy peripheral,,2023,Q3,2,F,20210705.0,20230725.0,20230627,20230801,EXP,,JP-GILEAD-2022-0586008,GILEAD,,55.0,YR,A,M,Y,,,20230801,,MD,JP,JP,2023,Q3,Adult
226550052,22655005,3,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q3,Rheumatoid arthritis,,2023,Q3,2,F,,20230724.0,20230629,20230802,PER,,US-JNJFOC-20230661495,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,,,20230802,,CN,US,US,2023,Q3,Adult
226687311,22668731,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Hyponatraemia,,2023,Q3,1,I,20221010.0,20230626.0,20230704,20230704,EXP,,JP-JNJFOC-20230701873,JOHNSON AND JOHNSON,,7.0,DEC,E,F,Y,,,20230704,,PH,JP,JP,2023,Q3,Child
226687311,22668731,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20221010.0,20230626.0,20230704,20230704,EXP,,JP-JNJFOC-20230701873,JOHNSON AND JOHNSON,,7.0,DEC,E,F,Y,,,20230704,,PH,JP,JP,2023,Q3,Child
226687311,22668731,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Urinary tract infection,,2023,Q3,1,I,20221010.0,20230626.0,20230704,20230704,EXP,,JP-JNJFOC-20230701873,JOHNSON AND JOHNSON,,7.0,DEC,E,F,Y,,,20230704,,PH,JP,JP,2023,Q3,Child
226687311,22668731,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Diabetic ketoacidosis,,2023,Q3,1,I,20221010.0,20230626.0,20230704,20230704,EXP,,JP-JNJFOC-20230701873,JOHNSON AND JOHNSON,,7.0,DEC,E,F,Y,,,20230704,,PH,JP,JP,2023,Q3,Child
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Road traffic accident,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Sensory loss,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Hallucination,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Insomnia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Neck injury,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Vitamin B12 decreased,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Middle insomnia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Ageusia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Anosmia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Muscle twitching,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Drug titration error,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Mobility decreased,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Back pain,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Nightmare,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Stress,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Fall,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Affective disorder,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Anger,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Abnormal dreams,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Pollakiuria,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Sleep talking,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Renal pain,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q3,Arthralgia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226760482,22676048,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Sudden hearing loss,,2023,Q3,2,F,,20230712.0,20230706,20230719,EXP,,JP-JNJFOC-20230709291,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,,,20230719,,MD,JP,JP,2023,Q3,Adult
226823751,22682375,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q3,Gastroenteritis,,2023,Q3,1,I,20220801.0,20230626.0,20230707,20230707,EXP,,JP-NOVOPROD-1086327,NOVO NORDISK,"Asano. H, et al.. Two cases which gastrointestinal disorder developed due to oral glucagon-like peptide-1 (GLP-1) receptor agonist used for the purpose of obesity treatment. The 686th Kanto local meeting held by Kanto chapter of The Japanese Society. 2023;35",27.0,YR,,F,Y,,,20230707,,MD,JP,JP,2023,Q3,Young Adult
226823751,22682375,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,20220801.0,20230626.0,20230707,20230707,EXP,,JP-NOVOPROD-1086327,NOVO NORDISK,"Asano. H, et al.. Two cases which gastrointestinal disorder developed due to oral glucagon-like peptide-1 (GLP-1) receptor agonist used for the purpose of obesity treatment. The 686th Kanto local meeting held by Kanto chapter of The Japanese Society. 2023;35",27.0,YR,,F,Y,,,20230707,,MD,JP,JP,2023,Q3,Young Adult
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Malnutrition,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Flatulence,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Haematoma muscle,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,White blood cell count decreased,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Cytomegalovirus test positive,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Chest wall haematoma,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Cerebral infarction,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Depressed level of consciousness,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Gram stain positive,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Generalised oedema,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Platelet count decreased,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Gastrointestinal haemorrhage,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Tachycardia,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Chest pain,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226860773,22686077,32,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100mg/day,,,,,UNKNOWN,,,,,,,2023,Q3,Electrocardiogram ST segment elevation,,2023,Q3,3,F,20230524.0,20230901.0,20230710,20230911,EXP,,JP-ROCHE-3383025,ROCHE,,7.0,DEC,,M,Y,65.0,KG,20230911,,MD,JP,JP,2023,Q3,Child
226960721,22696072,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Respiratory failure,,2023,Q3,1,I,,20230707.0,20230712,20230712,EXP,,JP-AstraZeneca-2023A148498,ASTRAZENECA,,76.0,YR,,M,Y,,,20230712,,MD,JP,,2023,Q3,Elderly
226960721,22696072,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Overlap syndrome,,2023,Q3,1,I,,20230707.0,20230712,20230712,EXP,,JP-AstraZeneca-2023A148498,ASTRAZENECA,,76.0,YR,,M,Y,,,20230712,,MD,JP,,2023,Q3,Elderly
227174011,22717401,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,100.0,MG,,QD,2023,Q3,Myopathy toxic,,2023,Q3,1,I,,20230710.0,20230718,20230718,EXP,,CA-AstraZeneca-2023A162638,ASTRAZENECA,,76.0,YR,,F,Y,,,20230718,,MD,CA,,2023,Q3,Elderly
227174011,22717401,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,100.0,MG,,QD,2023,Q3,Drug interaction,,2023,Q3,1,I,,20230710.0,20230718,20230718,EXP,,CA-AstraZeneca-2023A162638,ASTRAZENECA,,76.0,YR,,F,Y,,,20230718,,MD,CA,,2023,Q3,Elderly
227400971,22740097,1,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,1,I,,20230629.0,20230723,20230723,EXP,GB-002147023-NVSC2020GB026121,GB-MHRA-MIDB-ccf9279f-d2cb-42fc-adf9-3a1581d4a5bd,SANDOZ,,47.0,YR,,F,Y,,,20230723,,PH,GB,GB,2023,Q3,Adult
227400971,22740097,1,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230629.0,20230723,20230723,EXP,GB-002147023-NVSC2020GB026121,GB-MHRA-MIDB-ccf9279f-d2cb-42fc-adf9-3a1581d4a5bd,SANDOZ,,47.0,YR,,F,Y,,,20230723,,PH,GB,GB,2023,Q3,Adult
227476501,22747650,17,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Myocarditis,,2023,Q3,1,I,20191218.0,20230721.0,20230725,20230725,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-103695,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,,,20230725,,MD,CA,CA,2023,Q3,Adult
227560542,22756054,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Blood creatinine abnormal,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Diverticulum intestinal haemorrhagic,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Anaemia,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Lymphopenia,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Blood creatinine abnormal,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Diverticulum intestinal haemorrhagic,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Anaemia,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227560542,22756054,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Lymphopenia,,2023,Q3,2,F,,20230921.0,20230727,20230928,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
227566321,22756632,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227690721,22769072,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230721.0,20230731,20230731,EXP,,CA-TEVA-2023-CA-2910782,TEVA,,76.0,YR,E,F,Y,,,20230801,,HP,CA,CA,2023,Q3,Elderly
227690721,22769072,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230721.0,20230731,20230731,EXP,,CA-TEVA-2023-CA-2910782,TEVA,,76.0,YR,E,F,Y,,,20230801,,HP,CA,CA,2023,Q3,Elderly
227690721,22769072,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230721.0,20230731,20230731,EXP,,CA-TEVA-2023-CA-2910782,TEVA,,76.0,YR,E,F,Y,,,20230801,,HP,CA,CA,2023,Q3,Elderly
227690721,22769072,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230721.0,20230731,20230731,EXP,,CA-TEVA-2023-CA-2910782,TEVA,,76.0,YR,E,F,Y,,,20230801,,HP,CA,CA,2023,Q3,Elderly
227690721,22769072,13,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230721.0,20230731,20230731,EXP,,CA-TEVA-2023-CA-2910782,TEVA,,76.0,YR,E,F,Y,,,20230801,,HP,CA,CA,2023,Q3,Elderly
227729771,22772977,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230730.0,20230801,20230801,EXP,GB-MHRA-MIDB-9e156fba-787c-4e06-9db9-d2498baf89aa,GB-PFIZER INC-202300263366,PFIZER,,64.0,YR,,,Y,,,20230801,,PH,GB,GB,2023,Q3,Adult
227751991,22775199,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230730.0,20230802,20230802,EXP,GB-MHRA-MIDB-9e156fba-787c-4e06-9db9-d2498baf89aa,GB-UCBSA-2023038438,UCB,,64.0,YR,,,Y,,,20230802,,PH,GB,GB,2023,Q3,Adult
227757221,22775722,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"0.1 gram, qd",1.3,GM,,,146230406,,,0.1,GM,Tablet,QD,2023,Q3,Dermatitis allergic,,2023,Q3,1,I,20230712.0,20230727.0,20230802,20230802,EXP,,CN-TAKEDA-2023TUS074855,TAKEDA,,73.0,YR,,F,Y,58.0,KG,20230802,,HP,CN,CN,2023,Q3,Elderly
227818582,22781858,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,U,,,,,100.0,MG,Unknown,,2023,Q3,Anal haemorrhage,,2023,Q3,2,F,20230501.0,20230921.0,20230803,20230928,EXP,,IT-MYLANLABS-2023M1080682,MYLAN,,78.0,YR,,M,Y,78.0,KG,20230928,,CN,IT,IT,2023,Q3,Elderly
227818582,22781858,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,U,,,,,100.0,MG,Unknown,,2023,Q3,Anal cancer,,2023,Q3,2,F,20230501.0,20230921.0,20230803,20230928,EXP,,IT-MYLANLABS-2023M1080682,MYLAN,,78.0,YR,,M,Y,78.0,KG,20230928,,CN,IT,IT,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Disturbance in attention,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Sedation,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Restless legs syndrome,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Drug interaction,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Electrocardiogram QT prolonged,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
227857971,22785797,18,I,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,"150 mg/1000 mg,QD",,,,,,,,,,,QD,2023,Q3,Dizziness,,2023,Q3,1,I,,20221013.0,20230804,20230804,EXP,,US-OTSUKA-2022_048615,OTSUKA,"Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M. Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina-Lithuania. 2022;58(3):NIL_0001-NIL_0007",69.0,YR,,M,Y,,,20230804,,HP,US,US,2023,Q3,Elderly
228014661,22801466,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,,,,,204042.0,100.0,MG,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,20230326.0,20230731.0,20230809,20230809,EXP,,JP-JNJFOC-20230817238,JOHNSON AND JOHNSON,,41.0,YR,A,F,Y,,,20230809,,MD,JP,JP,2023,Q3,Adult
228014661,22801466,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,,,,,204042.0,100.0,MG,Tablet,,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,20230326.0,20230731.0,20230809,20230809,EXP,,JP-JNJFOC-20230817238,JOHNSON AND JOHNSON,,41.0,YR,A,F,Y,,,20230809,,MD,JP,JP,2023,Q3,Adult
228014661,22801466,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,,,,,204042.0,100.0,MG,Tablet,,2023,Q3,Transient ischaemic attack,,2023,Q3,1,I,20230326.0,20230731.0,20230809,20230809,EXP,,JP-JNJFOC-20230817238,JOHNSON AND JOHNSON,,41.0,YR,A,F,Y,,,20230809,,MD,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Drug interaction,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Prinzmetal angina,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Immunosuppressant drug level increased,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Drug interaction,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Immunosuppressant drug level decreased,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228026762,22802676,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q3,Acute kidney injury,,2023,Q3,2,F,20230716.0,20230905.0,20230809,20230907,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20230907,,HP,JP,JP,2023,Q3,Adult
228060981,22806098,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230730.0,20230809,20230809,EXP,GB-MHRA-MIDB-9e156fba-787c-4e06-9db9-d2498baf89aa,GB-TEVA-2023-GB-2914313,TEVA,,64.0,YR,A,,Y,,,20230809,,PH,GB,GB,2023,Q3,Adult
228087532,22808753,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,,,,UNK,,2023,Q3,Intentional overdose,,2023,Q3,2,F,,20230825.0,20230810,20230904,EXP,GB-MHRA-MIDB-9e156fba-787c-4e06-9db9-d2498baf89aa,GB-TORRENT-00032663,TORRENT,,64.0,YR,A,,Y,,,20230904,,PH,GB,GB,2023,Q3,Adult
228122501,22812250,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Death,,2023,Q3,1,I,,20230810.0,20230811,20230811,EXP,,CA-ROCHE-3403125,ROCHE,,50.0,YR,,M,Y,,,20230811,,HP,CA,,2023,Q3,Adult
228140001,22814000,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Renal neoplasm,,2023,Q3,1,I,,20230802.0,20230811,20230811,EXP,CA-MHPD-E2B 06359694,CA-Accord-371486,ACCORD,,56.0,YR,A,M,Y,,,20230811,,MD,CA,CA,2023,Q3,Adult
228185102,22818510,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,,,Unknown,,,100.0,MG,,QD,2023,Q3,Cholangitis,,2023,Q3,2,F,20230715.0,20230828.0,20230814,20230908,EXP,,JP-NOVOPROD-1100092,NOVO NORDISK,,50.0,YR,,M,Y,90.0,KG,20230908,,MD,JP,JP,2023,Q3,Adult
228203341,22820334,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228203341,22820334,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,,,2023,Q3,Treatment noncompliance,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228203341,22820334,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,,,,,100.0,MG,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228203341,22820334,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,,,,,100.0,MG,,,2023,Q3,Treatment noncompliance,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228206392,22820639,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2023,Q3,Pulmonary toxicity,,2023,Q3,2,F,20230525.0,20230809.0,20230814,20230821,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306011030,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20230821,,MD,JP,JP,2023,Q3,Elderly
228206392,22820639,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,2,F,20230525.0,20230809.0,20230814,20230821,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306011030,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20230821,,MD,JP,JP,2023,Q3,Elderly
228206392,22820639,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2023,Q3,Renal impairment,,2023,Q3,2,F,20230525.0,20230809.0,20230814,20230821,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306011030,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20230821,,MD,JP,JP,2023,Q3,Elderly
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Product prescribing error,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, visual",,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Anxiety,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Suicidal ideation,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228220131,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q3,Depression,,2023,Q3,1,I,,20230807.0,20230814,20230814,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Oxygen saturation decreased,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Pemphigus,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Blood pressure systolic increased,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Blood pressure fluctuation,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228253021,22825302,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Heart rate increased,,2023,Q3,1,I,,20230804.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011867,APOTEX,,62.0,YR,,M,Y,,,20230816,,HP,CA,CA,2023,Q3,Adult
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Decreased appetite,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Atrial flutter,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Bradycardia,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Cardiac arrest,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228319672,22831967,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,204042.0,,,Tablet,,2023,Q3,Spinal compression fracture,,2023,Q3,2,F,,20230920.0,20230817,20230928,EXP,,JP-JNJFOC-20230837249,JOHNSON AND JOHNSON,,81.0,YR,E,F,Y,,,20230928,,MD,JP,JP,2023,Q3,Elderly
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Anxiety,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Diabetic neuropathy,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Myalgia,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Pharyngotonsillitis,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Candida infection,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Hypercholesterolaemia,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Alopecia,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Hypokalaemia,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228323381,22832338,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,204042.0,300.0,MG,Tablet,QD,2023,Q3,Sleep disorder,,2023,Q3,1,I,20220728.0,20221003.0,20230817,20230817,EXP,,MX-JNJFOC-20230831233,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20230817,,HP,MX,MX,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228349861,22834986,6,C,CANAGLIFLOZIN;METFORMIN,,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Drug ineffective for unapproved indication,,2023,Q3,1,I,,20230615.0,20230818,20230818,PER,,US-STRIDES ARCOLAB LIMITED-2023SP009883,STRIDES,"Gannamani V, Varma A, Nathan S, Ustun C.. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.. Transpl-Immunol. 2023",51.0,YR,,F,Y,,,20230818,,HP,US,US,2023,Q3,Adult
228351641,22835164,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,Tablet,,2023,Q3,Renal failure,,2023,Q3,1,I,,20230810.0,20230818,20230818,EXP,,IN-JNJFOC-20230828025,JOHNSON AND JOHNSON,,35.0,YR,A,F,Y,,,20230818,,MD,IN,IN,2023,Q3,Adult
228351641,22835164,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,Tablet,,2023,Q3,Nephrolithiasis,,2023,Q3,1,I,,20230810.0,20230818,20230818,EXP,,IN-JNJFOC-20230828025,JOHNSON AND JOHNSON,,35.0,YR,A,F,Y,,,20230818,,MD,IN,IN,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Intentional product use issue,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Feeling hot,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Off label use,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Paraesthesia,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Therapeutic response shortened,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Incorrect dose administered,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Myalgia,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Haematochezia,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Weight increased,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228358842,22835884,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,300.0,MG,,,2023,Q3,Haemorrhoids,,2023,Q3,2,F,,20230814.0,20230818,20230818,EXP,,CA-JNJFOC-20230830043,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,84.0,KG,20230818,,HP,CA,CA,2023,Q3,Adult
228402462,22840246,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Colon cancer,,2023,Q3,2,F,,20230822.0,20230819,20230830,EXP,,JP-JNJFOC-20230837819,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228457981,22845798,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"1 dosage form, daily (before breakfast)",,,,,,,,,,,QD,2023,Q3,Dizziness,,2023,Q3,1,I,,20230817.0,20230821,20230821,EXP,GB-MHRA-TPP5516541C2189717YC1691678359888,GB-ELI_LILLY_AND_COMPANY-GB202308010530,ELI LILLY AND CO,,69.0,YR,,M,Y,92.0,KG,20230821,,CN,GB,GB,2023,Q3,Elderly
228457981,22845798,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"1 dosage form, daily (before breakfast)",,,,,,,,,,,QD,2023,Q3,Confusional state,,2023,Q3,1,I,,20230817.0,20230821,20230821,EXP,GB-MHRA-TPP5516541C2189717YC1691678359888,GB-ELI_LILLY_AND_COMPANY-GB202308010530,ELI LILLY AND CO,,69.0,YR,,M,Y,92.0,KG,20230821,,CN,GB,GB,2023,Q3,Elderly
228587451,22858745,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Drug interaction,,2023,Q3,1,I,,20230811.0,20230824,20230824,EXP,,CA-APOTEX-2023AP012288,APOTEX,,76.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Elderly
228587451,22858745,2,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, qd",,,U,,,,,100.0,MG,,,2023,Q3,Myopathy toxic,,2023,Q3,1,I,,20230811.0,20230824,20230824,EXP,,CA-APOTEX-2023AP012288,APOTEX,,76.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Elderly
228635521,22863552,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230816.0,20230825,20230825,EXP,,IT-Harman-000010,HARMAN FINOCHEM,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624. doi: 10.12659/AJCR.939624.",61.0,YR,,M,Y,,,20230819,,MD,IT,,2023,Q3,Adult
228635521,22863552,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230816.0,20230825,20230825,EXP,,IT-Harman-000010,HARMAN FINOCHEM,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624. doi: 10.12659/AJCR.939624.",61.0,YR,,M,Y,,,20230819,,MD,IT,,2023,Q3,Adult
228635521,22863552,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,1,I,,20230816.0,20230825,20230825,EXP,,IT-Harman-000010,HARMAN FINOCHEM,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624. doi: 10.12659/AJCR.939624.",61.0,YR,,M,Y,,,20230819,,MD,IT,,2023,Q3,Adult
228638181,22863818,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230820.0,20230825,20230825,EXP,,"IT-Saptalis Pharmaceuticals,LLC-000378",SAPTALIS PHARMACEUTICALS,"IT-Saptalis Pharmaceuticals,LLC-000378-01_Initial Source Document",61.0,YR,A,M,Y,85.0,KG,20230825,,HP,IT,,2023,Q3,Adult
228638181,22863818,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230820.0,20230825,20230825,EXP,,"IT-Saptalis Pharmaceuticals,LLC-000378",SAPTALIS PHARMACEUTICALS,"IT-Saptalis Pharmaceuticals,LLC-000378-01_Initial Source Document",61.0,YR,A,M,Y,85.0,KG,20230825,,HP,IT,,2023,Q3,Adult
228644821,22864482,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230821.0,20230825,20230825,EXP,,IT-ALS-001014,ALIGNSCIENCE PHARMA,"Greco S., Giovine A., Rocchi C., Resca R., Bigoni R., Formigaro L. et.al., Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023; 24:e939624. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,,,20230825,,HP,IT,IT,2023,Q3,Adult
228644821,22864482,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q3,Chest pain,,2023,Q3,1,I,,20230821.0,20230825,20230825,EXP,,IT-ALS-001014,ALIGNSCIENCE PHARMA,"Greco S., Giovine A., Rocchi C., Resca R., Bigoni R., Formigaro L. et.al., Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023; 24:e939624. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,,,20230825,,HP,IT,IT,2023,Q3,Adult
228644821,22864482,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q3,Odynophagia,,2023,Q3,1,I,,20230821.0,20230825,20230825,EXP,,IT-ALS-001014,ALIGNSCIENCE PHARMA,"Greco S., Giovine A., Rocchi C., Resca R., Bigoni R., Formigaro L. et.al., Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023; 24:e939624. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,,,20230825,,HP,IT,IT,2023,Q3,Adult
228644821,22864482,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230821.0,20230825,20230825,EXP,,IT-ALS-001014,ALIGNSCIENCE PHARMA,"Greco S., Giovine A., Rocchi C., Resca R., Bigoni R., Formigaro L. et.al., Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023; 24:e939624. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,,,20230825,,HP,IT,IT,2023,Q3,Adult
228766441,22876644,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,Unk,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230816.0,20230829,20230829,EXP,,IT-LAURUS LABS LIMITED-2023LAU000076,LAURUS LABS LIMITED,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. Am J Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230829,,HP,IT,IT,2023,Q3,Adult
228766441,22876644,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,Unk,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230816.0,20230829,20230829,EXP,,IT-LAURUS LABS LIMITED-2023LAU000076,LAURUS LABS LIMITED,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. Am J Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230829,,HP,IT,IT,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,10,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228789721,22878972,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230825.0,20230829,20230829,EXP,GB-MHRA-ADR 28139272,GB-ORGANON-O2308GBR002836,ORGANON,,64.0,YR,,,Y,,,20230829,,PH,GB,GB,2023,Q3,Adult
228812482,22881248,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,,Unknown,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,2,F,,20230823.0,20230830,20230906,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-09547,ALKEM,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. American Journal of Case Reports. 2023;24:e939624",61.0,YR,,M,Y,85.0,KG,20230906,,HP,IT,IT,2023,Q3,Adult
228812482,22881248,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,,Unknown,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,2,F,,20230823.0,20230830,20230906,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-09547,ALKEM,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. American Journal of Case Reports. 2023;24:e939624",61.0,YR,,M,Y,85.0,KG,20230906,,HP,IT,IT,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Depression,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228865441,22886544,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,U,UNK,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230818.0,20230831,20230831,EXP,,IT-NOVAST LABORATORIES INC.-2023NOV000302,NOVAST,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A, et al... Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. Am J Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230829,,HP,IT,IT,2023,Q3,Adult
228865441,22886544,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,U,UNK,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230818.0,20230831,20230831,EXP,,IT-NOVAST LABORATORIES INC.-2023NOV000302,NOVAST,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A, et al... Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. Am J Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230829,,HP,IT,IT,2023,Q3,Adult
228865621,22886562,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230825.0,20230831,20230831,EXP,GB-MHRA-ADR 28139272,GB-UCBSA-2023042500,UCB,,64.0,YR,,,Y,,,20230831,,PH,GB,GB,2023,Q3,Adult
228879071,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Heat illness,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Dehydration,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Heat illness,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Dehydration,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Heat illness,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228879071,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q3,Dehydration,,2023,Q3,1,I,20230724.0,20230822.0,20230831,20230831,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20230831,,MD,JP,JP,2023,Q3,Elderly
228896251,22889625,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,Unknown,,,,,,,2023,Q3,Oesophageal candidiasis,,2023,Q3,1,I,,20230822.0,20230831,20230831,EXP,,IT-EMD Serono-2023469744,EMD SERONO INC,"Bonazza A, Feo CV, Greco S, Giovine A, Rocchi C, Resca R, et al. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. The American journal of case reports. 2023 Aug 15;24: 1-7. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,85.0,KG,20230831,,MD,IT,IT,2023,Q3,Adult
228896251,22889625,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,Unknown,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230822.0,20230831,20230831,EXP,,IT-EMD Serono-2023469744,EMD SERONO INC,"Bonazza A, Feo CV, Greco S, Giovine A, Rocchi C, Resca R, et al. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. The American journal of case reports. 2023 Aug 15;24: 1-7. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,85.0,KG,20230831,,MD,IT,IT,2023,Q3,Adult
228896251,22889625,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,Unknown,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230822.0,20230831,20230831,EXP,,IT-EMD Serono-2023469744,EMD SERONO INC,"Bonazza A, Feo CV, Greco S, Giovine A, Rocchi C, Resca R, et al. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. The American journal of case reports. 2023 Aug 15;24: 1-7. doi:10.12659/AJCR.939624.",61.0,YR,A,M,Y,85.0,KG,20230831,,MD,IT,IT,2023,Q3,Adult
228924351,22892435,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230821.0,20230901,20230901,EXP,,IT-AJANTA-2023AJA00199,AJANTA PHARMA,,61.0,YR,A,M,Y,85.0,KG,20230901,,HP,IT,IT,2023,Q3,Adult
228924351,22892435,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230821.0,20230901,20230901,EXP,,IT-AJANTA-2023AJA00199,AJANTA PHARMA,,61.0,YR,A,M,Y,85.0,KG,20230901,,HP,IT,IT,2023,Q3,Adult
228973971,22897397,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230820.0,20230902,20230902,EXP,,IT-Indicus Pharma-000972,INDICUS,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L. Et al Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624.",61.0,YR,A,M,Y,85.0,KG,20230902,,HP,IT,IT,2023,Q3,Adult
228973971,22897397,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230820.0,20230902,20230902,EXP,,IT-Indicus Pharma-000972,INDICUS,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L. Et al Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624.",61.0,YR,A,M,Y,85.0,KG,20230902,,HP,IT,IT,2023,Q3,Adult
228974061,22897406,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230820.0,20230902,20230902,EXP,,IT-Inventia-000659,INVENTIA HEALTHCARE,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L. Et al Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624.",61.0,YR,A,M,Y,85.0,KG,20230902,,HP,IT,IT,2023,Q3,Adult
228974061,22897406,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230820.0,20230902,20230902,EXP,,IT-Inventia-000659,INVENTIA HEALTHCARE,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L. Et al Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023 Aug 15;24:e939624.",61.0,YR,A,M,Y,85.0,KG,20230902,,HP,IT,IT,2023,Q3,Adult
228994611,22899461,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,1,I,20230822.0,20230825.0,20230904,20230904,EXP,,JP-EMD Serono-2023470784,EMD SERONO INC,,5.0,DEC,A,M,Y,,,20230904,,HP,JP,JP,2023,Q3,Child
229011501,22901150,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,UNKNOWN,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230825.0,20230904,20230904,EXP,GB-MHRA-ADR 28139272,GB-TEVA-2023-GB-2922859,TEVA,,64.0,YR,A,,Y,,,20230904,,PH,GB,GB,2023,Q3,Adult
229026501,22902650,1,SS,CANAGLIFLOZIN ANHYDROUS,CANAGLIFLOZIN ANHYDROUS,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230823.0,20230904,20230904,EXP,,IT-SANDOZ INC.-SDZ2023IT018947,SANDOZ,"Salvatore Greco, Antonio Giovine, Cindy Rocchi, Riccardo Resca, Renato Bigoni, Luca Formigaro, Anna Grazia Angeletti, Nicolo Fabbri, Aurora Bonazza, Carlo V. Feo. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis  in a Diabetic Patient: A Case Report. 2023",61.0,YR,,M,Y,85.0,KG,20230904,,MD,IT,IT,2023,Q3,Adult
229026501,22902650,1,SS,CANAGLIFLOZIN ANHYDROUS,CANAGLIFLOZIN ANHYDROUS,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230823.0,20230904,20230904,EXP,,IT-SANDOZ INC.-SDZ2023IT018947,SANDOZ,"Salvatore Greco, Antonio Giovine, Cindy Rocchi, Riccardo Resca, Renato Bigoni, Luca Formigaro, Anna Grazia Angeletti, Nicolo Fabbri, Aurora Bonazza, Carlo V. Feo. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis  in a Diabetic Patient: A Case Report. 2023",61.0,YR,,M,Y,85.0,KG,20230904,,MD,IT,IT,2023,Q3,Adult
229124472,22912447,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Unknown,,,,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,2,F,,20230901.0,20230906,20230915,EXP,,IT-Unichem Pharmaceuticals (USA) Inc-UCM202309-001163,UNICHEM,,61.0,YR,A,M,Y,85.0,KG,20230915,,HP,IT,,2023,Q3,Adult
229124472,22912447,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Unknown,,,,,,,,,,,,2023,Q3,Fungal infection,,2023,Q3,2,F,,20230901.0,20230906,20230915,EXP,,IT-Unichem Pharmaceuticals (USA) Inc-UCM202309-001163,UNICHEM,,61.0,YR,A,M,Y,85.0,KG,20230915,,HP,IT,,2023,Q3,Adult
229124472,22912447,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Unknown,,,,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,2,F,,20230901.0,20230906,20230915,EXP,,IT-Unichem Pharmaceuticals (USA) Inc-UCM202309-001163,UNICHEM,,61.0,YR,A,M,Y,85.0,KG,20230915,,HP,IT,,2023,Q3,Adult
229142941,22914294,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230828.0,20230906,20230906,EXP,,IT-PRINSTON PHARMACEUTICAL INC.-2023PRN00427,PRINSTON PHARMACEUTICAL,"Greco S, Giovine A, Rocchi C, et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am. J. Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230906,,HP,IT,IT,2023,Q3,Adult
229142941,22914294,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,1,I,,20230828.0,20230906,20230906,EXP,,IT-PRINSTON PHARMACEUTICAL INC.-2023PRN00427,PRINSTON PHARMACEUTICAL,"Greco S, Giovine A, Rocchi C, et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am. J. Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230906,,HP,IT,IT,2023,Q3,Adult
229142941,22914294,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230828.0,20230906,20230906,EXP,,IT-PRINSTON PHARMACEUTICAL INC.-2023PRN00427,PRINSTON PHARMACEUTICAL,"Greco S, Giovine A, Rocchi C, et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am. J. Case Rep.. 2023;24",61.0,YR,,M,Y,85.0,KG,20230906,,HP,IT,IT,2023,Q3,Adult
229179641,22917964,5,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,5,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,5,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,5,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q3,Lipids increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229180001,22918000,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,1,I,,20230830.0,20230907,20230907,EXP,,IT-BAUSCH-BL-2023-013172,BAUSCH AND LOMB,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti A, Fabbri N, Bonazza A, Feo C. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. American Journal of Case Reports. 2023 AUG 15;24:1-7. doi:10.12659/AJCR.939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229180001,22918000,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230830.0,20230907,20230907,EXP,,IT-BAUSCH-BL-2023-013172,BAUSCH AND LOMB,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti A, Fabbri N, Bonazza A, Feo C. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. American Journal of Case Reports. 2023 AUG 15;24:1-7. doi:10.12659/AJCR.939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229180001,22918000,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230830.0,20230907,20230907,EXP,,IT-BAUSCH-BL-2023-013172,BAUSCH AND LOMB,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti A, Fabbri N, Bonazza A, Feo C. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. American Journal of Case Reports. 2023 AUG 15;24:1-7. doi:10.12659/AJCR.939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Chest pain,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Odynophagia,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229270083,22927008,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,3,F,,20230907.0,20230911,20230919,EXP,,IT-AUROBINDO-AUR-APL-2023-055016,AUROBINDO,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Bonazza A et. al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient. Am J Case Rep. 2023;24:e939624-1",61.0,YR,,M,Y,85.0,KG,20230919,,MD,IT,IT,2023,Q3,Adult
229294321,22929432,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Blood creatinine increased,,2023,Q3,1,I,20230806.0,20230901.0,20230911,20230911,EXP,IT-MINISAL02-941026,IT-TEVA-2023-IT-2924484,TEVA,,65.0,YR,E,M,Y,,,20230911,,MD,IT,IT,2023,Q3,Elderly
229294321,22929432,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Blood potassium increased,,2023,Q3,1,I,20230806.0,20230901.0,20230911,20230911,EXP,IT-MINISAL02-941026,IT-TEVA-2023-IT-2924484,TEVA,,65.0,YR,E,M,Y,,,20230911,,MD,IT,IT,2023,Q3,Elderly
229294321,22929432,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Hypotension,,2023,Q3,1,I,20230806.0,20230901.0,20230911,20230911,EXP,IT-MINISAL02-941026,IT-TEVA-2023-IT-2924484,TEVA,,65.0,YR,E,M,Y,,,20230911,,MD,IT,IT,2023,Q3,Elderly
229294321,22929432,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,20230806.0,20230901.0,20230911,20230911,EXP,IT-MINISAL02-941026,IT-TEVA-2023-IT-2924484,TEVA,,65.0,YR,E,M,Y,,,20230911,,MD,IT,IT,2023,Q3,Elderly
229326272,22932627,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Hyperkalaemia,,2023,Q3,2,F,,20230919.0,20230912,20230927,EXP,,JP-JNJFOC-20230916857,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20230927,,MD,JP,JP,2023,Q3,Elderly
229326272,22932627,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Chronic kidney disease,,2023,Q3,2,F,,20230919.0,20230912,20230927,EXP,,JP-JNJFOC-20230916857,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20230927,,MD,JP,JP,2023,Q3,Elderly
229326272,22932627,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Anaemia,,2023,Q3,2,F,,20230919.0,20230912,20230927,EXP,,JP-JNJFOC-20230916857,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20230927,,MD,JP,JP,2023,Q3,Elderly
229365641,22936564,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230828.0,20230912,20230912,EXP,,IT-BEXIMCO-2023BEX00050,BEXIMCO PHARMACEUTICALS,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. American Journal of Case Reports.. 2023;24:e939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229365641,22936564,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,1,I,,20230828.0,20230912,20230912,EXP,,IT-BEXIMCO-2023BEX00050,BEXIMCO PHARMACEUTICALS,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. American Journal of Case Reports.. 2023;24:e939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229365641,22936564,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230828.0,20230912,20230912,EXP,,IT-BEXIMCO-2023BEX00050,BEXIMCO PHARMACEUTICALS,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L et al.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report.. American Journal of Case Reports.. 2023;24:e939624",61.0,YR,,M,Y,85.0,KG,20230907,,HP,IT,IT,2023,Q3,Adult
229389201,22938920,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,100.0,MG,Tablet,,2023,Q3,Septic shock,,2023,Q3,1,I,,20230905.0,20230913,20230913,EXP,,JP-JNJFOC-20230927013,JOHNSON AND JOHNSON,"Harama T, Ishida A, Ban N, Yamamoto K, Matsumoto S. [2 A case of emphysematous pyelonephritis with hyperglycemic hyperosmolar syndrome (HHS)] Chiba Medical Journal/The 1465th Meeting of the Chiba Medical Society (2022 Meeting of Endocrinology and Metabolism/Hematology/Geriatrics) 2023.8.10;2023.2.23;99:4:105.",53.0,YR,A,F,Y,,,20230913,,MD,JP,JP,2023,Q3,Adult
229389201,22938920,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,100.0,MG,Tablet,,2023,Q3,Pyelonephritis,,2023,Q3,1,I,,20230905.0,20230913,20230913,EXP,,JP-JNJFOC-20230927013,JOHNSON AND JOHNSON,"Harama T, Ishida A, Ban N, Yamamoto K, Matsumoto S. [2 A case of emphysematous pyelonephritis with hyperglycemic hyperosmolar syndrome (HHS)] Chiba Medical Journal/The 1465th Meeting of the Chiba Medical Society (2022 Meeting of Endocrinology and Metabolism/Hematology/Geriatrics) 2023.8.10;2023.2.23;99:4:105.",53.0,YR,A,F,Y,,,20230913,,MD,JP,JP,2023,Q3,Adult
229389201,22938920,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,100.0,MG,Tablet,,2023,Q3,Hyperglycaemic hyperosmolar nonketotic syndrome,,2023,Q3,1,I,,20230905.0,20230913,20230913,EXP,,JP-JNJFOC-20230927013,JOHNSON AND JOHNSON,"Harama T, Ishida A, Ban N, Yamamoto K, Matsumoto S. [2 A case of emphysematous pyelonephritis with hyperglycemic hyperosmolar syndrome (HHS)] Chiba Medical Journal/The 1465th Meeting of the Chiba Medical Society (2022 Meeting of Endocrinology and Metabolism/Hematology/Geriatrics) 2023.8.10;2023.2.23;99:4:105.",53.0,YR,A,F,Y,,,20230913,,MD,JP,JP,2023,Q3,Adult
229444591,22944459,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,0.6,GM,,,146230502,,,0.1,GM,Tablet,QD,2023,Q3,Somnolence,,2023,Q3,1,I,20230906.0,20230911.0,20230914,20230914,EXP,,CN-AstraZeneca-2023A209542,ASTRAZENECA,,32263.0,DY,,M,Y,75.0,KG,20230914,,MD,CN,,2023,Q3,Elderly
229444591,22944459,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,0.6,GM,,,146230502,,,0.1,GM,Tablet,QD,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230906.0,20230911.0,20230914,20230914,EXP,,CN-AstraZeneca-2023A209542,ASTRAZENECA,,32263.0,DY,,M,Y,75.0,KG,20230914,,MD,CN,,2023,Q3,Elderly
229444591,22944459,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,0.6,GM,,,146230502,,,0.1,GM,Tablet,QD,2023,Q3,Hyponatraemia,,2023,Q3,1,I,20230906.0,20230911.0,20230914,20230914,EXP,,CN-AstraZeneca-2023A209542,ASTRAZENECA,,32263.0,DY,,M,Y,75.0,KG,20230914,,MD,CN,,2023,Q3,Elderly
229516141,22951614,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2023,Q3,Anterior chamber inflammation,,2023,Q3,1,I,20230425.0,20230907.0,20230918,20230918,EXP,,JP-ROCHE-3402983,ROCHE,,52.0,YR,,F,Y,58.0,KG,20230918,,MD,JP,JP,2023,Q3,Adult
229516141,22951614,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2023,Q3,Macular oedema,,2023,Q3,1,I,20230425.0,20230907.0,20230918,20230918,EXP,,JP-ROCHE-3402983,ROCHE,,52.0,YR,,F,Y,58.0,KG,20230918,,MD,JP,JP,2023,Q3,Adult
229516141,22951614,13,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2023,Q3,Eye inflammation,,2023,Q3,1,I,20230425.0,20230907.0,20230918,20230918,EXP,,JP-ROCHE-3402983,ROCHE,,52.0,YR,,F,Y,58.0,KG,20230918,,MD,JP,JP,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Product prescribing error,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Suicidal ideation,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, visual",,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Depression,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,"Hallucination, auditory",,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229578181,22957818,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 every 1 Days,,,U,,,,,100.0,MG,,,2023,Q3,Anxiety,,2023,Q3,1,I,,20230913.0,20230919,20230919,EXP,,CA-AstraZeneca-2023A212084,ASTRAZENECA,,56.0,YR,,M,Y,,,20230919,,MD,CA,,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Blood triglycerides increased,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Low density lipoprotein increased,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Off label use,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Retinal vein occlusion,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229587721,22958772,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,for 2 years and 1 month or more,,,U,,Unknown,,,100.0,MG,,QD,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,20210701.0,20230906.0,20230919,20230919,EXP,,JP-EMD Serono-2023475028,EMD SERONO INC,,49.0,YR,A,F,Y,83.0,KG,20230919,,PH,JP,JP,2023,Q3,Adult
229593841,22959384,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230801.0,20230920,20230920,EXP,GB-MHRA-ADR 28086034,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08804,ALKEM,,64.0,YR,,,Y,,,20230920,,PH,GB,GB,2023,Q3,Adult
229662621,22966262,3,SS,CANAGLIFLOZIN ANHYDROUS,CANAGLIFLOZIN ANHYDROUS,1,Unknown,UNK,,,U,U,,,,,,Unknown,,2023,Q3,Necrotising oesophagitis,,2023,Q3,1,I,,20230915.0,20230921,20230921,EXP,,IT-MYLANLABS-2023M1099132,MYLAN,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023",61.0,YR,,M,Y,85.0,KG,20230921,,MD,IT,IT,2023,Q3,Adult
229662621,22966262,3,SS,CANAGLIFLOZIN ANHYDROUS,CANAGLIFLOZIN ANHYDROUS,1,Unknown,UNK,,,U,U,,,,,,Unknown,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230915.0,20230921,20230921,EXP,,IT-MYLANLABS-2023M1099132,MYLAN,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023",61.0,YR,,M,Y,85.0,KG,20230921,,MD,IT,IT,2023,Q3,Adult
229674671,22967467,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (Preferably before breakfast),,,,,,,,,,Unknown,,2023,Q3,Malaise,,2023,Q3,1,I,20230410.0,20230917.0,20230921,20230921,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-MYLANLABS-2023M1099772,MYLAN,,79.0,YR,,M,Y,74.0,KG,20230921,,HP,GB,GB,2023,Q3,Elderly
229674671,22967467,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (Preferably before breakfast),,,,,,,,,,Unknown,,2023,Q3,Gastric disorder,,2023,Q3,1,I,20230410.0,20230917.0,20230921,20230921,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-MYLANLABS-2023M1099772,MYLAN,,79.0,YR,,M,Y,74.0,KG,20230921,,HP,GB,GB,2023,Q3,Elderly
229680782,22968078,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q3,Cough,,2023,Q3,2,F,,20230921.0,20230921,20230921,EXP,,GB-009507513-2309GBR006818,MERCK,,39.0,YR,,M,Y,149.0,KG,20230921,,CN,GB,GB,2023,Q3,Adult
229686751,22968675,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Removal of internal fixation,,2023,Q3,1,I,20141001.0,20230913.0,20230921,20230921,EXP,,JP-JNJFOC-20230947154,JOHNSON AND JOHNSON,,85.0,YR,E,F,Y,,,20230922,,MD,JP,JP,2023,Q3,Elderly
229686751,22968675,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Diarrhoea,,2023,Q3,1,I,20141001.0,20230913.0,20230921,20230921,EXP,,JP-JNJFOC-20230947154,JOHNSON AND JOHNSON,,85.0,YR,E,F,Y,,,20230922,,MD,JP,JP,2023,Q3,Elderly
229686751,22968675,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Coronary angioplasty,,2023,Q3,1,I,20141001.0,20230913.0,20230921,20230921,EXP,,JP-JNJFOC-20230947154,JOHNSON AND JOHNSON,,85.0,YR,E,F,Y,,,20230922,,MD,JP,JP,2023,Q3,Elderly
229686751,22968675,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Pneumonia,,2023,Q3,1,I,20141001.0,20230913.0,20230921,20230921,EXP,,JP-JNJFOC-20230947154,JOHNSON AND JOHNSON,,85.0,YR,E,F,Y,,,20230922,,MD,JP,JP,2023,Q3,Elderly
229686751,22968675,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,,,,204042.0,100.0,MG,Tablet,QD,2023,Q3,Dehydration,,2023,Q3,1,I,20141001.0,20230913.0,20230921,20230921,EXP,,JP-JNJFOC-20230947154,JOHNSON AND JOHNSON,,85.0,YR,E,F,Y,,,20230922,,MD,JP,JP,2023,Q3,Elderly
229753321,22975332,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, QD (Preferably Before Breakfast)",,,U,,UNK,,,,,,QD,2023,Q3,Malaise,,2023,Q3,1,I,20230410.0,20230917.0,20230924,20230924,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,NVSC2023GB205422,NOVARTIS,,79.0,YR,,M,Y,74.0,KG,20230924,,HP,GB,GB,2023,Q3,Elderly
229753321,22975332,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, QD (Preferably Before Breakfast)",,,U,,UNK,,,,,,QD,2023,Q3,Gastric disorder,,2023,Q3,1,I,20230410.0,20230917.0,20230924,20230924,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,NVSC2023GB205422,NOVARTIS,,79.0,YR,,M,Y,74.0,KG,20230924,,HP,GB,GB,2023,Q3,Elderly
229802081,22980208,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,Dose: 1 TABLET,,,,,,,,,,Tablet,BID,2023,Q3,Cytokine release syndrome,,2023,Q3,1,I,20210429.0,20230921.0,20230925,20230925,EXP,,ES-ROCHE-2823271,ROCHE,,66.0,YR,,F,Y,62.1,KG,20230925,,MD,ES,,2023,Q3,Elderly
229802081,22980208,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,Dose: 1 TABLET,,,,,,,,,,Tablet,BID,2023,Q3,Aspartate aminotransferase increased,,2023,Q3,1,I,20210429.0,20230921.0,20230925,20230925,EXP,,ES-ROCHE-2823271,ROCHE,,66.0,YR,,F,Y,62.1,KG,20230925,,MD,ES,,2023,Q3,Elderly
229843481,22984348,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, QD (Preferably Before Breakfast)",,,U,,UNK,,,,,,QD,2023,Q3,Malaise,,2023,Q3,1,I,20230410.0,20230917.0,20230926,20230926,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-SANDOZ INC.-SDZ2023GB033224,SANDOZ,,79.0,YR,,M,Y,74.0,KG,20230926,,HP,GB,GB,2023,Q3,Elderly
229843481,22984348,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, QD (Preferably Before Breakfast)",,,U,,UNK,,,,,,QD,2023,Q3,Gastric disorder,,2023,Q3,1,I,20230410.0,20230917.0,20230926,20230926,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-SANDOZ INC.-SDZ2023GB033224,SANDOZ,,79.0,YR,,M,Y,74.0,KG,20230926,,HP,GB,GB,2023,Q3,Elderly
229857761,22985776,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,Y,,,,,,,Tablet,QD,2023,Q3,Off label use,,2023,Q3,1,I,20230401.0,20230919.0,20230926,20230926,EXP,,JP-KOWA-23JP001355,KOWA PHARM,,49.0,YR,,M,Y,73.0,KG,20230926,,PH,JP,JP,2023,Q3,Adult
229857761,22985776,2,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,Y,,,,,,,Tablet,QD,2023,Q3,Suspected drug-induced liver injury,,2023,Q3,1,I,20230401.0,20230919.0,20230926,20230926,EXP,,JP-KOWA-23JP001355,KOWA PHARM,,49.0,YR,,M,Y,73.0,KG,20230926,,PH,JP,JP,2023,Q3,Adult
229857761,22985776,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, unk",,,U,,,,,,,Tablet,,2023,Q3,Off label use,,2023,Q3,1,I,20230401.0,20230919.0,20230926,20230926,EXP,,JP-KOWA-23JP001355,KOWA PHARM,,49.0,YR,,M,Y,73.0,KG,20230926,,PH,JP,JP,2023,Q3,Adult
229857761,22985776,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"UNK, unk",,,U,,,,,,,Tablet,,2023,Q3,Suspected drug-induced liver injury,,2023,Q3,1,I,20230401.0,20230919.0,20230926,20230926,EXP,,JP-KOWA-23JP001355,KOWA PHARM,,49.0,YR,,M,Y,73.0,KG,20230926,,PH,JP,JP,2023,Q3,Adult
229879771,22987977,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, Daily",,,U,,,,,300.0,MG,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230425.0,20230926,20230926,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396311,RANBAXY,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract Diabetes. 1900;40(2)::24-27",59.0,YR,,M,Y,,,20230926,,HP,GB,GB,2023,Q3,Adult
229879771,22987977,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, Daily",,,U,,,,,300.0,MG,,,2023,Q3,Ketoacidosis,,2023,Q3,1,I,,20230425.0,20230926,20230926,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396311,RANBAXY,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract Diabetes. 1900;40(2)::24-27",59.0,YR,,M,Y,,,20230926,,HP,GB,GB,2023,Q3,Adult
229879771,22987977,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, Daily",,,U,,,,,300.0,MG,,,2023,Q3,Acetonaemia,,2023,Q3,1,I,,20230425.0,20230926,20230926,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396311,RANBAXY,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract Diabetes. 1900;40(2)::24-27",59.0,YR,,M,Y,,,20230926,,HP,GB,GB,2023,Q3,Adult
229879771,22987977,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"300 milligram, Daily",,,U,,,,,300.0,MG,,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230425.0,20230926,20230926,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396311,RANBAXY,"Mung SM, Fonseca I, Azmi S, Balmuri LMR. Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low-carbohydrate diet. Pract Diabetes. 1900;40(2)::24-27",59.0,YR,,M,Y,,,20230926,,HP,GB,GB,2023,Q3,Adult
229934621,22993462,5,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,Dose unknown,,,,,,,,,,Tablet,,2023,Q3,Skin disorder,,2023,Q3,1,I,20230724.0,20230919.0,20230927,20230927,EXP,,JP-AstraZeneca-2023A215949,ASTRAZENECA,,73.0,YR,,M,Y,59.0,KG,20230927,,MD,JP,,2023,Q3,Elderly
229936331,22993633,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Preferably Before Breakfast,,,,,UNKNOWN,,,,,,QD,2023,Q3,Malaise,,2023,Q3,1,I,20230410.0,20230917.0,20230927,20230927,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-drreddys-SPO/UKI/23/0178280,DR REDDYS,,79.0,YR,E,M,Y,74.0,KG,20230927,,HP,GB,GB,2023,Q3,Elderly
229936331,22993633,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,Preferably Before Breakfast,,,,,UNKNOWN,,,,,,QD,2023,Q3,Gastric disorder,,2023,Q3,1,I,20230410.0,20230917.0,20230927,20230927,EXP,GB-MHRA-EMIS-557-055c2080-baec-4b50-95f8-19f9295f40fc,GB-drreddys-SPO/UKI/23/0178280,DR REDDYS,,79.0,YR,E,M,Y,74.0,KG,20230927,,HP,GB,GB,2023,Q3,Elderly
230005941,23000594,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day Preferably Before Breakfast",,,U,,,,,,,,QD,2023,Q3,Malaise,,2023,Q3,1,I,20230410.0,20230917.0,20230928,20230928,EXP,,GB-AUROBINDO-AUR-APL-2023-059530,AUROBINDO,,79.0,YR,,M,Y,74.0,KG,20230928,,HP,GB,GB,2023,Q3,Elderly
230005941,23000594,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day Preferably Before Breakfast",,,U,,,,,,,,QD,2023,Q3,Gastric disorder,,2023,Q3,1,I,20230410.0,20230917.0,20230928,20230928,EXP,,GB-AUROBINDO-AUR-APL-2023-059530,AUROBINDO,,79.0,YR,,M,Y,74.0,KG,20230928,,HP,GB,GB,2023,Q3,Elderly
230085981,23008598,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,19,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,20,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,20,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,20,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,20,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,20,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,21,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,22,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,22,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,22,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,22,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,22,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,23,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,24,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,24,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,24,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,24,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,24,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,25,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,26,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Asthma,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Full blood count abnormal,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230085981,23008598,34,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,,20230920.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2022CA214707,SANDOZ,,76.0,YR,,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Elderly
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,Product prescribing error,,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,Depression,,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,Suicidal ideation,,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,Anxiety,,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230098921,23009892,15,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,100.0,MG,,QD,2023,Q3,"Hallucination, auditory",,2023,Q3,1,I,,20230925.0,20230929,20230929,EXP,,CA-drreddys-SPO/CAN/23/0178671,DR REDDYS,,56.0,YR,A,M,Y,,,20230929,,HP,CA,CA,2023,Q3,Adult
230130991,23013099,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,ASKU,,,,,,,2023,Q3,Abdominal discomfort,,2023,Q3,1,I,,20230915.0,20230930,20230930,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-410245,RANBAXY,,53.0,YR,,F,Y,,,20230930,,PH,GB,GB,2023,Q3,Adult
230130991,23013099,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,ASKU,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230915.0,20230930,20230930,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-410245,RANBAXY,,53.0,YR,,F,Y,,,20230930,,PH,GB,GB,2023,Q3,Adult
1445851815,14458518,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,43,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1445851815,14458518,44,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20231013.0,20180130,20231023,EXP,,CA-APOTEX-2018AP005828,APOTEX,,76.0,YR,,F,Y,,,20231023,,MD,CA,CA,2023,Q4,Elderly
1719352822,17193528,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,110,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,111,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,112,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,112,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,112,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,112,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,112,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,113,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,113,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,113,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,113,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,113,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
1719352822,17193528,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,22,F,,20231009.0,20191223,20231114,EXP,,CA-BAUSCH-BL-2019-065992,BAUSCH AND LOMB,,76.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Elderly
181522302,18152230,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Diabetic ketoacidosis,,2023,Q4,2,F,,20231119.0,20200814,20231124,EXP,,US-JNJFOC-20200807308,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20231125,,HP,US,NL,2023,Q4,Adult
181522302,18152230,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Fournier's gangrene,,2023,Q4,2,F,,20231119.0,20200814,20231124,EXP,,US-JNJFOC-20200807308,JOHNSON AND JOHNSON,,37.0,YR,A,F,Y,,,20231125,,HP,US,NL,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hypoacusis,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Depression,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Dyspnoea,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Wheezing,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Spinal compression fracture,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Depressive symptom,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Diabetic nephropathy,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Insomnia,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Small intestinal haemorrhage,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Depression,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
1972718016,19727180,16,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 tablet per day,,,,,,,,100.0,MG,Tablet,,2023,Q4,Duodenal ulcer haemorrhage,,2023,Q4,16,F,20171222.0,20231101.0,20210819,20231107,EXP,,JP-ABBVIE-21P-087-4045425-00,ABBVIE,,69.0,YR,,M,Y,61.0,KG,20231107,,MD,JP,JP,2023,Q4,Elderly
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Tooth disorder,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Oropharyngeal pain,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract congestion,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Constipation,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Road traffic accident,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bladder disorder,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Disability assessment scale score increased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Muscle tightness,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Medication error,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Weight fluctuation,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic decreased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Swelling face,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract infection,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Sinus congestion,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Soft tissue injury,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic abnormal,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
201507306,20150730,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure decreased,,2023,Q4,6,F,,20231213.0,20211206,20231221,EXP,,CA-BAUSCH-BL-2021-039633,BAUSCH AND LOMB,,46.0,YR,,F,Y,88.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
204109432,20410943,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,U,,,,,100.0,MG,Tablet,QD,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,2,F,,20231019.0,20220201,20231031,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202201008423,ELI LILLY AND CO,,50.0,YR,,F,Y,36.0,KG,20231031,,CN,JP,JP,2023,Q4,Adult
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Anxiety,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Emotional distress,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Anhedonia,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bone pain,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bone density decreased,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
204676423,20467642,97,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bone demineralisation,,2023,Q4,3,F,20140101.0,20231121.0,20220214,20231122,PER,,US-GILEAD-2022-0569212,GILEAD,,69.0,YR,E,M,Y,78.005,KG,20231122,,LW,US,US,2023,Q4,Elderly
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Cough,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Swelling face,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Road traffic accident,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Sinus congestion,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure decreased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Weight fluctuation,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Oropharyngeal pain,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Constipation,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure diastolic abnormal,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Muscle tightness,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure systolic decreased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Bladder disorder,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Soft tissue injury,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Medication error,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Lower respiratory tract congestion,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Headache,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Disability assessment scale score increased,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Tooth disorder,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
207336483,20733648,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,3,F,,20231213.0,20220421,20231221,EXP,,CA-APOTEX-2022AP006141,APOTEX,,46.0,YR,,F,Y,94.0,KG,20231221,,HP,CA,CA,2023,Q4,Adult
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Adrenal insufficiency,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Thyroiditis,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Tubulointerstitial nephritis,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Adrenocorticotropic hormone deficiency,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Pyrexia,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Blood pressure decreased,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Decreased appetite,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Adrenocortical insufficiency acute,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Malaise,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Cortisol decreased,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208723093,20872309,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,,,,,,,,,,,Tablet,QD,2023,Q4,Renal impairment,,2023,Q4,3,F,20220405.0,20231030.0,20220525,20231109,EXP,,JP-EMD Serono-9314301,EMD SERONO INC,,72.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
208844862,20884486,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"300 mg, daily (in morning)",,,Y,,,,,300.0,MG,Tablet,QD,2023,Q4,Dehydration,,2023,Q4,2,F,,20231019.0,20220527,20231031,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202205006231,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20231031,,CN,GB,GB,2023,Q4,Adult
208844862,20884486,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"300 mg, daily (in morning)",,,Y,,,,,300.0,MG,Tablet,QD,2023,Q4,Diarrhoea,,2023,Q4,2,F,,20231019.0,20220527,20231031,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202205006231,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20231031,,CN,GB,GB,2023,Q4,Adult
208844862,20884486,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"300 mg, daily (in morning)",,,Y,,,,,300.0,MG,Tablet,QD,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,2,F,,20231019.0,20220527,20231031,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202205006231,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20231031,,CN,GB,GB,2023,Q4,Adult
209106385,20910638,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2023,Q4,Anaphylactic reaction,,2023,Q4,5,F,20220425.0,20221108.0,20220603,20231006,EXP,,JP-BAYER-2022A066783,BAYER,,31.0,YR,A,M,Y,136.4,KG,20231006,,MD,JP,JP,2023,Q4,Young Adult
210709693,21070969,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231023.0,20220712,20231031,EXP,,CA-AstraZeneca-2022A245163,ASTRAZENECA,,76.0,YR,,F,Y,,,20231031,,MD,CA,,2023,Q4,Elderly
210709693,21070969,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231023.0,20220712,20231031,EXP,,CA-AstraZeneca-2022A245163,ASTRAZENECA,,76.0,YR,,F,Y,,,20231031,,MD,CA,,2023,Q4,Elderly
210709693,21070969,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231023.0,20220712,20231031,EXP,,CA-AstraZeneca-2022A245163,ASTRAZENECA,,76.0,YR,,F,Y,,,20231031,,MD,CA,,2023,Q4,Elderly
210709693,21070969,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231023.0,20220712,20231031,EXP,,CA-AstraZeneca-2022A245163,ASTRAZENECA,,76.0,YR,,F,Y,,,20231031,,MD,CA,,2023,Q4,Elderly
210709693,21070969,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231023.0,20220712,20231031,EXP,,CA-AstraZeneca-2022A245163,ASTRAZENECA,,76.0,YR,,F,Y,,,20231031,,MD,CA,,2023,Q4,Elderly
2124017517,21240175,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablets,,2023,Q4,Dehydration,,2023,Q4,17,F,20220721.0,20230926.0,20220822,20231002,PER,,JP-Eisai Medical Research-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231002,,MD,JP,,2023,Q4,Adult
2124017517,21240175,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablets,,2023,Q4,Colitis,,2023,Q4,17,F,20220721.0,20230926.0,20220822,20231002,PER,,JP-Eisai Medical Research-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231002,,MD,JP,,2023,Q4,Adult
2124017517,21240175,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablets,,2023,Q4,Cholangitis sclerosing,Cholangitis sclerosing,2023,Q4,17,F,20220721.0,20230926.0,20220822,20231002,PER,,JP-Eisai Medical Research-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231002,,MD,JP,,2023,Q4,Adult
2124017517,21240175,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablets,,2023,Q4,Stomatitis,Stomatitis,2023,Q4,17,F,20220721.0,20230926.0,20220822,20231002,PER,,JP-Eisai Medical Research-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231002,,MD,JP,,2023,Q4,Adult
2124491215,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,126,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,127,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,128,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,129,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,130,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,131,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,132,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,133,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,134,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,135,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,136,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,137,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,138,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,139,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,140,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK (dosage form not specified),,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,141,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,142,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,143,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,144,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,145,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,146,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,147,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,148,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,149,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,150,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,151,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,152,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,499,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,500,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,501,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,502,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,503,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,504,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,505,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,506,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,507,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,508,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,509,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,510,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
2124491215,21244912,511,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,15,F,,20230925.0,20220823,20231002,EXP,,CA-ORGANON-O2206CAN002029,ORGANON,,76.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Elderly
215693083,21569308,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Back pain,,2023,Q4,3,F,20221101.0,20231017.0,20221109,20231026,EXP,,JP-AMGEN-JPNSP2022191997,AMGEN,,8.0,DEC,E,F,Y,,,20231026,,PH,JP,JP,2023,Q4,Child
215693083,21569308,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Hyperkalaemia,,2023,Q4,3,F,20221101.0,20231017.0,20221109,20231026,EXP,,JP-AMGEN-JPNSP2022191997,AMGEN,,8.0,DEC,E,F,Y,,,20231026,,PH,JP,JP,2023,Q4,Child
215693083,21569308,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, qd",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Disease progression,,2023,Q4,3,F,20221101.0,20231017.0,20221109,20231026,EXP,,JP-AMGEN-JPNSP2022191997,AMGEN,,8.0,DEC,E,F,Y,,,20231026,,PH,JP,JP,2023,Q4,Child
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Nausea,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Pulmonary embolism,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Chills,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Thrombocytosis,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Pneumonia,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Abdominal pain upper,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Abdominal abscess,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Renal disorder,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Cerebral venous sinus thrombosis,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Thrombosis,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Disease recurrence,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Drug ineffective,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Platelet count decreased,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Headache,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Platelet count increased,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Flank pain,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Haematuria,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Renal vein thrombosis,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
2175171612,21751716,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",,,U,,,,,100.0,MG,,QD,2023,Q4,Decreased appetite,,2023,Q4,12,F,20221125.0,20231005.0,20221220,20231013,EXP,,NVSC2022CA289979,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20231013,,CN,CA,CA,2023,Q4,Adult
218118613,21811861,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,QD,2023,Q4,Drug-induced liver injury,,2023,Q4,3,F,20221228.0,20231201.0,20230103,20231206,EXP,,GB-ROCHE-3255186,ROCHE,,74.0,YR,,M,Y,80.5,KG,20231206,,MD,GB,,2023,Q4,Elderly
218467233,21846723,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"UNK, qd",,,,,,,,,,,QD,2023,Q4,Drug-induced liver injury,,2023,Q4,3,F,20221228.0,20231208.0,20230111,20231215,PER,,GB-AMGEN-GBRNI2023001584,AMGEN,,74.0,YR,E,M,Y,80.5,KG,20231215,,MD,GB,GB,2023,Q4,Elderly
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Mouth ulceration,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Body temperature decreased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Pemphigus,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Heart rate increased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Off label use,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood pressure systolic increased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220632442,22063244,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,,20231204.0,20230306,20231218,EXP,,CA-APOTEX-2023AP004358,APOTEX,,62.0,YR,,M,Y,,,20231218,,HP,CA,CA,2023,Q4,Adult
220751303,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,27,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,28,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,29,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,30,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,31,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,32,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,33,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,34,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,35,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
220751303,22075130,130,SS,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Full blood count abnormal,,2023,Q4,3,F,,20231025.0,20230308,20231102,EXP,,CA-AstraZeneca-2023A050999,ASTRAZENECA,,76.0,YR,,F,Y,,,20231102,,MD,CA,,2023,Q4,Elderly
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Suicidal ideation,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, visual",,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Anxiety,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Depression,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Product prescribing error,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, auditory",,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
222952132,22295213,20,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Diabetes mellitus,,2023,Q4,2,F,,20231015.0,20230508,20231025,EXP,,CA-TEVA-2023-CA-2883509,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
227227463,22722746,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Hepatic function abnormal,,2023,Q4,3,F,20230608.0,20231221.0,20230719,20231225,EXP,,JP-ASTELLAS-2023JP008124,ASTELLAS,,74.0,YR,,M,Y,58.0,KG,20231225,,MD,JP,JP,2023,Q4,Elderly
227227463,22722746,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Prescribed overdose,,2023,Q4,3,F,20230608.0,20231221.0,20230719,20231225,EXP,,JP-ASTELLAS-2023JP008124,ASTELLAS,,74.0,YR,,M,Y,58.0,KG,20231225,,MD,JP,JP,2023,Q4,Elderly
227227463,22722746,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Alopecia,,2023,Q4,3,F,20230608.0,20231221.0,20230719,20231225,EXP,,JP-ASTELLAS-2023JP008124,ASTELLAS,,74.0,YR,,M,Y,58.0,KG,20231225,,MD,JP,JP,2023,Q4,Elderly
227227463,22722746,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Pulmonary toxicity,,2023,Q4,3,F,20230608.0,20231221.0,20230719,20231225,EXP,,JP-ASTELLAS-2023JP008124,ASTELLAS,,74.0,YR,,M,Y,58.0,KG,20231225,,MD,JP,JP,2023,Q4,Elderly
227370234,22737023,6,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK UNK, 1x/day",,,,,,,,,,,QD,2023,Q4,Angina pectoris,,2023,Q4,4,F,20230621.0,20231024.0,20230721,20231027,EXP,,JP-PFIZER INC-PV202300126153,PFIZER,,78.0,YR,,M,Y,57.8,KG,20231027,,MD,JP,JP,2023,Q4,Elderly
227370234,22737023,6,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK UNK, 1x/day",,,,,,,,,,,QD,2023,Q4,Pleural effusion,,2023,Q4,4,F,20230621.0,20231024.0,20230721,20231027,EXP,,JP-PFIZER INC-PV202300126153,PFIZER,,78.0,YR,,M,Y,57.8,KG,20231027,,MD,JP,JP,2023,Q4,Elderly
227370234,22737023,6,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK UNK, 1x/day",,,,,,,,,,,QD,2023,Q4,Blood glucose increased,,2023,Q4,4,F,20230621.0,20231024.0,20230721,20231027,EXP,,JP-PFIZER INC-PV202300126153,PFIZER,,78.0,YR,,M,Y,57.8,KG,20231027,,MD,JP,JP,2023,Q4,Elderly
227370234,22737023,6,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK UNK, 1x/day",,,,,,,,,,,QD,2023,Q4,Palpitations,,2023,Q4,4,F,20230621.0,20231024.0,20230721,20231027,EXP,,JP-PFIZER INC-PV202300126153,PFIZER,,78.0,YR,,M,Y,57.8,KG,20231027,,MD,JP,JP,2023,Q4,Elderly
227370234,22737023,6,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK UNK, 1x/day",,,,,,,,,,,QD,2023,Q4,Coronary artery disease,,2023,Q4,4,F,20230621.0,20231024.0,20230721,20231027,EXP,,JP-PFIZER INC-PV202300126153,PFIZER,,78.0,YR,,M,Y,57.8,KG,20231027,,MD,JP,JP,2023,Q4,Elderly
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Heart rate increased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic increased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Mouth ulceration,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Body temperature decreased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Pemphigus,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227459924,22745992,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,4,F,,20231114.0,20230725,20231120,EXP,,CA-ROCHE-3392494,ROCHE,,62.0,YR,,M,Y,,,20231120,,HP,CA,,2023,Q4,Adult
227560544,22756054,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Anaemia,,2023,Q4,4,F,20221229.0,20231106.0,20230727,20231115,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20231115,,MD,JP,JP,2023,Q4,Elderly
227560544,22756054,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Diverticulum intestinal haemorrhagic,,2023,Q4,4,F,20221229.0,20231106.0,20230727,20231115,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20231115,,MD,JP,JP,2023,Q4,Elderly
227560544,22756054,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,4,F,20221229.0,20231106.0,20230727,20231115,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20231115,,MD,JP,JP,2023,Q4,Elderly
227560544,22756054,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Lymphocyte count decreased,,2023,Q4,4,F,20221229.0,20231106.0,20230727,20231115,EXP,,JP-009507513-2307JPN011450,MERCK,,73.0,YR,,F,Y,,,20231115,,MD,JP,JP,2023,Q4,Elderly
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Drug interaction,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Acute kidney injury,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,COVID-19,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Immunosuppressant drug level decreased,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Prinzmetal angina,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Immunosuppressant drug level increased,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228026763,22802676,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, once daily, after breakfast",,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Drug interaction,,2023,Q4,3,F,20230716.0,20231211.0,20230809,20231218,EXP,,JP-ASTELLAS-2023JP009318,ASTELLAS,,60.0,YR,,M,Y,44.4,KG,20231218,,HP,JP,JP,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Product prescribing error,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Anxiety,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, auditory",,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Diabetes mellitus,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Depression,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, visual",,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Suicidal ideation,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228220132,22822013,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,QD,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231120.0,20230814,20231128,EXP,,CA-BAUSCH-BL-2023-012102,BAUSCH AND LOMB,UNKNOWN. Unspecified Article. Unspecified Journal.,56.0,YR,,M,Y,,,20231128,,HP,CA,CA,2023,Q4,Adult
228592552,22859255,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2023,Q4,Vulvovaginal candidiasis,,2023,Q4,2,F,20230801.0,20231010.0,20230824,20231012,EXP,,GB-ABBVIE-5379016,ABBVIE,,74.0,YR,,F,Y,,,20231012,,CN,GB,GB,2023,Q4,Elderly
228851413,22885141,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Acute kidney injury,,2023,Q4,3,F,20230721.0,20230928.0,20230830,20231005,EXP,,JP-JNJFOC-20230868158,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20231006,,PH,JP,JP,2023,Q4,Elderly
228851413,22885141,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Renal abscess,,2023,Q4,3,F,20230721.0,20230928.0,20230830,20231005,EXP,,JP-JNJFOC-20230868158,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20231006,,PH,JP,JP,2023,Q4,Elderly
228851413,22885141,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Sepsis,,2023,Q4,3,F,20230721.0,20230928.0,20230830,20231005,EXP,,JP-JNJFOC-20230868158,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20231006,,PH,JP,JP,2023,Q4,Elderly
228851413,22885141,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Urinary tract infection,,2023,Q4,3,F,20230721.0,20230928.0,20230830,20231005,EXP,,JP-JNJFOC-20230868158,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20231006,,PH,JP,JP,2023,Q4,Elderly
228879074,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Heat illness,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Decreased appetite,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Dehydration,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",3900.0,MG,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Chronic kidney disease,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Heat illness,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Decreased appetite,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Dehydration,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Chronic kidney disease,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Heat illness,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Decreased appetite,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Dehydration,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
228879074,22887907,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,3900.0,MG,Y,U,,,204042.0,,,Tablet,,2023,Q4,Chronic kidney disease,,2023,Q4,4,F,20230724.0,20231220.0,20230831,20231228,EXP,,JP-JNJFOC-20230830476,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20231228,,MD,JP,JP,2023,Q4,Elderly
229180952,22918095,2,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,,"1 DF, 1x/day after breakfast",,,,,,,,,,Tablet,QD,2023,Q4,Drug ineffective,,2023,Q4,2,F,20230906.0,20230920.0,20230907,20231002,EXP,,JP-PFIZER INC-PV202300151660,PFIZER,,90.0,YR,,F,Y,55.9,KG,20231002,,MD,JP,JP,2023,Q4,Elderly
229181882,22918188,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q4,Prerenal failure,,2023,Q4,2,F,20230727.0,20230922.0,20230907,20231004,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202308003880,ELI LILLY AND CO,,52.0,YR,,M,Y,73.1,KG,20231004,,CN,JP,JP,2023,Q4,Adult
229181882,22918188,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q4,Heat illness,,2023,Q4,2,F,20230727.0,20230922.0,20230907,20231004,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202308003880,ELI LILLY AND CO,,52.0,YR,,M,Y,73.1,KG,20231004,,CN,JP,JP,2023,Q4,Adult
229181882,22918188,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, daily",,,,,,,,100.0,MG,,QD,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,20230727.0,20230922.0,20230907,20231004,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202308003880,ELI LILLY AND CO,,52.0,YR,,M,Y,73.1,KG,20231004,,CN,JP,JP,2023,Q4,Adult
230222292,23022229,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2023,Q4,Endocrine disorder,,2023,Q4,2,F,20221005.0,20231114.0,20231003,20231121,EXP,,JP-EMD Serono-2023477266,EMD SERONO INC,,82.0,YR,E,M,Y,52.0,KG,20231121,,PH,JP,JP,2023,Q4,Elderly
230242701,23024270,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q4,Myopathy toxic,,2023,Q4,1,I,,20230921.0,20231004,20231004,EXP,,CA-AUROBINDO-AUR-APL-2023-060612,AUROBINDO,"Brailovski E, Kim RB, Juurlink D.. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment:. A Case Report. Ann Intern Med.. 2020",76.0,YR,,F,Y,,,20231001,,HP,CA,CA,2023,Q4,Elderly
230242701,23024270,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 milligram, Once a Day",,,U,,,,,100.0,MG,,QD,2023,Q4,Drug interaction,,2023,Q4,1,I,,20230921.0,20231004,20231004,EXP,,CA-AUROBINDO-AUR-APL-2023-060612,AUROBINDO,"Brailovski E, Kim RB, Juurlink D.. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment:. A Case Report. Ann Intern Med.. 2020",76.0,YR,,F,Y,,,20231001,,HP,CA,CA,2023,Q4,Elderly
230337011,23033701,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Renal neoplasm,,2023,Q4,1,I,,20230925.0,20231005,20231005,EXP,,CA-TEVA-2023-CA-2930918,TEVA,,56.0,YR,A,M,Y,,,20231005,,MD,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Anxiety,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Product prescribing error,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Depression,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, auditory",,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Suicidal ideation,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Diabetes mellitus,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, visual",,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230375162,23037516,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"100 mg, 1 every 1 Days",,,U,,,,,100.0,MG,,QD,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231124.0,20231006,20231127,EXP,,CA-SANDOZ INC.-SDZ2023CA038093,SANDOZ,,56.0,YR,,M,Y,,,20231127,,HP,CA,CA,2023,Q4,Adult
230539071,23053907,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q4,Necrotising oesophagitis,,2023,Q4,1,I,,20230929.0,20231011,20231011,EXP,,IT-Accord-383293,ACCORD,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023;15:24:e939624.",61.0,YR,A,M,Y,85.0,KG,20231011,,MD,IT,IT,2023,Q4,Adult
230539071,23053907,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2023,Q4,Metabolic acidosis,,2023,Q4,1,I,,20230929.0,20231011,20231011,EXP,,IT-Accord-383293,ACCORD,"Greco S, Giovine A, Rocchi C, Resca R, Bigoni R, Formigaro L, Angeletti AG, Fabbri N, Bonazza A, Feo CV.. Acute Esophageal Necrosis as a Rare Complication of Metabolic Acidosis in a Diabetic Patient: A Case Report. Am J Case Rep. 2023;15:24:e939624.",61.0,YR,A,M,Y,85.0,KG,20231011,,MD,IT,IT,2023,Q4,Adult
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Sleep disorder,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Rales,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Bone pain,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Flank pain,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Restless legs syndrome,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,8,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Middle insomnia,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230713542,23071354,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,,2023,Q4,Sepsis,,2023,Q4,2,F,20231012.0,20231129.0,20231016,20231201,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266646",BOEHRINGER INGELHEIM,,87.0,YR,E,M,Y,,,20231201,,PH,JP,JP,2023,Q4,Elderly
230713542,23071354,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,,2023,Q4,Gastrointestinal haemorrhage,,2023,Q4,2,F,20231012.0,20231129.0,20231016,20231201,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266646",BOEHRINGER INGELHEIM,,87.0,YR,E,M,Y,,,20231201,,PH,JP,JP,2023,Q4,Elderly
230713542,23071354,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,,2023,Q4,Pneumonia,,2023,Q4,2,F,20231012.0,20231129.0,20231016,20231201,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266646",BOEHRINGER INGELHEIM,,87.0,YR,E,M,Y,,,20231201,,PH,JP,JP,2023,Q4,Elderly
230812181,23081218,7,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,dose and frequency unknown,,,,,,,,,,Tablet,,2023,Q4,Eosinophil count increased,,2023,Q4,1,I,20230217.0,20231010.0,20231018,20231018,EXP,,JP-Eisai-EC-2023-150465,EISAI,,76.0,YR,E,M,Y,63.0,KG,20231019,,PH,JP,JP,2023,Q4,Elderly
230812181,23081218,7,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Unknown,dose and frequency unknown,,,,,,,,,,Tablet,,2023,Q4,Dermatitis acneiform,,2023,Q4,1,I,20230217.0,20231010.0,20231018,20231018,EXP,,JP-Eisai-EC-2023-150465,EISAI,,76.0,YR,E,M,Y,63.0,KG,20231019,,PH,JP,JP,2023,Q4,Elderly
230901472,23090147,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2023,Q4,Vomiting,,2023,Q4,2,F,20230818.0,20231025.0,20231020,20231102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310008393,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231102,,CN,JP,JP,2023,Q4,Adult
230901472,23090147,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2023,Q4,Dehydration,,2023,Q4,2,F,20230818.0,20231025.0,20231020,20231102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310008393,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231102,,CN,JP,JP,2023,Q4,Adult
230901472,23090147,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2023,Q4,Gastroenteritis,,2023,Q4,2,F,20230818.0,20231025.0,20231020,20231102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310008393,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231102,,CN,JP,JP,2023,Q4,Adult
230907942,23090794,7,C,CANAGLIFLOZINA,,2,,,,,,,,,,,,,,2023,Q4,Vaginal infection,,2023,Q4,2,F,20230721.0,20231107.0,20231020,20231115,EXP,,PT-AstraZeneca-2023A174300,ASTRAZENECA,,68.0,YR,,F,Y,,,20231115,,MD,PT,,2023,Q4,Elderly
230907942,23090794,7,C,CANAGLIFLOZINA,,2,,,,,,,,,,,,,,2023,Q4,Rash,,2023,Q4,2,F,20230721.0,20231107.0,20231020,20231115,EXP,,PT-AstraZeneca-2023A174300,ASTRAZENECA,,68.0,YR,,F,Y,,,20231115,,MD,PT,,2023,Q4,Elderly
230989501,23098950,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Weight increased,,2023,Q4,1,I,,20231016.0,20231024,20231024,EXP,,JP-EMD Serono-2023482582,EMD SERONO INC,,65.0,YR,E,M,Y,,,20231024,,MD,JP,JP,2023,Q4,Elderly
230989501,23098950,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Renal impairment,,2023,Q4,1,I,,20231016.0,20231024,20231024,EXP,,JP-EMD Serono-2023482582,EMD SERONO INC,,65.0,YR,E,M,Y,,,20231024,,MD,JP,JP,2023,Q4,Elderly
230989501,23098950,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Pyelonephritis,,2023,Q4,1,I,,20231016.0,20231024,20231024,EXP,,JP-EMD Serono-2023482582,EMD SERONO INC,,65.0,YR,E,M,Y,,,20231024,,MD,JP,JP,2023,Q4,Elderly
231027422,23102742,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Live birth,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Premature delivery,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Pre-eclampsia,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Blood glucose increased,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100.0,MG,Tablet,QD,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231037831,23103783,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Depression,,2023,Q4,1,I,,20231015.0,20231025,20231025,EXP,,CA-TEVA-2023-CA-2937434,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
231037831,23103783,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,Psychiatric symptom,,2023,Q4,1,I,,20231015.0,20231025,20231025,EXP,,CA-TEVA-2023-CA-2937434,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
231037831,23103783,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, auditory",,2023,Q4,1,I,,20231015.0,20231025,20231025,EXP,,CA-TEVA-2023-CA-2937434,TEVA,,56.0,YR,A,M,Y,,,20231025,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Product prescribing error,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, visual",,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,"Hallucination, auditory",,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Anxiety,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Psychotic disorder,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Depression,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231095801,23109580,18,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 Milligram Daily;,,,U,,,,,100.0,MG,,QD,2023,Q4,Suicidal ideation,,2023,Q4,1,I,,20231016.0,20231026,20231026,EXP,,CA-TEVA-2023-CA-2938113,TEVA,,56.0,YR,A,M,Y,,,20231026,,HP,CA,CA,2023,Q4,Adult
231158241,23115824,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,U,,,,300.0,MG,Unknown,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231158241,23115824,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,U,,,,300.0,MG,Unknown,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231158241,23115824,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,U,,,,100.0,MG,Unknown,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231158241,23115824,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 milligram,,,U,U,,,,100.0,MG,Unknown,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231160412,23116041,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, unknown",,,U,,,,,100.0,MG,Tablet,,2023,Q4,Helicobacter infection,,2023,Q4,2,F,20230701.0,20231115.0,20231027,20231121,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310013791,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20231121,,CN,JP,JP,2023,Q4,Elderly
231160412,23116041,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, unknown",,,U,,,,,100.0,MG,Tablet,,2023,Q4,Adenocarcinoma gastric,,2023,Q4,2,F,20230701.0,20231115.0,20231027,20231121,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310013791,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20231121,,CN,JP,JP,2023,Q4,Elderly
231164061,23116406,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231018.0,20231027,20231027,EXP,,CA-TEVA-2023-CA-2939045,TEVA,,76.0,YR,E,F,Y,,,20231027,,HP,CA,CA,2023,Q4,Elderly
231164061,23116406,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,100.0,MG,,,2023,Q4,Myopathy toxic,,2023,Q4,1,I,,20231018.0,20231027,20231027,EXP,,CA-TEVA-2023-CA-2939045,TEVA,,76.0,YR,E,F,Y,,,20231027,,HP,CA,CA,2023,Q4,Elderly
231296332,23129633,3,SS,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK, Oral Drug Unspecified Form",,,Y,,Unknown,,,,,,,2023,Q4,Pemphigoid,,2023,Q4,2,F,,20231108.0,20231031,20231109,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-154532,BRISTOL MYERS SQUIBB,"Irie K, Kikuchi N, Ishikawa M, Ito T, Endo M, Sato M, et al. Six cases of bullous pemphigoid after administration of anti-PD-1 antibody. The Japanese Journal of Dermatology. 2023;133(10):2373-84.",75.0,YR,E,M,Y,,,20231109,,MD,JP,JP,2023,Q4,Elderly
231303402,23130340,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,U,,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Gastric cancer stage IV,,2023,Q4,2,F,20230902.0,20231115.0,20231031,20231122,EXP,,JP-JNJFOC-20231077162,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20231122,,MD,JP,JP,2023,Q4,Elderly
231344444,23134444,3,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,Prolonged-release tablet,,,,,,,,,,Tablet,,2023,Q4,Product dose omission issue,,2023,Q4,4,F,20231012.0,20231117.0,20231101,20231210,30DAY,,US-JNJFOC-20231051658,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,85.806,KG,20231211,,CN,US,US,2023,Q4,Adult
231344444,23134444,3,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,Prolonged-release tablet,,,,,,,,,,Tablet,,2023,Q4,Accidental exposure to product,,2023,Q4,4,F,20231012.0,20231117.0,20231101,20231210,30DAY,,US-JNJFOC-20231051658,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,85.806,KG,20231211,,CN,US,US,2023,Q4,Adult
231344444,23134444,3,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Unknown,Prolonged-release tablet,,,,,,,,,,Tablet,,2023,Q4,Device deployment issue,,2023,Q4,4,F,20231012.0,20231117.0,20231101,20231210,30DAY,,US-JNJFOC-20231051658,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,85.806,KG,20231211,,CN,US,US,2023,Q4,Adult
231364871,23136487,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q4,Amputation,,2023,Q4,1,I,,20231026.0,20231102,20231102,EXP,GB-MHRA-MED-202310251144541800-QTDMS,GB-JNJFOC-20231065479,JOHNSON AND JOHNSON,,53.0,YR,A,F,Y,95.0,KG,20231102,,PH,GB,GB,2023,Q4,Adult
231401941,23140194,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,50/1000 2 times/day,,,,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,20231015.0,20231030.0,20231102,20231102,EXP,IT-MINISAL02-951614,IT-BAUSCH-BL-2023-016229,BAUSCH AND LOMB,,61.0,YR,,M,Y,88.0,KG,20231102,,MD,IT,IT,2023,Q4,Adult
231401941,23140194,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,50/1000 2 times/day,,,,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,1,I,20231015.0,20231030.0,20231102,20231102,EXP,IT-MINISAL02-951614,IT-BAUSCH-BL-2023-016229,BAUSCH AND LOMB,,61.0,YR,,M,Y,88.0,KG,20231102,,MD,IT,IT,2023,Q4,Adult
231401941,23140194,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,50/1000 2 times/day,,,,,,,,,,,,2023,Q4,Loss of consciousness,,2023,Q4,1,I,20231015.0,20231030.0,20231102,20231102,EXP,IT-MINISAL02-951614,IT-BAUSCH-BL-2023-016229,BAUSCH AND LOMB,,61.0,YR,,M,Y,88.0,KG,20231102,,MD,IT,IT,2023,Q4,Adult
231401941,23140194,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,50/1000 2 times/day,,,,,,,,,,,,2023,Q4,Oedema mouth,,2023,Q4,1,I,20231015.0,20231030.0,20231102,20231102,EXP,IT-MINISAL02-951614,IT-BAUSCH-BL-2023-016229,BAUSCH AND LOMB,,61.0,YR,,M,Y,88.0,KG,20231102,,MD,IT,IT,2023,Q4,Adult
231505651,23150565,4,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"UNK, daily",,,,,,,,,,Tablet,QD,2023,Q4,Cholangitis acute,,2023,Q4,1,I,20230911.0,20231025.0,20231106,20231106,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309009987,ELI LILLY AND CO,,78.0,YR,,M,Y,62.0,KG,20231106,,CN,JP,JP,2023,Q4,Elderly
231541512,23154151,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,,,,,,2023,Q4,Brain oedema,,2023,Q4,2,F,20231030.0,20231107.0,20231107,20231110,EXP,,JP-AstraZeneca-2023A251518,ASTRAZENECA,,95.0,YR,,F,Y,,,20231110,,PH,JP,,2023,Q4,Elderly
231543132,23154313,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2023,Q4,Interstitial lung disease,,2023,Q4,2,F,20231001.0,20231107.0,20231107,20231113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202310017365,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20231113,,CN,JP,JP,2023,Q4,Elderly
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure systolic increased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Mouth ulceration,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Body temperature decreased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Pemphigus,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231596002,23159600,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Heart rate increased,,2023,Q4,2,F,,20231219.0,20231108,20231222,EXP,,CA-SANDOZ INC.-NVSC2023CA055464,SANDOZ,,62.0,YR,,M,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Blood cholesterol increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Blood alkaline phosphatase increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Blood triglycerides increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Cystitis,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Blood lactate dehydrogenase increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Weight decreased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Protein urine present,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Blood magnesium increased,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231626762,23162676,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Glucose urine present,,2023,Q4,2,F,,20231121.0,20231109,20231201,EXP,,JP-EMD Serono-2023485713,EMD SERONO INC,,54.0,YR,A,F,Y,78.0,KG,20231201,,HP,JP,JP,2023,Q4,Adult
231671253,23167125,9,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,UNK,,,,,,,,,,Tablet,,2023,Q4,Heat illness,,2023,Q4,3,F,20230806.0,20231113.0,20231109,20231117,EXP,,JP-PFIZER INC-PV202300182812,PFIZER,,79.0,YR,,M,Y,50.0,KG,20231117,,MD,JP,JP,2023,Q4,Elderly
231672312,23167231,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Immune effector cell-associated neurotoxicity syndrome,,2023,Q4,2,F,20231011.0,20231115.0,20231109,20231116,EXP,ES-AEMPS-1441733,ES-GILEAD-2023-0650429,GILEAD,,62.0,YR,A,M,Y,60.0,KG,20231116,,PH,ES,ES,2023,Q4,Adult
231672312,23167231,7,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,,,,U,,,,,,,,,2023,Q4,Cytokine storm,,2023,Q4,2,F,20231011.0,20231115.0,20231109,20231116,EXP,ES-AEMPS-1441733,ES-GILEAD-2023-0650429,GILEAD,,62.0,YR,A,M,Y,60.0,KG,20231116,,PH,ES,ES,2023,Q4,Adult
231696241,23169624,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 milligram,,,U,U,,,204042.0,100.0,MG,Tablet,,2023,Q4,Cerebral infarction,,2023,Q4,1,I,,20231102.0,20231110,20231110,EXP,,JP-JNJFOC-20231127593,JOHNSON AND JOHNSON,"Muta D, Iwase M, Ide H, Aoya R, Hirata S, Takagi K, et al. [Case report: A case of type 2 diabetes mellitus complicated with posterior reversible encephalopathy syndrome (PRES) in which ASL perfusion-weighted image was useful for diagnosis] Journal of the Japan Diabetes Society. 2023.9.30;66:9:697-704",56.0,YR,A,M,Y,,,20231110,,MD,JP,JP,2023,Q4,Adult
231776501,23177650,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablet,,2023,Q4,Cholangitis sclerosing,Cholangitis sclerosing,2023,Q4,1,I,20220721.0,20231107.0,20231113,20231113,PER,,JP-Eisai-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231113,,MD,JP,JP,2023,Q4,Adult
231776501,23177650,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablet,,2023,Q4,Stomatitis,,2023,Q4,1,I,20220721.0,20231107.0,20231113,20231113,PER,,JP-Eisai-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231113,,MD,JP,JP,2023,Q4,Adult
231776501,23177650,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablet,,2023,Q4,Dehydration,,2023,Q4,1,I,20220721.0,20231107.0,20231113,20231113,PER,,JP-Eisai-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231113,,MD,JP,JP,2023,Q4,Adult
231776501,23177650,13,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,100.0,MG,Tablet,,2023,Q4,Colitis,Colitis,2023,Q4,1,I,20220721.0,20231107.0,20231113,20231113,PER,,JP-Eisai-EC-2022-121674,EISAI,,63.0,YR,A,M,Y,75.0,KG,20231113,,MD,JP,JP,2023,Q4,Adult
231790341,23179034,10,C,VOKANAMET [CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE],,2,Oral,1 tab 12/12 hours,,,,,,,,,,Film-coated tablet,BID,2023,Q4,Organising pneumonia,,2023,Q4,1,I,20230901.0,20231106.0,20231113,20231113,EXP,PT-INFARMED-B202310-714,PT-PFIZER INC-202300357538,PFIZER,,71.0,YR,,M,Y,,,20231113,,MD,PT,PT,2023,Q4,Elderly
231790341,23179034,10,C,VOKANAMET [CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE],,2,Oral,1 tab 12/12 hours,,,,,,,,,,Film-coated tablet,BID,2023,Q4,Respiratory failure,,2023,Q4,1,I,20230901.0,20231106.0,20231113,20231113,EXP,PT-INFARMED-B202310-714,PT-PFIZER INC-202300357538,PFIZER,,71.0,YR,,M,Y,,,20231113,,MD,PT,PT,2023,Q4,Elderly
231794001,23179400,8,C,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,,1 comp 12/12 hours,,,,,,,,,,"TABLET, FILM COATED",Q12H,2023,Q4,Organising pneumonia,,2023,Q4,1,I,20230902.0,20231107.0,20231113,20231113,EXP,PT-INFARMED-B202310-714,PT-ROCHE-3454295,ROCHE,,71.0,YR,,M,Y,,,20231114,,MD,PT,,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Lung opacity,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Off label use,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Insomnia,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Ichthyosis,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Xeroderma,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Nausea,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Upper respiratory tract infection,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Hepatic enzyme increased,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231795252,23179525,14,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300 mg,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,20230803.0,20231128.0,20231114,20231207,EXP,,NVSC2023US241329,NOVARTIS,,71.0,YR,,M,Y,59.1,KG,20231207,,MD,US,US,2023,Q4,Elderly
231796962,23179696,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231796962,23179696,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Renal impairment,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231796962,23179696,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231884661,23188466,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,,2023,Q4,Adverse drug reaction,,2023,Q4,1,I,20231109.0,20231113.0,20231115,20231115,EXP,GB-MHRA-TPP34827409C4992681YC1699536992696,GB-SANDOZ INC.-SDZ2023GB054155,SANDOZ,,43.0,YR,,F,Y,66.0,KG,20231115,,HP,GB,GB,2023,Q4,Adult
231914933,23191493,47,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,,QD,2023,Q4,Interstitial lung disease,,2023,Q4,3,F,20230927.0,20231213.0,20231116,20231218,EXP,,JP-DSJP-DSJ-2023-142661,DAIICHI,,49.0,YR,,F,Y,64.0,KG,20231218,,MD,JP,JP,2023,Q4,Adult
231914933,23191493,47,C,CANAGLIFLOZIN\TENELIGLIPTIN,CANAGLIFLOZIN\TENELIGLIPTIN,1,Oral,"1 DF, qd",,,,,,,,,,,QD,2023,Q4,Pneumocystis jirovecii pneumonia,,2023,Q4,3,F,20230927.0,20231213.0,20231116,20231218,EXP,,JP-DSJP-DSJ-2023-142661,DAIICHI,,49.0,YR,,F,Y,64.0,KG,20231218,,MD,JP,JP,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Depression,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Depression,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,16,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231982221,23198222,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 mg,,,U,,,,,100.0,MG,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
231982221,23198222,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,100 mg,,,U,,,,,100.0,MG,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
231982221,23198222,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,U,,,,,300.0,MG,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
231982221,23198222,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 mg,,,U,,,,,300.0,MG,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232056601,23205660,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,204042.0,,,Tablet,,2023,Q4,Acidosis,,2023,Q4,1,I,,20231112.0,20231120,20231120,EXP,,US-JNJFOC-20231144024,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,,,20231120,,HP,US,US,2023,Q4,Young Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Depression,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232076481,23207648,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Headache,,2023,Q4,1,I,20231107.0,20231113.0,20231120,20231120,EXP,GB-MHRA-TPP7482975C2182674YC1699369912532,GB-JNJFOC-20231134039,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,83.0,KG,20231121,,MD,GB,GB,2023,Q4,Elderly
232076481,23207648,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Abdominal pain,,2023,Q4,1,I,20231107.0,20231113.0,20231120,20231120,EXP,GB-MHRA-TPP7482975C2182674YC1699369912532,GB-JNJFOC-20231134039,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,83.0,KG,20231121,,MD,GB,GB,2023,Q4,Elderly
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Respiratory rate increased,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Oliguria,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Decreased immune responsiveness,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Symptom recurrence,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Hypokalaemia,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Feeling abnormal,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Hypotension,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Defaecation disorder,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232078732,23207873,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 mg, QD",300.0,MG,Y,,230517202,,,100.0,MG,Tablet,QD,2023,Q4,Volume blood decreased,,2023,Q4,2,F,20231109.0,20231113.0,20231121,20231124,EXP,,NVSC2023CN243435,NOVARTIS,,51.0,YR,,F,Y,65.0,KG,20231124,,HP,CN,CN,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Depression,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Asthma,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232100751,23210075,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,preferably before b...,2104.16666,MG,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Eye pruritus,,2023,Q4,1,I,20231030.0,20231115.0,20231121,20231121,EXP,GB-MHRA-TPP24659615C10320227YC1699445056017,GB-JNJFOC-20231141161,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,114.0,KG,20231121,,MD,GB,GB,2023,Q4,Elderly
232100751,23210075,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,preferably before b...,2104.16666,MG,U,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Rash erythematous,,2023,Q4,1,I,20231030.0,20231115.0,20231121,20231121,EXP,GB-MHRA-TPP24659615C10320227YC1699445056017,GB-JNJFOC-20231141161,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,114.0,KG,20231121,,MD,GB,GB,2023,Q4,Elderly
232133651,23213365,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,204042.0,,,Tablet,,2023,Q4,Therapeutic response decreased,,2023,Q4,1,I,,20231106.0,20231121,20231121,EXP,,JP-JNJFOC-20231136445,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20231121,,MD,JP,JP,2023,Q4,Adult
232133651,23213365,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,204042.0,,,Tablet,,2023,Q4,Hospitalisation,,2023,Q4,1,I,,20231106.0,20231121,20231121,EXP,,JP-JNJFOC-20231136445,JOHNSON AND JOHNSON,,43.0,YR,A,M,Y,,,20231121,,MD,JP,JP,2023,Q4,Adult
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Hip arthroplasty,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Osteoarthritis,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Device dislocation,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232200483,23220048,4,C,CANAGLIFLOZIN;METFORMIN,,1,,,,,,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,3,F,20230727.0,20231120.0,20231122,20231201,EXP,,US-ABBVIE-5506096,ABBVIE,,75.0,YR,,F,Y,68.0,KG,20231201,,HP,US,US,2023,Q4,Elderly
232256961,23225696,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,take one daily,,,U,,,,,,,UNK,,2023,Q4,Malaise,,2023,Q4,1,I,20231109.0,20231113.0,20231124,20231124,EXP,GB-MHRA-TPP34827409C4992681YC1699536992696,GB-TORRENT-00033977,TORRENT,,43.0,YR,A,F,Y,66.0,KG,20231124,,HP,GB,GB,2023,Q4,Adult
232331961,23233196,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,204042.0,300.0,MG,Tablet,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20231121.0,20231128,20231128,EXP,,US-JNJFOC-20231163172,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
232331961,23233196,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,U,,,,204042.0,,,,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20231121.0,20231128,20231128,EXP,,US-JNJFOC-20231163172,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
232361901,23236190,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,take one daily,,,U,,,,,,,,,2023,Q4,Malaise,,2023,Q4,1,I,20231109.0,20231114.0,20231128,20231128,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-420679,RANBAXY,,43.0,YR,,F,Y,66.0,KG,20231128,,HP,GB,GB,2023,Q4,Adult
232381641,23238164,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-drreddys-LIT/USA/23/0187166,DR REDDYS,"Manas F, Mols-Kowalczewski B, Mandal S. Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor. Journal of the Endocrine Society. 2023;5 (SUPPL. 1):A381-A382. doi:/10.1210/jendso/bvab048.777",52.0,YR,A,M,Y,,,20231129,,HP,US,US,2023,Q4,Adult
232382902,23238290,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,unknown,,,,,Tablet,,2023,Q4,Pancreatic carcinoma,,2023,Q4,2,F,20231027.0,20231128.0,20231129,20231208,EXP,,JP-NOVOPROD-1143909,NOVO NORDISK,,49.0,YR,,M,Y,,,20231208,,MD,JP,JP,2023,Q4,Adult
232401752,23240175,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,U,,,204042.0,,,Tablet,,2023,Q4,Lung adenocarcinoma,,2023,Q4,2,F,,20231205.0,20231129,20231213,EXP,,JP-JNJFOC-20231179557,JOHNSON AND JOHNSON,"Fujita T, Naemura Y. P23-10 A case of pure solid lung adenocarcinoma which was negative for FDG-PET. Japanese Journal of Lung Cancer. The 64th Annual Meeting of the Japan Lung Cancer Society. 2023.10. 1; 2023.11.2, 3, 4; 63:5:625",62.0,YR,A,F,Y,,,20231214,,MD,JP,JP,2023,Q4,Adult
232430491,23243049,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Emphysematous cystitis,,2023,Q4,1,I,,20231122.0,20231130,20231130,EXP,,JP-JNJFOC-20231179481,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,,,20231130,,MD,JP,JP,2023,Q4,Child
232434041,23243404,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,300mg OD; ;,,,Y,U,,,204042.0,,,Tablet,,2023,Q4,Prostatitis,,2023,Q4,1,I,20231123.0,20231124.0,20231130,20231130,EXP,GB-MHRA-MED-202311231140404450-WFTKZ,GB-JNJFOC-20231169013,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,94.0,KG,20231130,,PH,GB,GB,2023,Q4,Elderly
232576481,23257648,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,Unknown,,2023,Q4,Hypovolaemia,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-MYLANLABS-2023M1126781,MYLAN,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. J-Endocr-Soc 2022; 6 (Suppl.) A307.",48.0,YR,,F,Y,,,20231204,,HP,US,US,2023,Q4,Adult
232576481,23257648,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,Unknown,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-MYLANLABS-2023M1126781,MYLAN,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. J-Endocr-Soc 2022; 6 (Suppl.) A307.",48.0,YR,,F,Y,,,20231204,,HP,US,US,2023,Q4,Adult
232700781,23270078,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,Tablet,,2023,Q4,Dehydration,,2023,Q4,1,I,,20231130.0,20231207,20231207,EXP,,JP-JNJFOC-20231213025,JOHNSON AND JOHNSON,,6.0,DEC,A,M,Y,,,20231207,,PH,JP,JP,2023,Q4,Child
232700781,23270078,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,Tablet,,2023,Q4,Restlessness,,2023,Q4,1,I,,20231130.0,20231207,20231207,EXP,,JP-JNJFOC-20231213025,JOHNSON AND JOHNSON,,6.0,DEC,A,M,Y,,,20231207,,PH,JP,JP,2023,Q4,Child
232705311,23270531,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231127.0,20231207,20231207,EXP,,US-AUROBINDO-AUR-APL-2023-076283,AUROBINDO,"Manas F, Mols-Kowalczewski BL, Mandal S. Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor. Journal of the Endocrine Society. 2021;5 (Suppl. 1):A381-A382",52.0,YR,,M,Y,,,20231207,,MD,US,US,2023,Q4,Adult
232848332,23284833,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,Unknown,,,100.0,MG,Tablet,QD,2023,Q4,Renal failure,,2023,Q4,2,F,,20231205.0,20231211,20231215,EXP,,JP-EMD Serono-2023491868,EMD SERONO INC,"Omura I, Omura I. Two cases of acute kidney injury caused by continued oral administration of SGLT2 inhibitors during the summer. Japan Diabetes Society Kyushu Regional Association.",82.0,YR,E,M,Y,,,20231215,,HP,JP,JP,2023,Q4,Elderly
232891821,23289182,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231127.0,20231212,20231212,EXP,,US-TEVA-VS-3134794,TEVA,"Manas F, Mols-Kowalczewski BL, Mandal S. Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor. J-Endocr-Soc 2021; 5 (Suppl. 1) A381-A382.",52.0,YR,,,Y,,,20231212,,MD,US,US,2023,Q4,Adult
232891821,23289182,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231127.0,20231212,20231212,EXP,,US-TEVA-VS-3134794,TEVA,"Manas F, Mols-Kowalczewski BL, Mandal S. Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor. J-Endocr-Soc 2021; 5 (Suppl. 1) A381-A382.",52.0,YR,,,Y,,,20231212,,MD,US,US,2023,Q4,Adult
232902461,23290246,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,"1 DF, qd",,,,,,,,,,,QD,2023,Q4,Adverse drug reaction,,2023,Q4,1,I,20231204.0,20231205.0,20231213,20231213,EXP,GB-MHRA-TPP12521391C4431630YC1701681400631,GB-SANDOZ INC.-SDZ2023GB064287,SANDOZ,,69.0,YR,,M,Y,124.0,KG,20231213,,MD,GB,GB,2023,Q4,Elderly
232947562,23294756,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,100.0,MG,Tablet,QD,2023,Q4,Pancreatitis acute,,2023,Q4,2,F,,20231211.0,20231213,20231219,EXP,,JP-BAUSCHBL-2023BNL013165,BAUSCH AND LOMB,,4.0,DEC,,M,Y,98.0,KG,20231219,,MD,JP,JP,2023,Q4,Child
232950251,23295025,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20230828.0,20231213,20231213,EXP,GB-MHRA-ADR 28139272,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09995,ALKEM,,64.0,YR,,,Y,,,20231214,,PH,GB,GB,2023,Q4,Adult
232959792,23295979,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Metabolic acidosis,,2023,Q4,2,F,20230806.0,20231204.0,20231214,20231219,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-422606,RANBAXY,,65.0,YR,,M,Y,,,20231219,,MD,IT,IT,2023,Q4,Elderly
232959792,23295979,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,2,F,20230806.0,20231204.0,20231214,20231219,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-422606,RANBAXY,,65.0,YR,,M,Y,,,20231219,,MD,IT,IT,2023,Q4,Elderly
232959792,23295979,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood potassium increased,,2023,Q4,2,F,20230806.0,20231204.0,20231214,20231219,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-422606,RANBAXY,,65.0,YR,,M,Y,,,20231219,,MD,IT,IT,2023,Q4,Elderly
232959792,23295979,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,2,F,20230806.0,20231204.0,20231214,20231219,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-422606,RANBAXY,,65.0,YR,,M,Y,,,20231219,,MD,IT,IT,2023,Q4,Elderly
232982961,23298296,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018449,BAUSCH AND LOMB,UNKNOWN. Unspecified medical literature article. Unspecified medical literature journal.,55.0,YR,,F,Y,,,20231214,,HP,CA,CA,2023,Q4,Adult
232982961,23298296,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Ketoacidosis,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018449,BAUSCH AND LOMB,UNKNOWN. Unspecified medical literature article. Unspecified medical literature journal.,55.0,YR,,F,Y,,,20231214,,HP,CA,CA,2023,Q4,Adult
232995261,23299526,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,,Unknown,,,,,Tablet,,2023,Q4,Alopecia,,2023,Q4,1,I,20230201.0,20231204.0,20231215,20231215,EXP,,JP-NOVOPROD-1070503,NOVO NORDISK,,6.0,DEC,,F,Y,,,20231215,,PH,JP,JP,2023,Q4,Child
233000981,23300098,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,take one daily,,,U,,,,,,,UNK,,2023,Q4,Ocular myasthenia,,2023,Q4,1,I,20231204.0,20231205.0,20231215,20231215,EXP,GB-MHRA-TPP12521391C4431630YC1701681400631,GB-TORRENT-00034295,TORRENT,,69.0,YR,E,M,Y,124.0,KG,20231215,,MD,GB,GB,2023,Q4,Elderly
233055621,23305562,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Dizziness,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Decreased appetite,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Dehydration,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 milligram, qd",,,Y,U,,,204042.0,100.0,MG,Tablet,QD,2023,Q4,Malaise,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,204042.0,,,Tablet,,2023,Q4,Dizziness,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,204042.0,,,Tablet,,2023,Q4,Decreased appetite,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,204042.0,,,Tablet,,2023,Q4,Dehydration,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233055621,23305562,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,204042.0,,,Tablet,,2023,Q4,Malaise,,2023,Q4,1,I,20230907.0,20231208.0,20231218,20231218,EXP,,JP-JNJFOC-20231077125,JOHNSON AND JOHNSON,,91.0,YR,E,F,Y,,,20231218,,MD,JP,JP,2023,Q4,Elderly
233063781,23306378,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,20231017.0,20231206.0,20231218,20231218,EXP,CN-NMPA-3501031031611202301247,CN-NOVOPROD-1151018,NOVO NORDISK,,72.0,YR,,M,Y,,,20231218,,HP,CN,CN,2023,Q4,Elderly
233063781,23306378,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2023,Q4,White blood cell count decreased,,2023,Q4,1,I,20231017.0,20231206.0,20231218,20231218,EXP,CN-NMPA-3501031031611202301247,CN-NOVOPROD-1151018,NOVO NORDISK,,72.0,YR,,M,Y,,,20231218,,HP,CN,CN,2023,Q4,Elderly
233147011,23314701,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,,,,,,2023,Q4,Hypovolaemia,,2023,Q4,1,I,,20231204.0,20231219,20231219,EXP,,US-TEVA-VS-3136536,TEVA,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. J-Endocr-Soc 2022; 6 (Suppl.) A307.",48.0,YR,,,Y,,,20231219,,HP,US,US,2023,Q4,Adult
233147011,23314701,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,,,,,,2023,Q4,Acidosis,,2023,Q4,1,I,,20231204.0,20231219,20231219,EXP,,US-TEVA-VS-3136536,TEVA,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. J-Endocr-Soc 2022; 6 (Suppl.) A307.",48.0,YR,,,Y,,,20231219,,HP,US,US,2023,Q4,Adult
233147011,23314701,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,Y,U,,,,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231204.0,20231219,20231219,EXP,,US-TEVA-VS-3136536,TEVA,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. J-Endocr-Soc 2022; 6 (Suppl.) A307.",48.0,YR,,,Y,,,20231219,,HP,US,US,2023,Q4,Adult
233179381,23317938,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,204042.0,,,Tablet,,2023,Q4,Cardio-respiratory arrest,,2023,Q4,1,I,,20231212.0,20231219,20231219,EXP,,JP-JNJFOC-20231251127,JOHNSON AND JOHNSON,"Oda R, Nakayama S, Asaba K, Kutsumayaya N, Komatsu J, and Mitomori K. 2-D-01 A case of cardiopulmonary arrest due to euglycemic ketoacidosis during use of SGLT2 inhibitors. The 61st Chugoku and Shikoku Regional Meeting of Japan Diabetes Society. 2023.10.27,28; 82",9.0,DEC,E,F,Y,,,20231220,,MD,JP,JP,2023,Q4,Child
233179381,23317938,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,U,,,,204042.0,,,Tablet,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231212.0,20231219,20231219,EXP,,JP-JNJFOC-20231251127,JOHNSON AND JOHNSON,"Oda R, Nakayama S, Asaba K, Kutsumayaya N, Komatsu J, and Mitomori K. 2-D-01 A case of cardiopulmonary arrest due to euglycemic ketoacidosis during use of SGLT2 inhibitors. The 61st Chugoku and Shikoku Regional Meeting of Japan Diabetes Society. 2023.10.27,28; 82",9.0,DEC,E,F,Y,,,20231220,,MD,JP,JP,2023,Q4,Child
233205631,23320563,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,Tablet,,2023,Q4,Dry skin,,2023,Q4,1,I,,20231214.0,20231220,20231220,EXP,,US-JNJFOC-20231243236,JOHNSON AND JOHNSON,,61.0,YR,A,M,Y,,,20231220,,CN,US,US,2023,Q4,Adult
233205631,23320563,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,204042.0,,,,,2023,Q4,Dry skin,,2023,Q4,1,I,,20231214.0,20231220,20231220,EXP,,US-JNJFOC-20231243236,JOHNSON AND JOHNSON,,61.0,YR,A,M,Y,,,20231220,,CN,US,US,2023,Q4,Adult
233249091,23324909,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q4,Emphysematous cystitis,,2023,Q4,1,I,,20231212.0,20231221,20231221,EXP,,JP-JNJFOC-20231257778,JOHNSON AND JOHNSON,"Fujiwara H, Hara N, Hamakoji M, Takano E, Nakamura U, Nakamura U. [1-4-7 A case of type 2 diabetes mellitus in which emphysematous cystitis with septic shock developed after administration of SGLT2 inhibitors] The 61st Kyushu Branch Meeting of the Japan Diabetes Society. 2023.12.1,2;153",92.0,YR,E,F,Y,,,20231221,,MD,JP,JP,2023,Q4,Elderly
233249091,23324909,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,204042.0,,,Tablet,,2023,Q4,Septic shock,,2023,Q4,1,I,,20231212.0,20231221,20231221,EXP,,JP-JNJFOC-20231257778,JOHNSON AND JOHNSON,"Fujiwara H, Hara N, Hamakoji M, Takano E, Nakamura U, Nakamura U. [1-4-7 A case of type 2 diabetes mellitus in which emphysematous cystitis with septic shock developed after administration of SGLT2 inhibitors] The 61st Kyushu Branch Meeting of the Japan Diabetes Society. 2023.12.1,2;153",92.0,YR,E,F,Y,,,20231221,,MD,JP,JP,2023,Q4,Elderly
233274841,23327484,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,take one daily,,,U,,,,,,,,,2023,Q4,Adverse drug reaction,,2023,Q4,1,I,20231204.0,20231206.0,20231221,20231221,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-423945,RANBAXY,,69.0,YR,,M,Y,124.0,KG,20231221,,MD,GB,GB,2023,Q4,Elderly
233340051,23334005,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231215.0,20231223,20231223,EXP,,CA-APOTEX-2023AP018207,APOTEX,,55.0,YR,,F,Y,,,20231223,,HP,CA,CA,2023,Q4,Adult
233340051,23334005,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,300 milligram,,,U,,,,,300.0,MG,Tablet,,2023,Q4,Ketoacidosis,,2023,Q4,1,I,,20231215.0,20231223,20231223,EXP,,CA-APOTEX-2023AP018207,APOTEX,,55.0,YR,,F,Y,,,20231223,,HP,CA,CA,2023,Q4,Adult
233355371,23335537,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,Y,,Unknown,,,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231212.0,20231225,20231225,EXP,,US-862174955-ML2023-07383,Unknown Manufacturer,"Mason T, Ansar S. Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM. Journal of the Endocrine Society. 2022;Suppl 1(Volume 6): A 307. doi:10.1210/jendso/bvac150.635.",48.0,YR,A,F,Y,,,20231225,,HP,US,US,2023,Q4,Adult
